<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Psychological interventions for post‐traumatic stress disorder (PTSD) in people with severe mental illness - Sin, J - 2017 | Cochrane Library</title> <meta content="Psychological interventions for post‐traumatic stress disorder (PTSD) in people with severe mental illness - Sin, J - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011464.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Psychological interventions for post‐traumatic stress disorder (PTSD) in people with severe mental illness - Sin, J - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011464.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011464.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Psychological interventions for post‐traumatic stress disorder (PTSD) in people with severe mental illness" name="citation_title"/> <meta content="Jacqueline Sin" name="citation_author"/> <meta content="King's College London" name="citation_author_institution"/> <meta content="Jacqueline.sin@kcl.ac.uk" name="citation_author_email"/> <meta content="Debbie Spain" name="citation_author"/> <meta content="King's College London" name="citation_author_institution"/> <meta content="Marie Furuta" name="citation_author"/> <meta content="Graduate School of Medicine, Kyoto University" name="citation_author_institution"/> <meta content="Trevor Murrells" name="citation_author"/> <meta content="King's College London" name="citation_author_institution"/> <meta content="Ian Norman" name="citation_author"/> <meta content="King's College London" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD011464.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/01/24" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011464.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011464.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011464.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Cognitive Behavioral Therapy [*methods]; Eye Movement Desensitization Reprocessing [*methods]; Mental Disorders [*psychology]; Psychotherapy, Brief [*methods]; Quality of Life; Randomized Controlled Trials as Topic; Stress Disorders, Post‐Traumatic [etiology, *therapy]; Waiting Lists" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011464.pub2&amp;doi=10.1002/14651858.CD011464.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="18M35a5z";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011464\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011464\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","ms","hr","fr","pl","th","ja","fa","zh_HANT"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011464.pub2",title:"Psychological interventions for post\\u2010traumatic stress disorder (PTSD) in people with severe mental illness",firstPublishedDate:"Jan 24, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Schizophrenia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011464.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011464.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011464.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011464.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011464.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011464.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011464.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011464.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011464.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011464.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>16174 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011464.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-sec-0204"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-sec-0117"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-sec-0193"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/table_n/CD011464StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/table_n/CD011464StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Psychological interventions for post‐traumatic stress disorder (PTSD) in people with severe mental illness </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/information#CD011464-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Jacqueline Sin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/information#CD011464-cr-0003">Debbie Spain</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/information#CD011464-cr-0004">Marie Furuta</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/information#CD011464-cr-0005">Trevor Murrells</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011464.pub2/information#CD011464-cr-0006">Ian Norman</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/information/en#CD011464-sec-0213">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 24 January 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011464.pub2">https://doi.org/10.1002/14651858.CD011464.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011464-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011464-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011464-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011464-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011464-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD011464-abs-0013">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011464-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011464-abs-0001" lang="en"> <section id="CD011464-sec-0001"> <h3 class="title" id="CD011464-sec-0001">Background</h3> <p>Increasing evidence indicates that individuals who develop severe mental illness (SMI) are also vulnerable to developing post‐traumatic stress disorder (PTSD), due to increased risk of exposure to traumatic events and social adversity. The effectiveness of trauma‐focused psychological interventions (TFPIs) for PTSD in the general population is well‐established. TFPIs involve identifying and changing unhelpful beliefs about traumatic experiences, processing of traumatic memories, and developing new ways of responding to cues associated with trauma. Little is known about the potential feasibility, acceptability and effectiveness of TFPIs for individuals who have a SMI and PTSD. </p> </section> <section id="CD011464-sec-0002"> <h3 class="title" id="CD011464-sec-0002">Objectives</h3> <p>To evaluate the effectiveness of psychological interventions for PTSD symptoms or other symptoms of psychological distress arising from trauma in people with SMI. </p> </section> <section id="CD011464-sec-0003"> <h3 class="title" id="CD011464-sec-0003">Search methods</h3> <p>We searched the Cochrane Schizophrenia Group’s Trials Study‐Based Register (up until March 10, 2016), screened reference lists of relevant reports and reviews, and contacted trial authors for unpublished and/or specific outcome data. </p> </section> <section id="CD011464-sec-0004"> <h3 class="title" id="CD011464-sec-0004">Selection criteria</h3> <p>We included all relevant randomised controlled trials (RCTs) which investigated TFPIs for people with SMI and PTSD, and reported useable data. </p> </section> <section id="CD011464-sec-0005"> <h3 class="title" id="CD011464-sec-0005">Data collection and analysis</h3> <p>Three review authors (DS, MF, IN) independently screened the titles and abstracts of all references identified, and read short‐listed full text papers. We assessed risk of bias in each case. We calculated the risk ratio (RR) and 95% confidence interval (CI) for binary outcomes, and the mean difference (MD) and 95% CI for continuous data, on an intention‐to‐treat basis. We assessed quality of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) and created 'Summary of findings' tables. </p> </section> <section id="CD011464-sec-0006"> <h3 class="title" id="CD011464-sec-0006">Main results</h3> <p>Four trials involving a total of 300 adults with SMI and PTSD are included. These trials evaluated three active intervention therapies: trauma‐focused cognitive behavioural therapy (TF‐CBT), eye movement desensitisation and reprocessing (EMDR), and brief psychoeducation for PTSD, all delivered via individual sessions. Our main outcomes of interest were PTSD symptoms, quality of life/well‐being, symptoms of co‐morbid psychosis, anxiety symptoms, depressive symptoms, adverse events and health economic outcomes. </p> <p><i>1. TF‐CBT versus usual care/waiting list</i> </p> <p>Three trials provided data for this comparison, however, continuous outcome data available were more often found to be skewed than unskewed, leading to the necessity of conducting analyses separately for the two types of continuous data. Using the unskewed data only, results showed no significant differences between TF‐CBT and usual care in reducing clinician‐rated PTSD symptoms at short term (1 RCT, n =13, MD 13.15, 95% CI ‐4.09 to 30.39,<i>low‐quality evidence</i> ). Limited unskewed data showed equivocal results between groups in terms of general quality of life (1 RCT, n = 39, MD ‐0.60, 95% CI ‐4.47 to 3.27, <i>low‐quality evidence</i> ), symptoms of psychosis (1 RCT, n = 9, MD ‐6.93, 95% CI ‐34.17 to 20.31, <i>low‐quality evidence</i> ), and anxiety (1 RCT, n = 9, MD 12.57, 95% CI ‐5.54 to 30.68, <i>very low‐quality evidence</i> ), at medium term. The only available data on depression symptoms were skewed and were equivocal across groups at medium term (2 RCTs, n = 48, MD 3.26, 95% CI ‐3.66 to 10.18, <i>very low‐quality evidence</i> ). TF‐CBT was not associated with more adverse events (1 RCT, n = 100, RR 0.44, 95% CI 0.09 to 2.31, <i>low‐quality evidence</i>) at medium term. No data were available for health economic outcomes. Very limited data for PTSD and other symptoms were available over the long term. </p> <p><i>2. EMDR versus waiting list</i> </p> <p>One trial provided data for this comparison. Favourable effects were found for EMDR in terms of PTSD symptom severity at medium term but data were skewed (1 RCT, n = 83, MD ‐12.31, 95% CI ‐22.72 to ‐1.90, <i>very low‐quality evidence).</i> EMDR was not associated with more adverse events (1 RCT, n = 102, RR 0.21, 95% CI 0.02 to 1.85, <i>low‐quality evidence</i>). No data were available for quality of life, symptoms of co‐morbid psychosis, depression, anxiety and health economics. </p> <p>3. <i>TF‐CBT versus EMDR</i> </p> <p>One trial compared TF‐CBT with EMDR. PTSD symptom severity, based on skewed data (1 RCT, n = 88, MD ‐1.69, 95% CI ‐12.63 to 9.23, <i>very low‐quality evidence</i>) was similar between treatment groups. No data were available for the other main outcomes. </p> <p>4. <i>TF‐CBT versus psychoeducation</i> </p> <p>One trial compared TF‐CBT with psychoeducation. Results were equivocal for PTSD symptom severity (1 RCT, n = 52, MD 0.23, 95% CI ‐14.66 to 15.12, <i>low‐quality evidence</i> ) and general quality of life (1 RCT, n = 49, MD 0.11, 95% CI ‐0.74 to 0.95, <i>low‐quality evidence</i>) by medium term. No data were available for the other outcomes of interest. </p> </section> <section id="CD011464-sec-0007"> <h3 class="title" id="CD011464-sec-0007">Authors' conclusions</h3> <p>Very few trials have investigated TFPIs for individuals with SMI and PTSD. Results from trials of TF‐CBT are limited and inconclusive regarding its effectiveness on PTSD, or on psychotic symptoms or other symptoms of psychological distress. Only one trial evaluated EMDR and provided limited preliminary evidence favouring EMDR compared to waiting list. Comparing TF‐CBT head‐to‐head with EMDR and brief psychoeducation respectively, showed no clear effect for either therapy. Both TF‐CBT and EMDR do not appear to cause more (or less) adverse effects, compared to waiting list or usual care; these findings however, are mostly based on <i>low to very low‐quality</i> evidence. Further larger scale trials are now needed to provide high‐quality evidence to confirm or refute these preliminary findings, and to establish which intervention modalities and techniques are associated with improved outcomes, especially in the long term. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011464-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011464-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011464-abs-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011464-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011464-abs-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011464-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011464-abs-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD011464-abs-0015">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011464-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD011464-abs-0011">Polski</a> </li> <li class="section-language"> <a class="" href="full/th#CD011464-abs-0014">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011464-abs-0007">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD011464-abs-0018">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011464-abs-0005" lang="en"> <h3>Psychological interventions for post‐traumatic stress disorder (PTSD) in people with severe mental illness </h3> <p><i>Background</i> </p> <p>Post‐traumatic stress disorder (PTSD) typically develops after a traumatic event is experienced or witnessed by an individual, or may develop when trauma is experienced by someone close to them. There is growing evidence that people with a severe mental illness (SMI) are vulnerable to developing PTSD due to increased risk of childhood and adulthood trauma. It is estimated that around a third of individuals with SMI also suffer from PTSD. A number of psychological interventions are available for the treatment of PTSD which are collectively known as 'trauma‐focused psychological interventions' (TFPIs). </p> <p><i>Searching for evidence</i> </p> <p>We searched the Cochrane Schizophrenia Group Trial's Register in January 2015 and March 2016 and found four relevant studies involving 300 adults diagnosed with both SMI and PTSD. The participants received treatments that included trauma‐focused cognitive behavioural therapy (TF‐CBT), eye movement desensitisation and reprocessing (EMDR), and brief psychoeducation. All of these therapies support individuals to work through and process the memories, emotions and behaviours associated with trauma. </p> <p><i>Key results</i> </p> <p>When TF‐CBT was compared to the care usually received, no effect for reducing PTSD, psychotic, depressive or anxiety symptoms or improving quality of life, was noted. There was some low‐quality evidence from two studies that people with SMI and PTSD receiving TF‐CBT were more likely to recover from PTSD, that is, having PTSD symptoms which are below diagnostic threshold. TF‐CBT was not linked to an increase in side effects. </p> <p>A comparison of people receiving EMDR against those awaiting treatment showed a favourable effect for reducing the symptoms of PTSD (very low‐quality evidence). Again, there was no difference in side effects. No data were available for the effect of EMDR on quality of life, psychosis, depression or anxiety. </p> <p>A comparison of TF‐CBT with EMDR indicated no difference in reduction of PTSD symptom severity (very low‐quality evidence). </p> <p>Finally, when TF‐CBT was compared with brief psychoeducation there was no evidence that either therapy was superior in treating a range of PTSD symptoms. </p> <p><i>Quality of the evidence</i> </p> <p>The review identifies limited, low‐quality evidence on TF‐CBT and EMDR. The effects of these treatments in reducing the symptoms of PTSD remain unclear although they do not appear to cause any more side effects than waiting for treatment. However, many important outcomes of interest have not been reported on and more research into the benefits of trauma‐focused psychological interventions for individuals with SMI and PTSD is required. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011464-sec-0204" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011464-sec-0204"></div> <h3 class="title" id="CD011464-sec-0205">Implications for practice</h3> <section id="CD011464-sec-0205"> <section id="CD011464-sec-0206"> <h5 class="title">For people with co‐morbid psychosis and post‐traumatic stress disorder (PTSD)</h5> <p>Existing reviews support the effectiveness of trauma‐focused cognitive behavioural therapy (TF‐CBT) and eye movement desensitisation and reprocessing (EMDR) for PTSD in the general population. TF‐CBT and EMDR may be more effective than usual care in promoting recovery from PTSD in the medium term; however the evidence for this is drawn from one or two trials in which all participants also received support from multi‐disciplinary mental health services rather than trauma‐focused psychological interventions (TFPIs) alone. Due to the limited data available from the few studies carried out to date, the review findings on TF‐CBT and EMDR, in terms of their effect on PTSD symptoms, psychotic and other mood and anxiety symptoms remain inconclusive. The evidence‐base and availability of TFPIs should be made known to service users who could use this to consider and access treatment. </p> </section> <section id="CD011464-sec-0207"> <h5 class="title">For clinicians</h5> <p>Clinicians should be alerted to the potentially increased risk of co‐morbidity of PTSD and SMI. Increased knowledge in working with the co‐morbid illnesses should enhance clinicians' understanding of the often complex presentations of symptoms and needs of service users. This increased awareness may optimise the timely and early assessment of PTSD among people with psychosis. This review has provided some preliminary and limited evidence for the feasibility and safety of TF‐CBT and EMDR for individuals with SMI and PTSD, although its effectiveness on improving PTSD, psychotic and other symptoms remain unclear. Clinicians should consider these treatments for mental health service users on an individual basis, as an adjunct to support from a multi‐disciplinary mental health service. </p> </section> <section id="CD011464-sec-0208"> <h5 class="title">For policy makers</h5> <p>Although this review provides some preliminary albeit low‐quality evidence on the feasibility and safety of TF‐CBT and EMDR, targeting service users with SMI and PTSD, the results of treatment effect on PTSD, psychotic and other symptoms are largely equivocal. Due to a small number of studies of the effects of TFPIs for this co‐morbid population, there were limited data, often from only one study, available for the outcomes under investigation for each modality of therapy. Meta‐analysis was precluded on many outcomes, and the few analyses undertaken likely lack power. Given that people with SMI require support from multi‐disciplinary mental health services, it would be unwise to rely upon evidence from existing reviews of TF‐CBT for the general population to guide treatment of people with co‐morbid SMI and PTSD. Thus more research is needed of the effectiveness of TFPIs for people with SMI and PTSD to establish the clinical and cost‐effectiveness of the intervention with this co‐morbid client group. </p> </section> </section> <h3 class="title" id="CD011464-sec-0209">Implications for research</h3> <section id="CD011464-sec-0209"> <p>In general, this review shows that there is a lack of studies exploring PTSD psychological treatment for people with SMI, contrary to their increased vulnerability to developing PTSD and the implications of untreated PTSD in their general prognosis. Despite the small number of trials included in this review, we were pleased to have been able to include three emerging trials (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>), which reflect a significant increase of research and clinical interests in this subject over the recent years. The preliminary findings from the few pioneering trials, need support from further studies including sample sizes powered to detect clinically significant changes in PTSD symptoms and quality of life/well‐being in individuals with SMI and PTSD. We expect to see further long‐term follow‐up data from the included studies alongside other new studies in the coming years which will help expand the evidence base of TFPIs for the co‐morbid populations. In addition to extending the follow‐up duration to provide data on long‐term effects of treatments, future studies should also strive to explore health economic outcomes to inform cost‐effectiveness of treatment and policy development. </p> <p> As most of the included studies focused on people with long‐standing psychotic disorders and chronic and/or severe PTSD (e.g. onset of PTSD = 17 years in <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>; the average age of participants was mid‐40s in <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>, <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>, and <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>), such patient profiles raise some suggestions for future research. More research efforts focusing on younger people with early‐onset psychosis and/or more timely‐diagnosed PTSD are needed. It is pertinent to investigate whether the treatment effects identified by this review (when the interventions were applied to a sample with relatively chronic illnesses) will fare equally well for those who have a more recent onset of psychosis and/or PTSD. It is also worthwhile to investigate if the interventions apply effectively in those with SMI and trauma symptoms which may not necessarily meet the diagnostic threshold of PTSD. </p> <p>While there remains much need for further studies to explore different modalities of PTSD treatment and the optimal adaptation of well‐established therapies to suit the complex needs of individuals with SMI, more comparison studies of one type of psychological therapy against another will also enhance our understanding of comparative effectiveness of different treatments so to promote treatment options and choices for service users and clinicians (<a href="./references#CD011464-bbs2-0076" title="National Institute for Health and Care Excellence. Stepped Care for People with Common Mental Health Disorders Commissioning Guide. www.swscn.org.uk/wp/wp‐content/uploads/2015/03/non‐guidance‐commissioning‐stepped‐care‐for‐people‐with‐common‐mental‐health‐disorders‐pdf.pdf. London: NICE, (accessed 2011). ">NICE 2011</a>; <a href="./references#CD011464-bbs2-0085" title="RothA , FonagyP . What Works for Whom? A Critical Review of Psychotherapy Research. 2nd Edition. New York: Guilford Press, 2005. ">Roth 2005</a>). Future research should also focus on establishing effective training of therapists using various treatment protocols and large‐scale implementation of the evidence‐based psychological treatment of PTSD for people with SMI, in order to widen provision of treatment. </p> <p>We suggest an outline design for future trials in <a href="#CD011464-tbl-0005">Table 1</a>. </p> <div class="table" id="CD011464-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Suggested design for future studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation: randomised, full explicit description of methods of randomisation and allocation concealment </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diagnosis: Individuals with schizophrenia or psychosis (ICD or DSM) and co‐morbid PTSD (DSM) </p> <p>N = 450*</p> <p>Age: adolescents and adults</p> <p>Sex: both</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inteventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1. Trauma‐focused cognitive behavioural therapy (modality and format to be specified), n = 150 </p> <p>2. Eye movement desensitisation and reprocessing (or another well‐defined trauma‐focused therapy as a comparative treatment), n = 150 </p> <p>3. Standard care/waiting list, n = 150</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1. PTSD symptoms<br/> 2. Quality of life or well‐being<br/> 3. Psychotic symptoms<br/> 4. Depressive symptoms<br/> 5. Anxiety symptoms<br/> 6. Adverse events<br/> 7. Health economic outcomes </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>*Powered to be able to identify a difference of 20% between groups for primary outcome with adequate degree of certainty </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ICD: International Classification of Diseases<br/> DSM: Diagnostic and Statistical Manual of Mental Disorders<br/> PTSD: post‐traumatic stress disorder </p> </div> </div> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011464-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011464-sec-0043"></div> <div class="table" id="CD011464-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Individual TF‐CBT compared to waiting list/usual care for PTSD and severe mental illness</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Individual TF‐CBT compared to</b> waiting list<b>/usual care for PTSD and severe mental illness</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Adults with co‐morbid PTSD and SMI<br/> <b>Settings:</b> Community<br/> <b>Intervention:</b> Individual TF‐CBT<br/> <b>Comparison:</b> Waiting list/usual care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Waiting list/usual care</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Individual TF‐CBT </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PTSD symptoms: Clinician‐rated PTSD symptom severity ‐ average endpoint CAPS total score (high = poor) ‐ short term (6 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean clinician‐rated PTSD symptom severity ‐ average endpoint caps total score (high = poor) ‐ short term ‐ unskewed data in the intervention groups was<br/> <b>13.15 higher</b> <br/> (4.09 lower to 30.39 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other data available for this outcome were skewed.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life: 1. General quality of life ‐ average endpoint QLS total score (high = good) ‐ medium term</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The average endpoint QLS total score ‐ medium term (10‐12 months) in the intervention groups was <b>0.60 lower</b> <br/> (4.47 lower to 3.27 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptoms of co‐morbid psychosis: 1. Overall mental state ‐ average endpoint BPRS total score (high = poor) ‐ medium term</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall mental state ‐ average endpoint BPRS total score (high = poor) ‐ medium term, in the intervention groups was<br/> <b>6.93 lower</b> <br/> (34.17 lower to 20.31 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anxiety symptoms ‐ average endpoint BAI total score (high = poor) ‐ medium term (12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean anxiety symptoms in the intervention groups was<br/> <b>12.57 higher</b> <br/> (5.54 lower to 30.68 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depressive symptoms ‐ average endpoint BDI‐II total (high = poor) ‐ medium term (12 months) ‐ skewed data</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean depressive symptoms ‐ average endpoint BDI‐II total (high = poor) in the intervention groups was<br/> <b>3.26 higher</b> <br/> (3.66 lower to 10.18 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48<br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No unskewed data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Adverse events ‐ incidents of unspecified severe adverse events ‐ medium term</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>100<br/> (1 study) </p> <p><b>RR (0.44) CI 0.09 to 2.31</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b> <br/> (8 to 197) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b> <br/> (8 to 196) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Health economics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Indirectness: downgraded by one level to 'serious' ‐ continuous measure with a wide score range used which may not reflect clinical significant change accurately.<br/> <sup>2</sup> Imprecision: downgraded by one level to 'serious' ‐ only one study with a small sample size (or subgroup sample size) provides data for this outcome.<br/> <sup>3</sup> Imprecision: downgraded by one level to 'serious' ‐ all available data from 2 studies were skewed. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011464-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">EMDR compared to waiting list/usual care for PTSD and severe mental illness</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>EMDR compared to</b> waiting list<b>/usual care for PTSD and severe mental illness</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Adults with co‐morbid PTSD and SMI<br/> <b>Settings:</b> Community<br/> <b>Intervention:</b> EMDR<br/> <b>Comparison:</b> Waiting list </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Waiting list</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> EMDR </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PTSD symptom severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ Medium term ‐ skewed data</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean clinician‐rated PTSD symptom severity ‐ average endpoint caps total score (high = poor) ‐ medium term (7‐9 months) ‐ skewed data in the intervention groups was<br/> <b>12.31 lower</b> <br/> (22.72 to 1.90 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only available data were skewed.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life: 1. General quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptoms of co‐morbid psychosis: 1. Overall mental state</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anxiety symptoms</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depressive symptoms</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Adverse events ‐ incidents of unspecified severe adverse events ‐ medium term</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>102<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> <br/> (2 to 157) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> <br/> (2 to 157) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Health economics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Only data available were skewed.<br/> <sup>2</sup> Continuous measure with a wide score range used which may not reflect clinical significant change accurately.<br/> <sup>3</sup> Only one study provided data on this outcome. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011464-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Individual TF‐CBT compared to EMDR for PTSD and severe mental illness</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Individual TF‐CBT compared to EMDR for PTSD and severe mental illness</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Adults with co‐morbid PTSD and SMI<br/> <b>Settings:</b> Community<br/> <b>Intervention:</b> TF‐CBT<br/> <b>Comparison:</b> EMDR </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> EMDR</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> TF‐CBT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PTSD symptom severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ Medium term ‐ skewed data</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean clinician‐rated PTSD symptom severity ‐ average endpoint caps total score (high = poor) ‐ medium term (7‐9 months) ‐ skewed data in the intervention groups was<br/> <b>1.69 lower</b> <br/> (12.61 lower to 9.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only data available were skewed.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life: 1. General quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptoms of co‐morbid psychosis: 1. Overall mental state</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anxiety symptoms</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depressive symptoms</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events ‐ incidents of unspecified severe events ‐ medium term</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary review outcomes not analysed in this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Health economics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Only one study provided data which were skewed.<br/> <sup>2</sup> Continuous outcome measure with a wide score range was used, score changes may not reflect meaningful clinical changes. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011464-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Individual TF‐CBT compared to Brief PTSD psychoeducation for PTSD and severe mental illness</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Individual TF‐CBT compared to Brief PTSD psychoeducation for PTSD and severe mental illness</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Adults with co‐morbid PTSD and SMI<br/> <b>Settings:</b> Community<br/> <b>Intervention:</b> Individual TF‐CBT versus brief PTSD psychoeducation<br/> <b>Comparison:</b> Brief PTSD psychoeducation </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Brief PTSD psychoeducation</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Individual TF‐CBT versus brief PTSD psychoeducation</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PTSD symptom severity: 1. Clinician‐rated PTSD severity ‐ average endpoint CAPS total score (high = poor) ‐ Medium term</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean clinician‐rated PTSD symptom severity ‐ average endpoint caps total score (high = poor) ‐ medium term (10‐12 months) ‐ unskewed data in the intervention groups was<br/> <b>0.23 higher</b> <br/> (14.66 lower to 15.12 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life: 1. General quality of life ‐ average endpoint QoLI total score (high = good) ‐ Long term</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life: (a) general quality of life ‐ average endpoint QoLI total score (high = good) ‐ long term (16‐18 months) ‐ unskewed data in the intervention groups was<br/> <b>0.11 higher</b> <br/> (0.74 lower to 0.96 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptoms of co‐morbid psychosis: 1. Overall mental state</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary review outcomes not analysed in this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anxiety symptoms</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary review outcomes not analysed in this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depressive symptoms</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary review outcomes not analysed in this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events ‐ incidents of unspecified severe adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Health economics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Only data from one study with small subgroup sample available.<br/> <sup>2</sup> Continuous measure used which may not reflect clinical significant change accurately. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011464-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011464-sec-0044"></div> <section id="CD011464-sec-0045"> <h3 class="title" id="CD011464-sec-0045">Description of the condition</h3> <p>Severe mental illness (SMI) is defined according to three dimensions: 1) a non‐organic psychotic disorder; 2) treatment duration lasting for two years or more; and 3) disability resulting in impairments in social and occupational functioning (<a href="./references#CD011464-bbs2-0086" title="RuggeriM , LeeseM , ThornicroftG , BisoftiG , TansellaM . Definition and prevalence of severe and persistent mental illness. British Journal of Psychiatry2000;177:149‐55. ">Ruggeri 2000</a>). Psychosis is manifested by delusions or hallucinations into which an individual has limited insight (<a href="./references#CD011464-bbs2-0011" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edition). Arlington, VA: American Psychiatric Publishing, 2013. ">APA 2013</a>), and which subsequently causes disturbances in functioning and relationships, despite ongoing treatment and care. Psychosis is characterised by positive and negative symptoms, for example: delusions, hallucinations, thought disorder, perceptual disturbances, and blunting or incongruity of emotional responses. The cluster of schizophrenia and related disorders (e.g. schizoaffective disorder, schizophreniform disorder and delusional disorder) are considered to be the most common psychotic disorders (<a href="./references#CD011464-bbs2-0102" title="World Health Organization. International Statistical Classification of Diseases and Related Health problems. ICD 10. Geneva: WHO, 1992. ">WHO 1992</a>). Individuals living with 'early onset psychosis' or 'first episode psychosis' and those who are receiving treatment and support from early intervention services are also considered to meet criteria for SMI due to the similarities in their clinical presentation and the resultant impairment and disability (<a href="./references#CD011464-bbs2-0078" title="National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Adults ‐ Treatment and Management (Clinical Guideline 136). www.nice.org.uk/guidance/cg178/evidence/full‐guideline‐490503565. London: National Collaborating Centre for Mental Health, (accessed 2014). ">NICE 2014</a>). Bipolar disorder (Type 1) diagnoses also fall within the remit of SMI. Bipolar disorder is primarily characterised by episodes of fluctuating mood: alternating between elevated mood and increased activity ‐ that is often accompanied by psychotic symptoms, and decreased energy and activity (<a href="./references#CD011464-bbs2-0102" title="World Health Organization. International Statistical Classification of Diseases and Related Health problems. ICD 10. Geneva: WHO, 1992. ">WHO 1992</a>). </p> <p>The onset of SMI tends to occur around late adolescence and early adulthood (<a href="./references#CD011464-bbs2-0078" title="National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Adults ‐ Treatment and Management (Clinical Guideline 136). www.nice.org.uk/guidance/cg178/evidence/full‐guideline‐490503565. London: National Collaborating Centre for Mental Health, (accessed 2014). ">NICE 2014</a>). The prevalence of schizophrenia ‐ based on a 2005 review of surveys undertaken in 46 countries ‐ has been reported to be 0.4% for lifetime prevalence up to the point of assessment, and 0.3% in the 12‐month period prior to assessment (<a href="./references#CD011464-bbs2-0087" title="SahaS , ChantD , WelhamJ , McGrathJ . A systematic review of the prevalence of schizophrenia. PLoS Medicine2005;2(5):e141. ">Saha 2005</a>). The 12‐month prevalence rate of Type 1 bipolar disorder is estimated to be 0.72% and the lifetime prevalence rate is reported to be 0.8%, according to a 2004 review of previous surveys (<a href="./references#CD011464-bbs2-0099" title="WaraichP , GoldnerEM , SomersJM , HsuL . Prevalence and incidence studies of mood disorders: a systematic review of the literature. Canadian Journal of Psychiatry2004;49(2):124‐38. ">Waraich 2004</a>). It is well‐established that people living with SMI often have co‐morbid mental health problems, most commonly depression, anxiety disorders, and post‐traumatic stress disorder (PTSD; <a href="./references#CD011464-bbs2-0078" title="National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Adults ‐ Treatment and Management (Clinical Guideline 136). www.nice.org.uk/guidance/cg178/evidence/full‐guideline‐490503565. London: National Collaborating Centre for Mental Health, (accessed 2014). ">NICE 2014</a>; <a href="./references#CD011464-bbs2-0081" title="ReadJ , FinkPJ , RudegeairT , FelittiV , WhitfieldCL . Child maltreatment and psychosis: a return to a genuinely integrated bio‐psycho‐social model. Clinical Schizophrenia &amp; Related Psychoses2008;2(3):235‐54. ">Read 2008</a>). </p> <p>The relationship between SMI and co‐morbid PTSD is complex and poorly understood, but there is increasing evidence to suggest that the much higher prevalence of childhood sexual and physical abuse, and social adversity continuing into adulthood amongst people affected by SMI are likely to be risk mechanisms for PTSD (<a href="./references#CD011464-bbs2-0014" title="BebbingtonP , JonasS , KuipersE , KingM , CooperC , BrughaT , et al. Childhood sexual abuse and psychosis: data from a cross‐sectional national psychiatric survey in England. British Journal of Psychiatry2011;199:19‐37. ">Bebbington 2011</a>; <a href="./references#CD011464-bbs2-0081" title="ReadJ , FinkPJ , RudegeairT , FelittiV , WhitfieldCL . Child maltreatment and psychosis: a return to a genuinely integrated bio‐psycho‐social model. Clinical Schizophrenia &amp; Related Psychoses2008;2(3):235‐54. ">Read 2008</a>). It is estimated that around a third of individuals with SMI also suffer from PTSD (<a href="./references#CD011464-bbs2-0023" title="BrunetK , BirchwoodM , UpthegroveR , MichailM , RossK . A prospective study of PTSD following recovery from first‐episode psychosis: the threat from persecutors, voices, and patienthood. British Journal of Clinical Psychology2012;51:418‐33. ">Brunet 2012</a>; <a href="./references#CD011464-bbs2-0060" title="Kilcommons AM, MorrisonAP . Relationships between trauma and psychosis: an exploration of cognitive and dissociative factors. Acta Psychiatrica Scandinavica2005;112:351‐9. ">Kilcommons 2005</a>; <a href="./references#CD011464-bbs2-0078" title="National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Adults ‐ Treatment and Management (Clinical Guideline 136). www.nice.org.uk/guidance/cg178/evidence/full‐guideline‐490503565. London: National Collaborating Centre for Mental Health, (accessed 2014). ">NICE 2014</a>). </p> <p>Post‐traumatic stress disorder is a trauma and stress‐related disorder. An individual may develop PTSD in response to directly experiencing or witnessing a traumatic event in person or vicariously, for example to a family member or close friend (<a href="./references#CD011464-bbs2-0011" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edition). Arlington, VA: American Psychiatric Publishing, 2013. ">APA 2013</a>). The Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria highlights that a traumatic stressor usually involves a perceived threat to life (either one's own life or that of another person), or physical integrity (A1 ‐ stressor criteria), and intense fear, helplessness or horror (A2 ‐ specific subjective emotional reaction criteria; <a href="./references#CD011464-bbs2-0011" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edition). Arlington, VA: American Psychiatric Publishing, 2013. ">APA 2013</a>; <a href="./references#CD011464-bbs2-0012" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edition, text rev.). Washington DC: APA, 2000. ">APA, 2000</a>). DSM diagnostic criteria are considered to be more strict than the International Classification of Diseases‐10 (ICD‐10) diagnostic criteria; hence most randomised controlled trials (RCTs) of PTSD use DSM criteria (<a href="./references#CD011464-bbs2-0075" title="National Institute for Clinical Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ The Management of PTSD in Adults and Children in Primary and Secondary Care. London: National Collaborating Centre for Mental Health, 2005. ">NICE 2005</a>). DSM‐5 outlines four distinct diagnostic clusters of PTSD symptoms (<a href="./references#CD011464-bbs2-0011" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edition). Arlington, VA: American Psychiatric Publishing, 2013. ">APA 2013</a>), instead of the three clusters described in the previous version (<a href="./references#CD011464-bbs2-0012" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edition, text rev.). Washington DC: APA, 2000. ">APA, 2000</a>), as follows: re‐experiencing (e.g. intrusive thoughts/images related to the trauma), avoidance (e.g. sites or cues related to the trauma), arousal (e.g. 'fight or flight' reactions, or panic), and negative cognitions and low mood. PTSD is relatively common, with prevalence rates estimated as 0.4% and 3.5% in the general adult population (<a href="./references#CD011464-bbs2-0017" title="BissonJI , RobertsNP , AndrewM , CooperR , LewisC . Psychological therapies for chronic post‐traumatic stress disorder (PTSD) in adults. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD003388.pub4] ">Bisson 2013</a>; <a href="./references#CD011464-bbs2-0028" title="Darves‐BornozJM , AlonzoJ , deGirolamoG , deGraafR , HaroJM , Kovess‐MasfetyV , et al. Main traumatic events in Europe: PTSD in the European study of the epidemiology of mental disorders survey. Journal of Traumatic Stress2008;21(5):455‐62. ">Darves‐Bornoz 2008</a>; <a href="./references#CD011464-bbs2-0059" title="KesslerRC , SonnegaA , BrometE , HughesM , NelsonCB . Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry1995;52(12):1048‐60. ">Kessler 1995</a>; <a href="./references#CD011464-bbs2-0075" title="National Institute for Clinical Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ The Management of PTSD in Adults and Children in Primary and Secondary Care. London: National Collaborating Centre for Mental Health, 2005. ">NICE 2005</a>). The symptoms of PTSD often cause intense distress, physiological reactions, and can significantly impair individuals' quality of life and functioning in multiple domains including interpersonal relationships (e.g. difficulties with trusting others, avoidance of intimacy; <a href="./references#CD011464-bbs2-0011" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edition). Arlington, VA: American Psychiatric Publishing, 2013. ">APA 2013</a>; <a href="./references#CD011464-bbs2-0075" title="National Institute for Clinical Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ The Management of PTSD in Adults and Children in Primary and Secondary Care. London: National Collaborating Centre for Mental Health, 2005. ">NICE 2005</a>). PTSD is also commonly associated with other co‐morbid conditions, such as substance use, depression, and/or ongoing physical health concerns such as pain and disability resulting from the traumatic event (<a href="./references#CD011464-bbs2-0075" title="National Institute for Clinical Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ The Management of PTSD in Adults and Children in Primary and Secondary Care. London: National Collaborating Centre for Mental Health, 2005. ">NICE 2005</a>; <a href="./references#CD011464-bbs2-0077" title="National Institute for Health and Care Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ Evidence Update December 2013 (Evidence Update 49). file:///C:/Users/mszter/Downloads/PTSD+Evidence+Update+December+2013.pdf. London: NICE, (accessed 2013). ">NICE 2013</a>). </p> <p>While the concept of PTSD has been conventionally applied to survivors of combat, accidents and disasters, and victims of violent crimes such as physical and sexual assaults, it has recently been suggested that the illness experience of SMI itself, for example, experiencing threatening or persecutory psychotic symptoms, can be traumatic (<a href="./references#CD011464-bbs2-0055" title="JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47:454‐62. ">Jackson 2009</a>; <a href="./references#CD011464-bbs2-0060" title="Kilcommons AM, MorrisonAP . Relationships between trauma and psychosis: an exploration of cognitive and dissociative factors. Acta Psychiatrica Scandinavica2005;112:351‐9. ">Kilcommons 2005</a>). In about one‐third of people with SMI, the experience of a recent onset of psychosis is an event of such severity that it can lead to PTSD or at least to PTSD symptoms (<a href="./references#CD011464-bbs2-0023" title="BrunetK , BirchwoodM , UpthegroveR , MichailM , RossK . A prospective study of PTSD following recovery from first‐episode psychosis: the threat from persecutors, voices, and patienthood. British Journal of Clinical Psychology2012;51:418‐33. ">Brunet 2012</a>; <a href="./references#CD011464-bbs2-0072" title="MorrisonAP , FrameL , LarkinW . Relationships between trauma and psychosis: a review and integration. British Journal of Clinical Psychology2003;42:331‐53. ">Morrison 2003</a>; <a href="./references#CD011464-bbs2-0074" title="MueserKT , LuW , RosenbergSD , WolfeR . The trauma of psychosis: posttraumatic stress disorder and recent onset psychosis. Schizophrenia Research2010;116:217‐27. ">Mueser 2010</a>), with the traumagenic elements of the psychotic experiences meeting the criteria for a traumatic event according to the DSM‐IV‐tr A1 and A2 criteria (<a href="./references#CD011464-bbs2-0012" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edition, text rev.). Washington DC: APA, 2000. ">APA, 2000</a>). </p> </section> <section id="CD011464-sec-0046"> <h3 class="title" id="CD011464-sec-0046">Description of the intervention</h3> <p>Several psychological therapies have been found to be effective treatments for PTSD in the general population. These include several modes of exposure therapy, trauma‐focused cognitive behavioural therapy (TF‐CBT) and eye movement desensitisation and reprocessing (EMDR) (<a href="./references#CD011464-bbs2-0017" title="BissonJI , RobertsNP , AndrewM , CooperR , LewisC . Psychological therapies for chronic post‐traumatic stress disorder (PTSD) in adults. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD003388.pub4] ">Bisson 2013</a>; <a href="./references#CD011464-bbs2-0022" title="BradleyR , GreeneJ , RussE , DutraL , WestenD . A multidimensional meta‐analysis of psychotherapy for PTSD. American Journal of Psychiatry2005;162(2):214‐27. ">Bradley 2005</a>; <a href="./references#CD011464-bbs2-0075" title="National Institute for Clinical Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ The Management of PTSD in Adults and Children in Primary and Secondary Care. London: National Collaborating Centre for Mental Health, 2005. ">NICE 2005</a>). All these therapies share some core elements that support individuals to work through and process their trauma memories, cognitions and attributions of traumatic events, and hence they are collectively known as 'trauma‐focused psychological therapies' (<a href="./references#CD011464-bbs2-0017" title="BissonJI , RobertsNP , AndrewM , CooperR , LewisC . Psychological therapies for chronic post‐traumatic stress disorder (PTSD) in adults. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD003388.pub4] ">Bisson 2013</a>; <a href="./references#CD011464-bbs2-0036" title="EhlersA , BissonJ , ClarkDM , CreamerM , PillingS , RichardsD , et al. Do all psychological treatments really work the same in posttraumatic stress disorder?. Clinical Psychology Review2010;30:269‐76. ">Ehlers 2010</a>; <a href="./references#CD011464-bbs2-0075" title="National Institute for Clinical Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ The Management of PTSD in Adults and Children in Primary and Secondary Care. London: National Collaborating Centre for Mental Health, 2005. ">NICE 2005</a>; <a href="./references#CD011464-bbs2-0077" title="National Institute for Health and Care Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ Evidence Update December 2013 (Evidence Update 49). file:///C:/Users/mszter/Downloads/PTSD+Evidence+Update+December+2013.pdf. London: NICE, (accessed 2013). ">NICE 2013</a>; <a href="./references#CD011464-bbs2-0088" title="SchnyderU , EhlersA , ElbertT , FoaEB , GersonsBPR , ResickPA , et al. Psychotherapies for PTSD: what do they have in common?. European Journal of Psychotramatology2015;6:28186. ">Schnyder 2015</a>). Both TF‐CBT and EMDR are recommended by the UK National Institute for Health and Care Excellence (NICE) guideline about the treatment of PTSD in child and adult populations; with a course of eight to 12 individual outpatient sessions of TF‐CBT or EMDR being the most common form of treatment (<a href="./references#CD011464-bbs2-0075" title="National Institute for Clinical Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ The Management of PTSD in Adults and Children in Primary and Secondary Care. London: National Collaborating Centre for Mental Health, 2005. ">NICE 2005</a>; <a href="./references#CD011464-bbs2-0077" title="National Institute for Health and Care Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ Evidence Update December 2013 (Evidence Update 49). file:///C:/Users/mszter/Downloads/PTSD+Evidence+Update+December+2013.pdf. London: NICE, (accessed 2013). ">NICE 2013</a>). Exposure therapy typically involves asking the person to relive the trauma, either in their imagination or by writing or audio‐recording a trauma narrative to create a detailed account of the event. The individual is then asked repeatedly to listen to or read the narrative in order to become habituated to the anxiety symptoms that are generated. An alternative form of exposure therapy involves graded re‐exposure to cues associated with the traumatic event, for example, using a hierarchy of cues (which are related to the trauma) (<a href="./references#CD011464-bbs2-0027" title="CreamerM , ForbesD , PhelpsA , HumphreysL . TreatingTraumatic Stress: Conducting Imaginal Exposure. Phoenix: Australian Centre for Posttraumatic Mental Health, 2004. ">Creamer 2004</a>; <a href="./references#CD011464-bbs2-0088" title="SchnyderU , EhlersA , ElbertT , FoaEB , GersonsBPR , ResickPA , et al. Psychotherapies for PTSD: what do they have in common?. European Journal of Psychotramatology2015;6:28186. ">Schnyder 2015</a>). Prolonged exposure (PE) therapy stipulates two such principal components: imaginal exposure (i.e. repeated revisiting and recounting of distressing trauma memories) followed by 15‐20 minutes of processing in which the imaginal exposure experience and other related emotions and perceptions are discussed, and, in vivo exposure (i.e. gradual approaching of avoided, safe trauma‐related situations) (<a href="./references#CD011464-bbs2-0043" title="FoaEB , HembreeEA , RothbaumBO . Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences ‐ Therapist Guide. Oxford, England: Oxford University Press, 2007. ">Foa 2007</a>). TF‐CBT primarily involves supporting individuals to identify, examine and change unhelpful thoughts about others (e.g. people are not trustworthy), themselves (e.g. it is my fault this happened, I am a failure), the world (e.g. the world is dangerous); or unhelpful behavioural responses that may perpetuate trauma symptoms or hamper functioning (e.g. avoiding using public transport in London following the 7 July 2005 (7/7) bombing; or drinking to excess in an attempt to promote sleep), or both (<a href="./references#CD011464-bbs2-0035" title="EhlersA , ClarkDM , HackmannA , McManusF , FennellM . Cognitive therapy for post‐traumatic stress disorder: development and evaluation. Behaviour Research andTherapy2005;43(4):413‐31. ">Ehlers 2005</a>; <a href="./references#CD011464-bbs2-0082" title="ResickPA , NishithP , GriffinMG . How well does cognitive behavioral therapy treat symptoms of complex PTSD? An examination of child sexual abuse survivors within a clinical trial. CNS Spectrums2003;8(5):340‐55. ">Resick 2003</a>). EMDR was discovered accidentally by Shapiro through her personal experience of rapid eye movements easing distress (<a href="./references#CD011464-bbs2-0090" title="ShapiroF . Eye‐movement desensitization ‐ a new treatment for post‐traumatic stress disorder. Journal of Behavior Therapy and Experimental Psychiatry1989;20(3):211‐7. ">Shapiro 1989</a>). Shapiro further developed EMDR into a structured protocol‐driven trauma‐focused therapy to alleviate the distress associated with traumatic memories, based upon the adaptive information process model of PTSD (<a href="./references#CD011464-bbs2-0091" title="ShapiroF . Eye Movement Desensitization and Reprocessing, Basic Principles, Protocols and Procesures. 2nd Edition. New York: The Guilford Press, 2001. ">Shapiro 2001</a>). EMDR therapy consists of eight phases that includes the individual recalling an image, thought, emotion and a bodily sensation associated with the traumatic event, whilst receiving bilateral stimulation, most commonly in the form of eye movements (<a href="./references#CD011464-bbs2-0091" title="ShapiroF . Eye Movement Desensitization and Reprocessing, Basic Principles, Protocols and Procesures. 2nd Edition. New York: The Guilford Press, 2001. ">Shapiro 2001</a>). </p> </section> <section id="CD011464-sec-0047"> <h3 class="title" id="CD011464-sec-0047">How the intervention might work</h3> <p>Exposure therapy and exposure‐based TF‐CBT are thought to work by promoting emotional habituation by repeated exposure to the traumatic events or cues associated with the events (<a href="./references#CD011464-bbs2-0024" title="BryantRA , MouldsML , GuthrieRM , DangST , NixonRDV . Imaginal exposure alone and imaginal exposure with cognitive structuring in the treatment of posttraumatic stress disorder. Journal of Consulting and Clinical Psychology2003;71:706‐12. ">Bryant 2003</a>; <a href="./references#CD011464-bbs2-0035" title="EhlersA , ClarkDM , HackmannA , McManusF , FennellM . Cognitive therapy for post‐traumatic stress disorder: development and evaluation. Behaviour Research andTherapy2005;43(4):413‐31. ">Ehlers 2005</a>; <a href="./references#CD011464-bbs2-0068" title="MarksIM , LovellK , NoshirvaniH , LivanouM , ThrasherS . Treatment of postraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Archives of General Psychiatry1998;55:317‐25. ">Marks 1998</a>). Psychoeducation about common reactions to trauma is a key feature of all TF‐CBT therapies, which aim to normalise the individual's symptoms and give a rationale for the interventions that follow (<a href="./references#CD011464-bbs2-0036" title="EhlersA , BissonJ , ClarkDM , CreamerM , PillingS , RichardsD , et al. Do all psychological treatments really work the same in posttraumatic stress disorder?. Clinical Psychology Review2010;30:269‐76. ">Ehlers 2010</a>; <a href="./references#CD011464-bbs2-0075" title="National Institute for Clinical Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ The Management of PTSD in Adults and Children in Primary and Secondary Care. London: National Collaborating Centre for Mental Health, 2005. ">NICE 2005</a>). TF‐CBT, whilst relying on repeated exposure to the trauma memory and in vivo exposure to situations avoided since the event, also actively incorporates cognitive restructuring to modify the excessively negative appraisals of the trauma or its sequelae, or both (<a href="./references#CD011464-bbs2-0035" title="EhlersA , ClarkDM , HackmannA , McManusF , FennellM . Cognitive therapy for post‐traumatic stress disorder: development and evaluation. Behaviour Research andTherapy2005;43(4):413‐31. ">Ehlers 2005</a>; <a href="./references#CD011464-bbs2-0036" title="EhlersA , BissonJ , ClarkDM , CreamerM , PillingS , RichardsD , et al. Do all psychological treatments really work the same in posttraumatic stress disorder?. Clinical Psychology Review2010;30:269‐76. ">Ehlers 2010</a>). Cognitive therapy for PTSD focuses on identifying and modifying the idiosyncratic meanings of the trauma and problematic appraisal of trauma sequelae (e.g. initial PTSD symptoms, other peoples' responses after the event) and a wide range of behavioural and cognitive maintaining strategies (e.g. rumination, overt and covert safety behaviours that often hamper functioning; <a href="./references#CD011464-bbs2-0017" title="BissonJI , RobertsNP , AndrewM , CooperR , LewisC . Psychological therapies for chronic post‐traumatic stress disorder (PTSD) in adults. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD003388.pub4] ">Bisson 2013</a>; <a href="./references#CD011464-bbs2-0035" title="EhlersA , ClarkDM , HackmannA , McManusF , FennellM . Cognitive therapy for post‐traumatic stress disorder: development and evaluation. Behaviour Research andTherapy2005;43(4):413‐31. ">Ehlers 2005</a>). In some TF‐CBT, behavioural experiments are also used to demonstrate the way in which various maintaining processes (such as thought suppression, hypervigilance for danger, avoidance of any cues) operate and support the individual to adopt more adaptive or effective coping mechanisms (<a href="./references#CD011464-bbs2-0035" title="EhlersA , ClarkDM , HackmannA , McManusF , FennellM . Cognitive therapy for post‐traumatic stress disorder: development and evaluation. Behaviour Research andTherapy2005;43(4):413‐31. ">Ehlers 2005</a>; <a href="./references#CD011464-bbs2-0082" title="ResickPA , NishithP , GriffinMG . How well does cognitive behavioral therapy treat symptoms of complex PTSD? An examination of child sexual abuse survivors within a clinical trial. CNS Spectrums2003;8(5):340‐55. ">Resick 2003</a>). Despite its well‐established effectiveness in treating PTSD in the general population, there is no agreed mechanism by which EMDR is thought to operate, hence there is no definitive explanatory model of how it works, although it is suggested that bilateral stimulation aids the processing of traumatic memories (<a href="./references#CD011464-bbs2-0090" title="ShapiroF . Eye‐movement desensitization ‐ a new treatment for post‐traumatic stress disorder. Journal of Behavior Therapy and Experimental Psychiatry1989;20(3):211‐7. ">Shapiro 1989</a>). </p> </section> <section id="CD011464-sec-0048"> <h3 class="title" id="CD011464-sec-0048">Why it is important to do this review</h3> <p>People with SMI have been found to be at increased risk of experiencing traumatic events (<a href="./references#CD011464-bbs2-0013" title="BebbingtonPE , BhugraD , BrughaT , SingletonN , FarrellM , JenkinsR , et al. Psychosis, victimisation and childhood disadvantage: evidence from the second British National Survey of Psychiatric Morbidity. British Journal of Psychiatry2004;185:220‐6. ">Bebbington 2004</a>; <a href="./references#CD011464-bbs2-0039" title="FisherHL , CaspiA , PoultonR , MeierMH , HoutsR , HarringtonH , et al. Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study. Psychological Medicine2013;43:2077‐86. ">Fisher 2013</a>; <a href="./references#CD011464-bbs2-0072" title="MorrisonAP , FrameL , LarkinW . Relationships between trauma and psychosis: a review and integration. British Journal of Clinical Psychology2003;42:331‐53. ">Morrison 2003</a>; <a href="./references#CD011464-bbs2-0081" title="ReadJ , FinkPJ , RudegeairT , FelittiV , WhitfieldCL . Child maltreatment and psychosis: a return to a genuinely integrated bio‐psycho‐social model. Clinical Schizophrenia &amp; Related Psychoses2008;2(3):235‐54. ">Read 2008</a>). These include traumatic events during childhood (such as physical and sexual abuse; <a href="./references#CD011464-bbs2-0013" title="BebbingtonPE , BhugraD , BrughaT , SingletonN , FarrellM , JenkinsR , et al. Psychosis, victimisation and childhood disadvantage: evidence from the second British National Survey of Psychiatric Morbidity. British Journal of Psychiatry2004;185:220‐6. ">Bebbington 2004</a>; <a href="./references#CD011464-bbs2-0098" title="VareseF , SmeetsF , DrukkerM , LieverseR , LatasterT , ViechtbauerW , et al. Childhood adversities increase the risk of psychosis: a meta‐analysis of patient‐control, prospective‐ and cross‐sectional cohort studies. Schizophrenia Bulletin2012;38(4):661‐71. ">Varese 2012</a>), as well as in adulthood (such as being a victim of crime and abusive relationships (<a href="./references#CD011464-bbs2-0028" title="Darves‐BornozJM , AlonzoJ , deGirolamoG , deGraafR , HaroJM , Kovess‐MasfetyV , et al. Main traumatic events in Europe: PTSD in the European study of the epidemiology of mental disorders survey. Journal of Traumatic Stress2008;21(5):455‐62. ">Darves‐Bornoz 2008</a>; <a href="./references#CD011464-bbs2-0039" title="FisherHL , CaspiA , PoultonR , MeierMH , HoutsR , HarringtonH , et al. Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study. Psychological Medicine2013;43:2077‐86. ">Fisher 2013</a>). Also, there is some evidence to suggest that the illness experience of SMI itself, such as experiences of threatening or persecutory psychotic symptoms (<a href="./references#CD011464-bbs2-0055" title="JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47:454‐62. ">Jackson 2009</a>; <a href="./references#CD011464-bbs2-0060" title="Kilcommons AM, MorrisonAP . Relationships between trauma and psychosis: an exploration of cognitive and dissociative factors. Acta Psychiatrica Scandinavica2005;112:351‐9. ">Kilcommons 2005</a>), can be traumatic. </p> <p>Subsequently, it is estimated that around a third of individuals with SMI also suffer from PTSD, across different phases of the illness, from early onset, to acute and remission from positive symptoms (<a href="./references#CD011464-bbs2-0023" title="BrunetK , BirchwoodM , UpthegroveR , MichailM , RossK . A prospective study of PTSD following recovery from first‐episode psychosis: the threat from persecutors, voices, and patienthood. British Journal of Clinical Psychology2012;51:418‐33. ">Brunet 2012</a>; <a href="./references#CD011464-bbs2-0060" title="Kilcommons AM, MorrisonAP . Relationships between trauma and psychosis: an exploration of cognitive and dissociative factors. Acta Psychiatrica Scandinavica2005;112:351‐9. ">Kilcommons 2005</a>; <a href="./references#CD011464-bbs2-0078" title="National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Adults ‐ Treatment and Management (Clinical Guideline 136). www.nice.org.uk/guidance/cg178/evidence/full‐guideline‐490503565. London: National Collaborating Centre for Mental Health, (accessed 2014). ">NICE 2014</a>). This rate far exceeds that of the general population. Prolonged and untreated PTSD is associated with exacerbation of both PTSD and psychotic symptoms, associated affective symptoms and a reduction in overall functioning and quality of life in affected individuals (<a href="./references#CD011464-bbs2-0073" title="MueserKM , RosenbergSD , RosenbergHJ . Treatment of Posttraumatic Stress Disorder in Special Populations: A Cognitive Restructuring Program. New York: American Psychological Association, 2009. ">Mueser 2009</a>; <a href="./references#CD011464-bbs2-0081" title="ReadJ , FinkPJ , RudegeairT , FelittiV , WhitfieldCL . Child maltreatment and psychosis: a return to a genuinely integrated bio‐psycho‐social model. Clinical Schizophrenia &amp; Related Psychoses2008;2(3):235‐54. ">Read 2008</a>). However, despite trauma‐focused psychological interventions being consistently demonstrated to be effective for the treatment of PTSD (<a href="./references#CD011464-bbs2-0017" title="BissonJI , RobertsNP , AndrewM , CooperR , LewisC . Psychological therapies for chronic post‐traumatic stress disorder (PTSD) in adults. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD003388.pub4] ">Bisson 2013</a>; <a href="./references#CD011464-bbs2-0022" title="BradleyR , GreeneJ , RussE , DutraL , WestenD . A multidimensional meta‐analysis of psychotherapy for PTSD. American Journal of Psychiatry2005;162(2):214‐27. ">Bradley 2005</a>; <a href="./references#CD011464-bbs2-0075" title="National Institute for Clinical Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ The Management of PTSD in Adults and Children in Primary and Secondary Care. London: National Collaborating Centre for Mental Health, 2005. ">NICE 2005</a>), empirical studies investigating feasibility, acceptability, and clinical and cost‐effectiveness of psychological interventions for PTSD tend to exclude people with psychosis (<a href="./references#CD011464-bbs2-0074" title="MueserKT , LuW , RosenbergSD , WolfeR . The trauma of psychosis: posttraumatic stress disorder and recent onset psychosis. Schizophrenia Research2010;116:217‐27. ">Mueser 2010</a>; <a href="./references#CD011464-bbs2-0078" title="National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Adults ‐ Treatment and Management (Clinical Guideline 136). www.nice.org.uk/guidance/cg178/evidence/full‐guideline‐490503565. London: National Collaborating Centre for Mental Health, (accessed 2014). ">NICE 2014</a>). In routine service settings, provision of psychological interventions (targeting psychotic symptoms specifically or other common co‐morbid problems such as PTSD) has also been criticised to be limited for people with psychotic disorders (<a href="./references#CD011464-bbs2-0096" title="The Schizophrenia Commission. The Abandoned Illness: A Report from the Schizophrenia Commission. London: Rethink Mental Illness, 2012. ">The Schizophrenia Commission 2012</a>). This may be attributed to clinical and methodological factors, including: 1) diagnostic overshadowing whereby there are overlaps in the symptom presentations of psychosis and PTSD (<a href="./references#CD011464-bbs2-0026" title="CalvertC , LarkinW , Jellicoe‐JonesL . An exploration of the links between trauma and delusional ideation in secure services. Behavioural and Cognitive Psychotherapy2008;36(5):589‐604. ">Calvert 2008</a>; <a href="./references#CD011464-bbs2-0057" title="JonesV , SteelC . Examining vulnerability to involuntary memories in schizophrenia comorbid with post‐traumatic stress disorder. Schizophrenia Research2014;152(2):487‐9. ">Jones 2014</a>); 2) concerns that this clinical population may find it hard to engage with psychological therapies (<a href="./references#CD011464-bbs2-0025" title="CallcottP , StandartS , TurkingtonD . Trauma within psychosis: using a CBT model for PTSD in psychosis. Behavioural and Cognitive Psychotherapy2004;32(2):239‐44. ">Callcott 2004</a>; <a href="./references#CD011464-bbs2-0045" title="GairnsS , Alvarez‐JimenezM , HulbertC , McGorryP , BendallS . Perceptions of clinicians treating young people with first‐episode psychosis for post‐traumatic stress disorder. Early Intervention in Psychiatry2015;9:12‐20. ">Gairns 2015</a>); 3) concern that standard treatment/interventions may exacerbate positive symptoms (<a href="./references#CD011464-bbs2-0045" title="GairnsS , Alvarez‐JimenezM , HulbertC , McGorryP , BendallS . Perceptions of clinicians treating young people with first‐episode psychosis for post‐traumatic stress disorder. Early Intervention in Psychiatry2015;9:12‐20. ">Gairns 2015</a>); and 4) potential high attrition rates (<a href="./references#CD011464-bbs2-0025" title="CallcottP , StandartS , TurkingtonD . Trauma within psychosis: using a CBT model for PTSD in psychosis. Behavioural and Cognitive Psychotherapy2004;32(2):239‐44. ">Callcott 2004</a>; <a href="./references#CD011464-bbs2-0055" title="JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47:454‐62. ">Jackson 2009</a>). Hence, relatively little is known about the utility and effectiveness of such treatments for this co‐morbid population. This review aims to address this knowledge gap by investigating the effectiveness of psychological interventions in improving PTSD symptoms and well‐being of individuals affected by PTSD and SMI. This information can then be used to inform the development of clinical services for this highly co‐morbid group. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011464-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011464-sec-0049"></div> <p>To evaluate the effectiveness of psychological interventions for post‐traumatic stress disorder (PTSD) symptoms or other symptoms of psychological distress arising from trauma in people with severe mental illness (SMI). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011464-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011464-sec-0050"></div> <section id="CD011464-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011464-sec-0052"> <h4 class="title">Types of studies</h4> <p>All relevant randomised controlled trials that investigate psychological interventions for the co‐morbid post‐traumatic stress disorder (PTSD) and severe mental illness (SMI) group. If a trial was described as 'double‐blind' and implied randomisation, we planned to include such trials in a sensitivity analysis (see <a href="#CD011464-sec-0111">Sensitivity analysis</a>). We excluded quasi‐randomised studies, such as those allocating to interventions by alternate days of the week. Where participants were given additional treatments within a psychological intervention for PTSD, we planned to only include the data if the adjunct treatment was evenly distributed between the intervention and control groups, and it was the only psychological intervention (with the primary purpose of treating PTSD or alleviating PTSD symptoms) that was randomised. </p> </section> <section id="CD011464-sec-0053"> <h4 class="title">Types of participants</h4> <p>Adolescents (aged 11 to 17 years) and adults (aged 18 years and over) with SMI as defined above, and also diagnosed with PTSD, and treated in any (clinical) setting. We also included studies with participants diagnosed with PTSD and co‐morbid primary diagnoses other than SMI as defined by this review (e.g. severe depression or bipolar disorder), but only if at least 50% or more of the participants had a psychosis‐related disorder; or if data specific to the participants with co‐morbid psychosis were reported independently, or obtainable from the study's authors. </p> </section> <section id="CD011464-sec-0054"> <h4 class="title">Types of interventions</h4> <section id="CD011464-sec-0055"> <h5 class="title">1. Psychological interventions</h5> <p>We included psychological interventions if they were trauma‐focused treatments or other psychological treatments that had been used with the explicit intention of treating PTSD, that is, they aimed to reduce PTSD symptoms or other related distress that developed in relation to traumatic events relating to life events, or the experience of SMI. These included the following. </p> <p> <ol id="CD011464-list-0001"> <li> <p>Individual trauma‐focused cognitive behavioural therapy (TF‐CBT): any psychological therapy that predominately used trauma‐focused cognitive or behavioural techniques or a combination to address PTSD symptoms or other symptoms of psychological distress arising from trauma (<a href="./references#CD011464-bbs2-0035" title="EhlersA , ClarkDM , HackmannA , McManusF , FennellM . Cognitive therapy for post‐traumatic stress disorder: development and evaluation. Behaviour Research andTherapy2005;43(4):413‐31. ">Ehlers 2005</a>). Using the definition adopted by the Cochrane review for psychological therapies for PTSD (<a href="./references#CD011464-bbs2-0017" title="BissonJI , RobertsNP , AndrewM , CooperR , LewisC . Psychological therapies for chronic post‐traumatic stress disorder (PTSD) in adults. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD003388.pub4] ">Bisson 2013</a>), this category also includes exposure therapy. </p> </li> <li> <p>Group TF‐CBT: any approach delivered in a group setting using predominately trauma‐focused cognitive, behavioural or cognitive‐behavioural techniques. </p> </li> <li> <p>Eye movement desensitisation and reprocessing (EMDR; <a href="./references#CD011464-bbs2-0090" title="ShapiroF . Eye‐movement desensitization ‐ a new treatment for post‐traumatic stress disorder. Journal of Behavior Therapy and Experimental Psychiatry1989;20(3):211‐7. ">Shapiro 1989</a>; <a href="./references#CD011464-bbs2-0091" title="ShapiroF . Eye Movement Desensitization and Reprocessing, Basic Principles, Protocols and Procesures. 2nd Edition. New York: The Guilford Press, 2001. ">Shapiro 2001</a>). </p> </li> <li> <p>Any other psychological intervention that did not fit the above categories of modalities, but clearly described its theoretical underpinnings and was intended to target PTSD symptoms and related distress in people with SMI. </p> </li> </ol> </p> </section> <section id="CD011464-sec-0056"> <h5 class="title">2. Control conditions</h5> <p>Comparator interventions included either:</p> <p> <ol id="CD011464-list-0002"> <li> <p>usual care/treatment as usual/waiting list: this usually includes care co‐ordination or case management and (antipsychotic) medication; </p> </li> <li> <p>any other intervention: any alternative (psychological) intervention other than a specific trauma‐focused psychological intervention whose content, mode of delivery and design were clearly defined, e.g. non‐trauma‐focused CBT, non‐directive/supportive counselling (<a href="./references#CD011464-bbs2-0083" title="RogerC . On Becoming a Person: A Therapist's View of Psychotherapy. London: Constable, 1961. ">Rogers 1961</a>), stress inoculation training (SIT; <a href="./references#CD011464-bbs2-0070" title="MeichenbaumD , DeffenbacherJL . Stress inoculation training. Counseling Psychologist1988;16:69‐90. ">Meichenbaum 1988</a>); and less structured approaches such as befriending and psychodynamic therapies. </p> </li> </ol> </p> <p>We conducted separate analyses focusing on each category of active psychological interventions based on a shared modality and format of delivery (i.e. TF‐CBT ‐ individual or group based, EMDR, or any other psychological intervention for PTSD), comparing them to all the control conditions pooled together. Whenever there were sufficient data extracted from included studies, we then proceeded to analyse each category of active psychological intervention targeting PTSD comparing each modality and format of active intervention against: 1) active control conditions (i.e. non‐PTSD focused intervention/s); 2) usual care/treatment as usual/waiting list; and 3) other modality and format of trauma‐focused psychological intervention, for primary outcomes. </p> </section> </section> <section id="CD011464-sec-0057"> <h4 class="title">Types of outcome measures</h4> <p>We divided all outcomes into short‐term (less than six months), medium‐term (seven to 12 months) and long‐term (over one year) categories. </p> <section id="CD011464-sec-0058"> <h5 class="title">Primary outcomes</h5> <section id="CD011464-sec-0059"> <h6 class="title">1. PTSD symptom severity ‐ as reported by validated measures</h6> <p>1.1 Average change or endpoint in PTSD symptom severity using a clinician‐conducted standardised and validated measure (but not administered by the treating therapist), such as the Clinician Administered PTSD Symptom Scale (CAPS) (<a href="./references#CD011464-bbs2-0018" title="BlakeDD , WeathersFW , NagyLM , KaloupekDG , GusmanFD , CharneyDS , et al. The development of a clinician administered PTSD scale. Journal of Traumatic Stress1995;8(1):75‐90. ">Blake 1995</a>).<br/> 1.2 Average change or endpoint in self‐reported PTSD symptoms using a standardised measure, for example, Impact of Events Scale (IES) by <a href="./references#CD011464-bbs2-0052" title="HorowitzMJ , WilnerNR , AlvarezW . Impact of event scale ‐ a measure of subjective stress. Psychosomatic Medicine1979;41:209‐18. ">Horowitz 1979</a>), post‐traumatic stress diagnostic scale (PDS) by <a href="./references#CD011464-bbs2-0041" title="FoaEB . Posttraumatic Stress Diagnostic Scale Manual. Minneapolis: National Computer Systems Inc., 1995. ">Foa 1995</a>.<br/> 1.3 Recovery or remission from PTSD (i.e. no longer meeting diagnostic criteria of PTSD). </p> </section> <section id="CD011464-sec-0060"> <h6 class="title">2. Quality of life or well‐being ‐ as measured by validated self‐reported scales</h6> <p>2.1 Clinically important change or endpoint scores in general quality of life or well‐being scores, generic or specific to the participants' physical, psychological, social, or cognitive functioning.<br/> 2.2 Average change or endpoint scores in general quality of life or well‐being scores, generic or specific to the participants' physical, psychological, social, or cognitive functioning. </p> </section> </section> <section id="CD011464-sec-0061"> <h5 class="title">Secondary outcomes</h5> <p><b>3. Symptoms of co‐morbid psychosis</b> </p> <p>3.1 Endpoint or average change in severity of overall or general mental state score, as measured by validated scales, such as the Brief Psychiatric Rating Scale (BPRS, <a href="./references#CD011464-bbs2-0079" title="OverallJE , GorhamDR . The brief psychiatric rating scale. Psychological Reports1962;10:799‐812. ">Overall 1962</a>) or the Positive and Negative Symptoms Scale (PANSS, <a href="./references#CD011464-bbs2-0058" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi‐Health Systems, 1986. ">Kay 1986</a>).<br/> 3.2 Endpoint or average change in severity of positive psychotic symptoms.<br/> 3.3 Endpoint or average change in severity of negative psychotic symptoms.<br/> 3.4 Recovery or remission from the pre‐existing psychotic disorder. </p> <p><b>4. Depressive symptoms</b> </p> <p>4.1 Endpoint or average change in severity of depressive symptoms, as measured by validated scales, for example the Beck Depression Inventory (BDI) (<a href="./references#CD011464-bbs2-0016" title="BeckAT , SteerRA , BrownGK . Manual for the Beck Depression Inventory ‐ II. San Antonio, TX: Psychological Corporation, 1996. ">Beck 1996</a>).<br/> 4.2 Recovery or remission from depression. </p> <p><b>5. Anxiety symptoms</b> </p> <p>5.1 Endpoint or average change in severity of anxiety symptoms, as reported by validated measures, e.g. the Spielberger State Anxiety Inventory (STAI) (<a href="./references#CD011464-bbs2-0094" title="SpielbergerCD , GorsuchRL , LusheneR . Manual for the State‐Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologist Press, 1973. ">Spielberger 1973</a>) or Beck Anxiety Inventory (BAI) (<a href="./references#CD011464-bbs2-0015" title="BeckAT , SteerRA . Manual for the Beck Anxiety Inventory. San Antonio, TX: Psychological Corporation, 1990. ">Beck 1990</a>).<br/> 5.2 Recovery or remission from anxiety disorder. </p> <p><b>6. Adverse events</b> </p> <p>6.1 Increased PTSD symptoms or severity.<br/> 6.2 Increased severity of overall psychotic symptoms.<br/> 6.3 Any other adverse events, e.g. death including suicide and natural causes. </p> <p><b>7. Leaving the study early</b> </p> <p>7.1 Withdrawal from the treatment programme.<br/> 7.2 Loss to follow‐up. </p> <p><b>8. Satisfaction or perceived acceptability of treatment</b> </p> <p>8.1 Subjective satisfaction with treatment, as measured by validated self‐report scales.<br/> 8.2 Perceived acceptability of treatment, as measured by validated self‐report scales. </p> <p><b>9. Health economic outcomes</b> </p> <p>9.1 Direct costs, e.g. treatment costs, service use.<br/> 9.2 Indirect costs. </p> <section id="CD011464-sec-0062"> <h6 class="title">'Summary of findings' table/s</h6> <p>We used the GRADE approach to interpret findings (<a href="./references#CD011464-bbs2-0089" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011</a>), and we used the GRADE profiler to import data from RevMan 5.3 to create 'Summary of findings' tables (<a href="http://www.ims.cochrane.org/revman/gradepro" target="_blank">GRADEPRO</a>; <a href="http://www.ims.cochrane.org/revman" target="_blank">Review Manager</a>). These tables provide outcome‐specific information concerning the overall quality of evidence from each included study in the comparison, the magnitude of effect of the interventions examined, and the sum of available data on all outcomes we rated as important to patient‐care and decision‐making. We aimed to select the following main outcomes for inclusion in the 'Summary of findings' tables: </p> <p>1. PTSD symptoms<br/> 2. Quality of life or well‐being<br/> 3. Symptoms of co‐morbid psychosis<br/> 4. Depressive symptoms<br/> 5. Anxiety symptoms<br/> 6. Adverse events<br/> 7. Health economics </p> </section> </section> </section> </section> <section id="CD011464-sec-0063"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011464-sec-0064"> <h4 class="title">Electronic searches</h4> <section id="CD011464-sec-0065"> <h5 class="title">1. Cochrane Schizophrenia Group’s Trials Register</h5> <p>On January 29, 2015 and March 10, 2016, the information specialist (TSC) searched the Cochrane Schizophrenia Group’s Trials Register using the following search strategies: </p> <p>(*trauma* or *ptsd*):ti,ab,kw of REFERENCE or (*trauma* or *ptsd*):sco of STUDY</p> <p>The Cochrane Schizophrenia Group’s Register of Trials is compiled by systematic searches of major resources (including AMED, BIOSIS, CINAHL, Embase, MEDLINE, PsycINFO, PubMed, and registries of clinical trials) and their monthly updates, handsearches, grey literature, and conference proceedings (see <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/SCHIZ/frame.html" target="_blank">Group Module</a>). There are no language, date, document type, or publication status limitations for inclusion of records into the register. </p> </section> </section> <section id="CD011464-sec-0066"> <h4 class="title">Searching other resources</h4> <section id="CD011464-sec-0067"> <h5 class="title">1. Reference searching</h5> <p>We inspected the references of all included studies for further relevant studies.</p> </section> <section id="CD011464-sec-0068"> <h5 class="title">2. Personal contact</h5> <p>We contacted the first and/or corresponding author of each screened study for information regarding unpublished or ongoing trials. We noted the outcome of these contacts in the included or excluded studies tables. </p> </section> </section> </section> <section id="CD011464-sec-0069"> <h3 class="title" id="CD011464-sec-0069">Data collection and analysis</h3> <section id="CD011464-sec-0070"> <h4 class="title">Selection of studies</h4> <p>Review authors DS and MF independently examined citations from the searches and identified relevant abstracts. review authors IN independently re‐inspected a random 20% sample to ensure reliability. Where disputes or uncertainty arose, we acquired the full report for more detailed scrutiny. DS and MF obtained and inspected full reports of the abstracts meeting the review criteria independently. Again, IN re‐inspected a random 20% of these full reports in order to ensure reliable selection. Where it was not possible to resolve disagreement by discussion, we made contact with the authors of the study for clarification. </p> </section> <section id="CD011464-sec-0071"> <h4 class="title">Data extraction and management</h4> <section id="CD011464-sec-0072"> <h5 class="title">1. Extraction</h5> <p>Review authors DS and MF extracted data from all included studies. Again, we discussed any disagreement and documented decisions. If necessary, authors of studies were contacted for clarification and for obtaining further unpublished or subgroup data. IN helped clarify issues for any remaining problems and these final decisions were documented. We planned to extract data presented in graphs and figures only, but included these data only if two review authors independently obtained the same result. In the event, we did not need to extract data from graphs and/or figures. We contacted authors through an open‐ended request in order to obtain missing information or for clarification whenever necessary. If studies were multi‐centre, where possible, we planned to extract data relevant to each component centre independently. </p> </section> <section id="CD011464-sec-0073"> <h5 class="title">2. Management</h5> <section id="CD011464-sec-0074"> <h6 class="title">2.1 Forms</h6> <p>We extracted data onto simple, standard forms.</p> </section> <section id="CD011464-sec-0075"> <h6 class="title">2.2 Scale‐derived data</h6> <p>We included continuous data from rating scales only if:</p> <p> <ol id="CD011464-list-0003"> <li> <p>the psychometric properties of the measuring instrument had been described in a peer‐reviewed journal (<a href="./references#CD011464-bbs2-0069" title="MarshallM , LockwoodA , BradleyC , AdamsC , JoyC , FentonM . Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry2000;176:249‐52. ">Marshall 2000</a>); and </p> </li> <li> <p>the measuring instrument had not been written or modified by one of the trialists for that particular trial. Partial use of a validated instrument would be included only if complete subscale results were available for interpretation. </p> </li> </ol> </p> <p>Ideally, the measuring instrument should either be a self‐report or a report completed by an independent rater or relative (not the therapist). We realised that this is often not reported clearly; we noted if this was the case or not in the <a href="#CD011464-sec-0118">Description of studies</a> section. </p> </section> <section id="CD011464-sec-0076"> <h6 class="title">2.3 Endpoint versus change data</h6> <p>There are advantages of both endpoint and change data. Change data can remove a component of between‐person variability from the analysis, however calculation of change needs two assessments (baseline and endpoint), which can be difficult in unstable and difficult to measure conditions such as schizophrenia. We decided primarily to use endpoint data as much as possible, and only used change data if the former were not available. For continuous outcomes, we calculated the mean difference (MD) and 95% confidence intervals (CI) where all outcomes were measured using the same scale or there was only one trial. We also anticipated that different studies might use different instruments (e.g. different outcome measures or psychological tests) to assess the outcomes. In this case, the scale of measurement would differ from study to study and we decided it would only be meaningful to calculate the standardised mean difference (SMD; i.e. by dividing the MD in each study by that study's standard deviation (SD)). We planned to use a SMD value that was comparable across studies in the analysis (<a href="./references#CD011464-bbs2-0021" title="BorensteinM , HedgesLV , HigginsJPT , RothsteinHR . Introduction to Meta‐Analysis. Available from eu.wiley.com/WileyCDA/WileyTitle/productCd‐EHEP002313.html. Wiley, 2011. ">Borenstein 2011</a>), in such circumstances. </p> </section> <section id="CD011464-sec-0077"> <h6 class="title">2.4 Skewed data</h6> <p>Continuous data on clinical and social outcomes are often not normally distributed. To avoid the pitfall of applying parametric tests to non‐parametric data, we applied the following standards to all data before inclusion. </p> <p> <ol id="CD011464-list-0004"> <li> <p>SDs and means are reported in the paper or obtainable from the authors.</p> </li> <li> <p>When a scale starts from the finite number zero, we planned to subtract the lowest possible value from the mean, and divide this by the SD. If this value is lower than 1, it strongly suggests a skew and the study would be excluded. If this ratio is higher than one but below two, there is suggestion of skew. We entered the study and tested whether its inclusion or exclusion would change the results substantially; in the event of significant differences in the results, we performed analyses grouping the unskewed and skewed data separately. Finally, if the ratio is larger than 2 the study would have been included, because skew is less likely (<a href="./references#CD011464-bbs2-0010" title="AltmanDG , BlandJM . Detecting skewness from summary information. BMJ1996;313(7066):1200. ">Altman 1996</a>; <a href="./references#CD011464-bbs2-0031" title="DeeksJJ , HigginsJPT , AltmanDG . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.. Available from hanbook.cochrane.org. ">Deeks 2011</a>). </p> </li> <li> <p>If a scale starts from a positive value (such as the Positive and Negative Syndrome Scale (PANSS; <a href="./references#CD011464-bbs2-0058" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi‐Health Systems, 1986. ">Kay 1986</a>), which can have values from 30 to 210), we planned to modify the calculation described above to take the scale starting point into account. In these cases skew is present if 2 SD &gt; (S‐S min), where S is the mean score and 'S min' is the minimum score. </p> </li> </ol> </p> <p>Endpoint scores on scales often have a finite start and end point and these rules can be applied. Skewed data pose less of a problem when looking at means if the sample size is large (&gt; 200) (<a href="./references#CD011464-bbs2-0071" title='MooreRA , EcclestonC , DerryS , WiffenP , BellBF , StraubeS , et al. "Evidence" in chronic pain ‐ establishing best practice in the reporting of systematic reviews. Pain2010;150:386‐9. '>Moore 2010</a>) and we planned to include these data into the syntheses. We planned to present skewed endpoint data from studies of less than 200 participants in 'other tables' within the data analysis section rather than enter such data into statistical analyses together with the unskewed data. </p> <p>When continuous data are presented on a scale that includes a possibility of negative value (such as change data), it is difficult to tell whether data are skewed or not. We planned to present and enter change data into statistical analyses. </p> </section> <section id="CD011464-sec-0078"> <h6 class="title">2.5 Common measures</h6> <p>To facilitate comparison between trials, we intended to convert variables that can be reported in different metrics, such as days in hospital (mean days per year, per week or per month) to a common metric (e.g. mean days per month). </p> </section> <section id="CD011464-sec-0079"> <h6 class="title">2.6 Conversion of continuous data to binary data</h6> <p>Where possible, we intended to convert outcome measures to dichotomous data. This can be done by identifying cut‐off points on rating scales and dividing participants accordingly into 'clinically improved' or 'not clinically improved'. In general, we assumed that if there was a 50% reduction in a scale‐derived score such as the Brief Psychiatric Rating Scale (BPRS; <a href="./references#CD011464-bbs2-0079" title="OverallJE , GorhamDR . The brief psychiatric rating scale. Psychological Reports1962;10:799‐812. ">Overall 1962</a>), or the Positive and Negative Syndrome Scale (PANSS; <a href="./references#CD011464-bbs2-0058" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi‐Health Systems, 1986. ">Kay 1986</a>), this could be considered as a clinically significant response (<a href="./references#CD011464-bbs2-0064" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelRR . What does the PANSS mean?. Schizophrenia Research2005;79(2‐3):231‐8. [PUBMED: 15982856] ">Leucht 2005a</a>; <a href="./references#CD011464-bbs2-0065" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelR . Clinical implications of brief psychiatric rating scale scores. British Journal of Psychiatry2005;187:366‐71. [PUBMED: 16199797] ">Leucht 2005b</a>). If data based on these thresholds were not available, we planned to use the primary cut‐off presented by the original authors. </p> </section> <section id="CD011464-sec-0080"> <h6 class="title">2.7 Direction of graphs</h6> <p>Where possible, we entered data in such a way that the area to the left of the line of no effect indicates a favourable outcome for trauma‐focused psychological interventions. Where keeping to this made it impossible to avoid outcome titles with clumsy double‐negatives (e.g. 'Not un‐improved') we reported data where the left of the line indicated an unfavourable outcome. This would have been noted in the relevant graphs. </p> </section> </section> </section> <section id="CD011464-sec-0081"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Review authors DS and MF worked independently to assess risk of bias by using criteria described in the <i>Cochrane Handbook for Systemic Reviews of Interventions</i> to assess trial quality (<a href="./references#CD011464-bbs2-0051" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins, JP, Green, S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). This set of criteria is based on evidence of associations between overestimate of effect and high risk of bias of the article, such as sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting. </p> <p>If the raters disagreed, the final rating was made by consensus, with the involvement of other members of the review group (TM and IN). Where inadequate details of randomisation and other characteristics of trials were provided, we contacted the authors of the studies to obtain further information. We also planned to report non‐concurrence in quality assessment, but if disputes arose regarding the category to which a trial was to be allocated, again, we would have resolved these by discussion. </p> <p>We noted the level of risk of bias in both the text of the review and in the 'Summary of findings' tables. </p> </section> <section id="CD011464-sec-0082"> <h4 class="title">Measures of treatment effect</h4> <section id="CD011464-sec-0083"> <h5 class="title">1. Binary data</h5> <p>For binary outcomes we planned to calculate a standard estimation of the risk ratio (RR) and its 95% CI. It has been shown that RR is more intuitive than odds ratios (<a href="./references#CD011464-bbs2-0020" title="BoisselJP , CucheratM , LiW , ChatellierG , GueyffierF , BuyseM , et al. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [Apercu sur la problematique des indices d'efficacite therapeutique, 3: comparaison des indices et utilisation. Groupe d'Etude des Indices D'efficacite]. Therapie1999;54(4):405‐11. [PUBMED: 10667106] ">Boissel 1999</a>), and that odds ratios tend to be interpreted as RR by clinicians (<a href="./references#CD011464-bbs2-0030" title="DeeksJ . Issues in the selection for meta‐analyses of binary data. 8th International Cochrane Colloquium; 2000 Oct 25‐28; Cape Town. Cape Town: The Cochrane Collaboration, 2000. ">Deeks 2000</a>). The number needed to treat for an additional beneficial outcome (NNTB)/number needed to treat for an additional harmful outcome (NNTH) statistic with its CIs is intuitively attractive to clinicians but is problematic both in its accurate calculation in meta‐analyses and interpretation (<a href="./references#CD011464-bbs2-0054" title="HuttonJL . Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials. British Journal of Haematology2009;146(1):27‐30. ">Hutton 2009</a>). For binary data presented in the 'Summary of findings' tables, where possible, we planned to calculate illustrative comparative risks. </p> </section> <section id="CD011464-sec-0084"> <h5 class="title">2. Continuous data</h5> <p>For continuous outcomes, we calculated the mean difference (MD) and its 95% CI where all outcomes were measured using the same scale or where there was only one trial. If different scales had been used, we planned to calculate the standardised mean difference (SMD) and 95% CI. We preferred not to calculate effect size measures (SMD). However, if scales of very considerable similarity had been used, we would have considered that there was a small difference in measurement, and proceeded to calculate effect size and transform the effect back to the units of one or more of the specific instruments. </p> </section> </section> <section id="CD011464-sec-0085"> <h4 class="title">Unit of analysis issues</h4> <section id="CD011464-sec-0086"> <h5 class="title">1. Cluster trials</h5> <p>Studies increasingly employ 'cluster randomisation' (such as randomisation by clinician or practice) but analysis and pooling of clustered data poses problems. Firstly, authors often fail to account for intra‐class correlation in clustered studies, leading to a 'unit of analysis' error whereby P values are spuriously low (<a href="./references#CD011464-bbs2-0032" title="DivineGW , BrownJT , FrazierLM . The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine1992;7(6):623‐9. ">Divine 1992</a>), CIs are unduly narrow and statistical significance overestimated. This causes type I errors (<a href="./references#CD011464-bbs2-0019" title="BlandJM . Statistics notes. Trials randomised in clusters. BMJ1997;315:600. ">Bland 1997</a>; <a href="./references#CD011464-bbs2-0047" title="GullifordMC . Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149:876‐83. ">Gulliford 1999</a>). </p> <p>Where clustering had not been accounted for in primary studies, we planned to present data in a table, with a (*) symbol to indicate the presence of a probable unit of analysis error. In subsequent versions of this review, if we include cluster‐randomised trials, we will contact the first or corresponding authors of studies to obtain intra‐class correlation coefficients (ICCs) for their clustered data and will adjust for this by using accepted methods (<a href="./references#CD011464-bbs2-0047" title="GullifordMC . Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149:876‐83. ">Gulliford 1999</a>). If clustering has been incorporated into the analysis of primary studies, we will present these data as if from a non‐cluster randomised study, but adjust for the clustering effect. </p> <p>We sought statistical advice and have been advised that the binary data as presented in a report should be divided by a 'design effect'. This is calculated using the mean number of participants per cluster (m) and the ICC [Design effect = 1+(m‐1)*ICC] (<a href="./references#CD011464-bbs2-0033" title="DonnerA , KlarN . Issues in the meta‐analysis of cluster randomized trials. Statistics in Medicine2002;21:2971‐80. ">Donner 2002</a>). If the ICC was not reported, we would assume it to be 0.1 (<a href="./references#CD011464-bbs2-0097" title="UkoumunneOC , GullifordMC , ChinnS , SterneJAC , BurneyPGJ . Methods for evaluating area‐wide and organisation‐based intervention in health and health care: a systematic review. Health Technology Assessment1999;3(5):1‐75. ">Ukoumunne 1999</a>). If cluster studies have been appropriately analysed taking into account ICCs and relevant data documented in the report, synthesis with other studies will be possible using the generic inverse variance technique. </p> </section> <section id="CD011464-sec-0087"> <h5 class="title">2. Cross‐over trials</h5> <p>A major concern of cross‐over trials is the carry‐over effect. It occurs if an effect (e.g. pharmacological, physiological or psychological) of the treatment in the first phase is carried over to the second phase. As a consequence, the participants can differ systematically from their initial state on entry to the second phase, despite a wash‐out phase. For the same reason cross‐over trials are not appropriate if the condition of interest is unstable (<a href="./references#CD011464-bbs2-0037" title="ElbourneD , AltmanDG , HigginsJPT , CurtinaF , WorthingtondHV , VaileA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31(1):140‐9. ">Elbourne 2002</a>). As both effects are very likely in severe mental illness, we planned only to use data from the first phase of cross‐over studies if included in the review. </p> </section> <section id="CD011464-sec-0088"> <h5 class="title">3. Studies with multiple treatment groups</h5> <p>We included a study that involved more than two treatment arms: <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> investigated two types of trauma‐focused psychological interventions and compared them as a distinctive treatment condition respectively against the waiting‐list control condition. We have presented the data of all three treatment arms in comparisons (see <a href="#CD011464-sec-0194">Summary of main results</a>). Had the additional treatment arms not been relevant, we would not have used these data. </p> </section> </section> <section id="CD011464-sec-0089"> <h4 class="title">Dealing with missing data</h4> <section id="CD011464-sec-0090"> <h5 class="title">1. Overall loss of credibility</h5> <p>At some degree of loss of follow‐up, the data must lose credibility (<a href="./references#CD011464-bbs2-0103" title="XiaJ , AdamsCE , BhagatN , BhagatV , BhoopathiP , El‐SayehH , et al. Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin2009;33(7):254‐7. ">Xia 2009</a>). We chose that, for any particular outcome, should more than 50% of the data be unaccounted for, we would not reproduce the data or use them within analyses. If, however, more than 50% of those in one arm of a study were lost, but the total loss across arms was less than 50%, we addressed this within the 'Summary of findings' tables by down‐rating quality. This was the case with one included study (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>), which had a loss of follow‐up rate of 71% (i.e. five out of seven participants allocated to the treatment as usual (TAU) control arm) at six‐month follow‐up time point, although the overall loss of follow‐up combining both active treatment and control arms was 53% (i.e. only three out of 10 participants allocated to the active treatment arm were lost). </p> </section> <section id="CD011464-sec-0091"> <h5 class="title">2. Binary</h5> <p>In the case where attrition for a binary outcome was between 0% and 50% and where these data were not clearly described, we planned to present data on a 'once‐randomised‐always‐analyse' basis (an intention‐to‐treat (ITT) analysis). We planned to undertake sensitivity analyses by imputing outcomes for the missing participants with the most optimistic scenario and with the most pessimistic scenario and then compare the results of these two analyses. We also planned to undertake sensitivity analyses to test how prone the primary outcomes were to change when only data from people who completed the study (i.e. available‐case analysis) were compared to the ITT analysis using the above assumptions. For the current review, we did not encounter this level of missing binary outcome data and therefore did not undertake the aforementioned sensitivity analyses. </p> </section> <section id="CD011464-sec-0092"> <h5 class="title">3. Continuous</h5> <section id="CD011464-sec-0093"> <h6 class="title">3.1 Attrition</h6> <p>In the case when attrition for a continuous outcome was between 0 and 50%, and only data from people who completed the study to that point were reported, we planned to reproduce these. </p> </section> <section id="CD011464-sec-0094"> <h6 class="title">3.2 Standard deviations</h6> <p>If SDs were not reported, as in one included study (<a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>), we contacted the trial authors who provided us with the raw group means and SDs of all reported outcomes, which we presented and used in the review. If these were not available, where there were missing measures of variance for continuous data, but an exact standard error (SE) and CIs available for group means, and either P value or 't' value available for differences in mean, we could have calculated them according to the rules described in the <i>Cochrane Handbook for Systemic reviews of Interventions</i> (<a href="./references#CD011464-bbs2-0051" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins, JP, Green, S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). When only the SE is reported, SDs are calculated by the formula SD = SE * square root (n). Chapters 7.7.3 and 16.1.3 of the <i>Cochrane Handbook for Systemic reviews of Interventions</i> present detailed formulae for estimating SDs from P values, t or F values, CIs, ranges or other statistics. If these formulae did not apply, we would have calculated the SDs according to a validated imputation method that is based on the SDs of the other included studies (<a href="./references#CD011464-bbs2-0044" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta‐analyses can provide accurate results. Journal of Clinical Epidemiology2006;59(7):7‐10. ">Furukawa 2006</a>). Although some of these imputation strategies can introduce error, the alternative would be to exclude a given study’s outcome and thus to lose information. We nevertheless also planned to examine the validity of the imputations in a sensitivity analysis excluding imputed values. </p> </section> <section id="CD011464-sec-0095"> <h6 class="title">3.3 Assumptions about participants who left the trials early or were lost to follow‐up</h6> <p>Various methods are available to account for participants who left the trials early or were lost to follow‐up. Some trials just present the results of study completers (this was the case with three included studies: <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>), others use the method of last observation carried forward (LOCF) or more sophisticated approaches, such as multiple imputation or mixed‐effects models for repeated measurements (MMRM) (<a href="./references#CD011464-bbs2-0063" title="LeonAC , MallinckrodtCH , Chuang‐SteinC , ArchibaldDG , ArcherGE , ChartierK . Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. Biological Psychiatry2006;59(11):1001‐5. [PUBMED: 16905632] ">Leon 2006</a>). As all methods of imputation to deal with missing data introduce uncertainty about the reliability of the results (<a href="./references#CD011464-bbs2-0066" title="LeuchtS , EngelRR , BaumlJ , DavisJM . Is the superior efficacy of new generation antipsychotics an artefact of LOCF?. Schizophrenia Bulletin2007;33(1):183‐91. ">Leucht 2007</a>), we obtained the completers' outcome data from the authors which we presented and used in the review. Moreover, we also addressed this issue in the 'incomplete outcome data' item of the 'Risk of bias' tool. </p> </section> </section> </section> <section id="CD011464-sec-0096"> <h4 class="title">Assessment of heterogeneity</h4> <section id="CD011464-sec-0097"> <h5 class="title">1. Clinical heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge clinical heterogeneity. We simply inspected all studies for clearly outlying people or situations that we had not predicted would arise. If such situations or participant groups arose, these would have been fully discussed by all review authors. </p> </section> <section id="CD011464-sec-0098"> <h5 class="title">2. Methodological heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge methodological heterogeneity. Again, we simply inspected all studies for clearly outlying methods that we had not predicted would arise. When such methodological outliers arose, the review authors discussed these fully. </p> </section> <section id="CD011464-sec-0099"> <h5 class="title">3. Statistical heterogeneity</h5> <section id="CD011464-sec-0100"> <h6 class="title">3.1 Visual inspection</h6> <p>We inspected graphs visually to investigate the possibility of statistical heterogeneity.</p> </section> <section id="CD011464-sec-0101"> <h6 class="title">3.2 Employing the I<sup>2</sup> statistic </h6> <p>We investigated heterogeneity between studies by considering the I<sup>2</sup> method alongside the Chi<sup>2</sup> P value. The I<sup>2</sup> provides an estimate of the percentage of inconsistency thought to be due to chance (<a href="./references#CD011464-bbs2-0050" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>). The importance of the observed value of I<sup>2</sup> depends on firstly, magnitude and direction of effects and secondly, the strength of evidence for heterogeneity (e.g. P value from Chi<sup>2</sup>  test, or a CI for I<sup>2</sup>). We interpreted an I<sup>2</sup> estimate greater than or equal to around 50% accompanied by a statistically significant Chi<sup>2</sup> statistic as evidence of substantial levels of heterogeneity (Section 9.5.2; <a href="./references#CD011464-bbs2-0031" title="DeeksJJ , HigginsJPT , AltmanDG . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.. Available from hanbook.cochrane.org. ">Deeks 2011</a>). When substantial levels of heterogeneity were found in the primary outcome, we explored reasons for heterogeneity (<a href="#CD011464-sec-0106">Subgroup analysis and investigation of heterogeneity</a>). </p> </section> </section> </section> <section id="CD011464-sec-0102"> <h4 class="title">Assessment of reporting biases</h4> <section id="CD011464-sec-0103"> <h5 class="title">1. Protocol versus full study</h5> <p>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results. These are described in section 10.1 of the <i>Cochrane Handbook for Systemic reviews of Interventions</i> (<a href="./references#CD011464-bbs2-0095" title="SterneJAC , EggerM , MoherD . Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Sterne 2011</a>). We tried to locate protocols of included randomised trials by both searching the databases and by contacting authors of registered trials. Whenever the protocol was available, we compared outcomes in the protocol and in the published report. If the protocol was not available, we compared outcomes listed in the methods section of the trial report with the results reported. </p> </section> <section id="CD011464-sec-0104"> <h5 class="title">2. Funnel plot</h5> <p>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results (<a href="./references#CD011464-bbs2-0034" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315:629‐34. ">Egger 1997</a>). These are again described in Section 10 of the <i>Cochrane Handbook for Systemic reviews of Interventions</i> (<a href="./references#CD011464-bbs2-0095" title="SterneJAC , EggerM , MoherD . Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Sterne 2011</a>). We are aware that funnel plots may be useful in investigating reporting biases but have limited power to detect small‐study effects. We therefore did not use funnel plots for outcomes where there were 10 or fewer studies, or where all studies were of similar sizes. In other cases, where funnel plots were possible, we planned to seek statistical advice in their interpretation. </p> </section> </section> <section id="CD011464-sec-0105"> <h4 class="title">Data synthesis</h4> <p>We understand that there is no closed argument for preference for the use of fixed‐effect or random‐effects models. The random‐effects method incorporates an assumption that the different studies are estimating different, yet related, intervention effects. This often seems to be true to us and the random‐effects model takes into account differences between studies, even if there is no statistically significant heterogeneity. There is, however, a disadvantage to the random‐effects model. It puts added weight onto small studies which often are the most biased ones. Depending on the direction of effect, these studies can either inflate or deflate the effect size. As there were only few studies (i.e. four studies in total, and a maximum of three included in some analyses), random‐effects model analyses may be inadequate to estimate accurately the width of the distribution of intervention effects (<a href="./references#CD011464-bbs2-0031" title="DeeksJJ , HigginsJPT , AltmanDG . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.. Available from hanbook.cochrane.org. ">Deeks 2011</a>; <a href="./references#CD011464-bbs2-0061" title="KontopantelisE , SpringateDA , ReevesD . A re‐analysis of the Cochrane Library data: the dangers of unobserved heterogeneity in meta‐analyses. PLoS ONE2013;8(7):e69930. ">Kontopantelis 2013</a>). We chose to use the random‐effects model for analyses involving more than one study, and check and note if the analysis results were different if using a fixed‐effect model. The reader is, however, able to choose to inspect the data using the fixed‐effect model. </p> </section> <section id="CD011464-sec-0106"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <section id="CD011464-sec-0107"> <h5 class="title">1. Subgroup analyses</h5> <section id="CD011464-sec-0108"> <h6 class="title">1.1 Primary outcomes</h6> <p>We proposed to perform subgroup analyses by age (i.e. adults versus adolescents &lt; 18 years of age) and by types of trauma (i.e. conventional trauma, such as road traffic accidents, physical or sexual assaults versus SMI symptom‐related trauma, such as persecutory delusions). We planned to undertake these comparisons only for the primary outcomes to minimise the risk of multiple comparisons. </p> </section> <section id="CD011464-sec-0109"> <h6 class="title">1.2 Clinical state, stage or problem</h6> <p>We proposed to undertake this review and provide an overview of the effects of psychological interventions for PTSD in people with SMI in general. In addition, however, we planned to report data on subgroups of people with similar clinical presentations and demographics. </p> </section> </section> <section id="CD011464-sec-0110"> <h5 class="title">2. Investigation of heterogeneity</h5> <p>If inconsistency was high, this would have been reported. Firstly, we planned to investigate whether data had been entered correctly. Secondly, if data were correct, we would proceed to inspect the graph visually and remove outlying studies successively to see if homogeneity was restored. For this review, we decided that, should this occur with data contributing to the summary finding of no more than around 10% of the total weighting, the data would have been presented. If not, data would not be pooled and issues would be discussed. We know of no research that supports this 10% cut‐off, but are investigating use of prediction intervals as an alternative to this unsatisfactory state. </p> <p>When unanticipated clinical or methodological heterogeneity were obvious, we planned to simply state hypotheses regarding these for future reviews or versions of this review. We had not pre‐planned any analyses relating to these. </p> </section> </section> <section id="CD011464-sec-0111"> <h4 class="title">Sensitivity analysis</h4> <section id="CD011464-sec-0112"> <h5 class="title">1. Implication of randomisation</h5> <p>We planned to include trials in a sensitivity analysis if they were described in some way that implied randomisation. For the primary outcomes, we planned to include these studies and, if there was no substantive difference when the implied randomised studies were added to those with better description of randomisation, then all data would have been employed from these studies. </p> </section> <section id="CD011464-sec-0113"> <h5 class="title">2. Assumptions for lost binary data</h5> <p>If assumptions had to be made regarding people lost to follow‐up (see <a href="#CD011464-sec-0089">Dealing with missing data</a>), we planned to compare the findings of the primary outcomes when we used our assumptions and when we used only the data from people who completed the study to that point. If there was a substantial difference, we would have reported the results and discuss them, but would have continued to employ our assumption(s). </p> <p>If assumptions had to be made regarding missing SDs (see <a href="#CD011464-sec-0089">Dealing with missing data</a>), we planned to compare the findings of the primary outcomes when we used our assumptions and when we used data only from people who completed the study to that point. We planned to undertake a sensitivity analysis to test how prone results were to change when completer‐only data were compared to the imputed data using the above assumptions. If these analyses yielded similar results in terms of the effects of the treatment, we would have presented the results of the available‐case analyses. If there was a substantial difference, we would have reported and discussed the difference and presented all results in the 'Summary of findings' tables. </p> </section> <section id="CD011464-sec-0114"> <h5 class="title">3. Risk of bias</h5> <p>We intended to analyse the effects of excluding trials that were judged to be at high risk of bias across one or more of the domains of randomisation (i.e. implied as randomised with no further details available), allocation concealment, blinding and outcome reporting for the meta‐analysis of the primary outcome. If the exclusion of trials at high risk of bias did not substantially alter the direction of effect or the precision of the effect estimates, then we would have included data from these trials in the analysis. </p> </section> <section id="CD011464-sec-0115"> <h5 class="title">4. Imputed values</h5> <p>If we had included cluster‐randomised trials, if necessary, we planned to undertake a sensitivity analysis to assess the effects of including data from trials where we had used imputed values for ICC in calculating the design effect in cluster‐randomised trials. </p> <p>If substantial differences were noted in the direction or precision of effect estimates in any of the sensitivity analyses listed above, we would not have pooled data from the excluded trials with the other trials contributing to the outcome, but would have presented them separately. </p> </section> <section id="CD011464-sec-0116"> <h5 class="title">5. Fixed‐effect and random‐effects models</h5> <p>As aforementioned (<a href="#CD011464-sec-0105">Data synthesis</a>), we synthesised data using a random‐effects model primarily and further compared the results obtained from using both random‐effects and fixed‐effect models to seek potential bias and heterogeneity (<a href="./references#CD011464-bbs2-0061" title="KontopantelisE , SpringateDA , ReevesD . A re‐analysis of the Cochrane Library data: the dangers of unobserved heterogeneity in meta‐analyses. PLoS ONE2013;8(7):e69930. ">Kontopantelis 2013</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011464-sec-0117" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011464-sec-0117"></div> <section id="CD011464-sec-0118"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD011464-sec-0219" title="">Characteristics of included studies</a> and <a href="./references#CD011464-sec-0220" title="">Characteristics of excluded studies</a> for detailed description of each screened study. </p> <section id="CD011464-sec-0119"> <h4 class="title">Results of the search</h4> <p>The search results from the Cochrane Schizophrenia Group Trial Register yielded 35 unique titles and abstracts. After examination, two duplicates were removed and two additional references which belong to two studies were identified by contacting trial authors and updated publication of registered trials (31st March 2015). Seventeen full‐text articles or trial registration details of eight studies were assessed for inclusion or exclusion. For trials that included people with severe mental illness (SMI) as participants with others who had a non‐SMI diagnosis as defined by this review as their primary diagnosis, we contacted the trial authors by email for specific data in relation to the SMI participants. We also contacted trial authors to inquire if they had unpublished or completed study outcomes relevant for this review, again by email correspondence. Trial authors' responses are summarised in the <a href="./references#CD011464-sec-0219" title="">Characteristics of included studies</a> and <a href="./references#CD011464-sec-0220" title="">Characteristics of excluded studies</a> sections. The results of the search is summarised in <a href="#CD011464-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD011464-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011464-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011464-sec-0120"> <h4 class="title">Included studies</h4> <p>With additional subgroup data specific to participants with a psychotic disorder (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>) and unpublished data obtained from trial authors (<a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>), four studies (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>) were included that met all the inclusion criteria and provided data specific to individuals with co‐morbid psychotic disorder and post‐traumatic stress disorder (PTSD) (n = 300). See also <a href="./references#CD011464-sec-0219" title="">Characteristics of included studies</a> for description of the four included studies (including eight papers and/or trial registration detail). </p> <section id="CD011464-sec-0121"> <h5 class="title">1. Design</h5> <p>All included studies were described as 'randomised'. <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> reported using an independent randomisation bureau to randomise the participants into the three treatment conditions using "stratified randomisation blocks per therapist with equal strata sizes" (<a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>, p. e3). Altogether, 20 therapists were trained in both active interventions trialled in the study (i.e. Prolonged Exposure (PE) and eye movement desensitisation and reprocessing (EMDR)), they delivered both treatments and it was not possible to blind them to the participant‐allocation. <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a> reported using a computer‐based randomisation programme to randomly allocate participants to the two arms in blocks of four within each of the 12 strata (i.e. stratification was devised by four treatment sites and by the three major diagnostic groups, i.e. major mood disorder with or without borderline personality disorder and schizophrenia or schizoaffective disorder). Another study by Mueser (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>) also used a computer programme operated by an off‐site data manager for randomisation which was stratified by sites (i.e. five) and by primary diagnosis (i.e. three similar to the aforementioned categories used in <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>). In both USA‐based studies, it was not possible to blind the therapists nor the participants to the treatment‐allocation (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>). <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a> did not describe the method used to randomly allocate the participants, however, it was clear that neither the therapist nor the participants were blinded to the treatment allocation. </p> </section> <section id="CD011464-sec-0122"> <h5 class="title">2. Setting</h5> <p><a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>'s three‐arm randomised controlled trial (RCT) was based in the Netherlands; <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>'s trial was based in the State of New Hampshire, USA, while a more recent trial by Mueser and colleagues (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>), was based in the State of New Jersey, USA. <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>'s study was based in South East England, UK. Both trials based in the USA (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>), recruited individuals in community dwellings who had a diagnosis of SMI and a co‐morbid PTSD. The UK‐based study (<a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>), and the Netherlands study (<a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>), also focused on community‐dwelling patients. All patients received the psychological treatment at out‐patient clinics. </p> </section> <section id="CD011464-sec-0123"> <h5 class="title">3. Participants</h5> <p>All participants in <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a> (n = 61) had a diagnosis of schizophrenia or schizoaffective disorder and current symptoms consistent with a diagnosis of PTSD, both with reference to the DSM‐IV diagnostic criteria (<a href="./references#CD011464-bbs2-0012" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edition, text rev.). Washington DC: APA, 2000. ">APA, 2000</a>). <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> recruited 155 adults with a lifetime diagnosis of a psychotic disorder or mood disorder with psychotic features according to the Mini‐International Neuropsychiatric Interview‐Plus (<a href="./references#CD011464-bbs2-0092" title="SheehanDV , LecrubierY , Harnett SheehanK , JanavsJ , WeillerE , KeskinerA , et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID‐P and its reliability. European Psychiatry1997;12(5):232‐41. ">Sheehan 1997</a>; <a href="./references#CD011464-bbs2-0093" title="SheehanDV , LecrubierY , Harnett SheehanK , AmorimP , JanavsJ , Weiller , et al. The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM‐IV and ICD‐10. Journal of Clinical Psychiatry1998;59(Suppl 20):22‐33. ">Sheehan 1998</a>) and a concurrent diagnosis of chronic PTSD meeting all the DSM‐IV‐tr criteria (<a href="./references#CD011464-bbs2-0012" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edition, text rev.). Washington DC: APA, 2000. ">APA, 2000</a>). The two USA‐based studies recruited individuals meeting the State of New Hampshire (n = 108) (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>) or State of New Jersey (n = 201) (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>) definition of 'severe mental illness' which included a range of DSM‐IV Axis‐I disorders (including schizophreniform disorders, schizoaffective disorders, major depression or bipolar disorder) and persistent impairment in the areas of work, school, or ability to care for oneself, and a DSM‐IV diagnosis of severe PTSD. Out of the total 108 participants in <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>, 17 individuals (16%) had co‐morbid psychotic disorder and PTSD. And, 67 out of the total 201 participants (33%) in <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a> met the inclusion criteria of co‐morbid SMI and PTSD as defined by this review. All 300 participants across the four studies were adults aged 18 or above, as stipulated in the study eligibility criteria. Apart from <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a> (which was not yet published at the time of writing this review but the lead trialist provided us with some unpublished outcome data), the remaining three studies recruited community‐dwelling patients with an average age of early to mid 40s (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>, <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>). There were more female than male patients in both USA studies with female samples ranging from 61% (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>) to 71% (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>). <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>'s trial included 71 male patients (46%) and 84 female patients (54%). </p> </section> <section id="CD011464-sec-0124"> <h5 class="title">4. Nature of trauma and duration of trauma symptoms</h5> <p>Assessment for a current diagnosis of PTSD in all potentially eligible participants across all included studies (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>) was conducted by using the Clinician Administered PTSD Scale (CAPS by <a href="./references#CD011464-bbs2-0018" title="BlakeDD , WeathersFW , NagyLM , KaloupekDG , GusmanFD , CharneyDS , et al. The development of a clinician administered PTSD scale. Journal of Traumatic Stress1995;8(1):75‐90. ">Blake 1995</a>; <a href="./references#CD011464-bbs2-0101" title="WeathersFW , KeaneTM , DavidsonJR . Clinician‐Administered PTSD Scale: a review of the first ten years of research. Depression and Anxiety2001;13(3):132‐56. ">Weathers 2001</a>). <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a> specified that their intervention focused on people with severe PTSD as defined by having a minimum CAPS total score of 65 (<a href="./references#CD011464-bbs2-0101" title="WeathersFW , KeaneTM , DavidsonJR . Clinician‐Administered PTSD Scale: a review of the first ten years of research. Depression and Anxiety2001;13(3):132‐56. ">Weathers 2001</a>). While <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> specified a diagnosis of chronic PTSD as part of their inclusion criteria for their participants; no minimum duration of PTSD symptoms was stipulated as part of the eligibility criteria, although the baseline data of all participants (n = 155) reported an average duration of PTSD of 21 years (SD = 13.5 years). No details could be found in relation to the nature of traumatic events participants experienced in two studies (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>). Nonetheless, in the remaining studies that reported the nature of the trauma the participants experienced (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>), it was reported that most participants experienced multiple childhood traumas, including sexual, emotional and physical abuse. <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> further identified 28 participants (18%) who developed PTSD due to traumatic psychosis experiences. </p> </section> <section id="CD011464-sec-0125"> <h5 class="title">5. Interventions</h5> <section id="CD011464-sec-0126"> <h6 class="title">5.1 Intervention groups</h6> <p>In order to compare data in a meaningful way, we had made an a priori decision to group different psychological interventions based upon their theoretical basis into four categories when devising our review protocol (see <a href="#CD011464-sec-0054">Types of interventions</a>). These four categories of trauma‐focused interventions were: individual trauma‐focused cognitive behavioural therapy (TF‐CBT) including exposure‐based therapy; group TF‐CBT; EMDR; and any other psychological intervention with an explicit aim to treat PTSD symptoms and related distress.The interventions trialled in the included studies are described below. </p> <p><b>5.1.1 Individual trauma‐focused cognitive behavioural therapy (TF‐CBT)</b> </p> <p>All four included studies evaluated TF‐CBT that was delivered to patients on an individual basis. <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a> reported devising and trialling a 12‐ to 16‐week CBT programme that was developed based on cognitive models of PTSD (<a href="./references#CD011464-bbs2-0035" title="EhlersA , ClarkDM , HackmannA , McManusF , FennellM . Cognitive therapy for post‐traumatic stress disorder: development and evaluation. Behaviour Research andTherapy2005;43(4):413‐31. ">Ehlers 2005</a>; <a href="./references#CD011464-bbs2-0052" title="HorowitzMJ , WilnerNR , AlvarezW . Impact of event scale ‐ a measure of subjective stress. Psychosomatic Medicine1979;41:209‐18. ">Horowitz 1979</a>): the initial three sessions were dedicated to teaching breathing retraining for anxiety and psychoeducation about PTSD; while the remaining nine to 13 sessions focused on cognitive restructuring. Treatment exposure was a priori defined as completion of at least six sessions. An earlier study by <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a> also trialled a 12‐ to 16‐ session CBT for PTSD programme, with the initial few sessions focusing on psychoeducation and breathing retraining and the remaining sessions split into two parts of cognitive restructuring. Again, participants were required to complete at least six sessions including a minimum of three sessions of cognitive restructuring, to satisfy the definition of treatment exposure. The UK‐based study by <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a> adopted the 16‐sessions CBT programme developed by <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a> in which the 12‐to 16‐session CBT programme was delivered to patients individually over a six‐month duration. <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> devised and trialled eight sessions prolonged exposure (PE) therapy run within a 10‐week time frame, which was developed based upon a protocol by Foa et al (<a href="./references#CD011464-bbs2-0043" title="FoaEB , HembreeEA , RothbaumBO . Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences ‐ Therapist Guide. Oxford, England: Oxford University Press, 2007. ">Foa 2007</a>). Whilst the first of the eight 90‐minute PE sessions was used to develop a case conceptualisation between the therapist and the individual patient, the remaining sessions focused on imaginal and in vivo exposure targeting a list of avoided trauma‐related stimuli. </p> <p><b>5.1.2 Group TF‐CBT</b> </p> <p>No study reported on group‐based interventions.</p> <p><b>5.1.3 Eye movement desensitisation and reprocessing (EMDR)</b> </p> <p>An eight weekly 90‐minute EMDR therapy delivered to patients individually over a 10‐week period was also trialled in <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>. The study used the Dutch EMDR therapy protocol (<a href="./references#CD011464-bbs2-0029" title="deJonghA , tenBroekeE . Handbook of EMDR: A Standardised Treatent for the Consequences of Psychotrauma. Amsterdam, the Netherlands: Harcourt, 2003. ">de Jongh 2003</a>), which was translated and adapted from the standard eight‐phase protocol by Shapiro (<a href="./references#CD011464-bbs2-0091" title="ShapiroF . Eye Movement Desensitization and Reprocessing, Basic Principles, Protocols and Procesures. 2nd Edition. New York: The Guilford Press, 2001. ">Shapiro 2001</a>). Bilateral eye movements were applied as the dual‐attention stimuli when traumatic memories were processed from the second through to the eighth (i.e. last) session, whilst the first session was used to develop a case conceptualisation including identifying a hierarchy of relevant traumatic experiences for the individual patients. </p> <p><b>5.1.4 Any other trauma‐focused psychological intervention that does not fit the above categories of modality and format</b> </p> <p>In addition to the TF‐CBT programme, <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a> also trialled a brief PTSD psychoeducation programme, adapted from an earlier therapy the researchers developed to educate persons with SMI about PTSD (<a href="./references#CD011464-bbs2-0080" title="PrattSI , RosenbergSD , MueserKT , BrancatoJ , SalyersMP , JankowskiMK , et al. Evaluation of a PTSD psychoeducational program for psychiatric inpatients. Journal of Mental Health2005;14:121‐7. ">Pratt 2005</a>). The brief psychoeducation programme included three sessions, the first of which covered the same breathing retraining and education components as the TF‐CBT programme, which was tested in the other arm of the study. The remaining two sessions focused on education on anxiety management and discussion about the causes and nature of PTSD. Treatment exposure was defined a priori as completion of at least two sessions. </p> </section> <section id="CD011464-sec-0127"> <h6 class="title">5.2 Comparison groups</h6> <p>Comparisons most commonly used were 'Treatment as Usual (TAU)' or 'standard treatment' which usually included out‐patient follow‐up and case management or care co‐ordination, pharmacological treatment and access to a range of supportive psychotherapies excluding any trauma‐focused therapies (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>). <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> used a 'wait list' (WL) control group as comparison to the PE and EMDR groups, participants in the WL group received the usual treatment during the 6‐month follow‐up period and was then offered either PE or EMDR based on their own choice after the follow‐up period. <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a> used the brief PTSD psychoeducation programme (as detailed in Section 5.1.4) as an active comparison against the TF‐CBT programme. </p> </section> </section> <section id="CD011464-sec-0128"> <h5 class="title">6. Outcomes</h5> <section id="CD011464-sec-0129"> <h6 class="title">6.1 Outcome scales</h6> <p>Primary outcomes of the review were PTSD symptom severity and quality of life or well‐being of the individuals with co‐morbid SMI and PTSD (see <a href="#CD011464-sec-0058">Primary outcomes</a> for further details). Secondary outcomes included patients' psychotic symptoms, depressive and anxiety symptoms, adverse events, leaving the study early, satisfaction or perceived acceptability of treatment, and health economic outcomes (see <a href="#CD011464-sec-0061">Secondary outcomes</a>). Most of these outcomes were reported by the four included studies, using various scales as described below. </p> <p><b>6.1.1 PTSD symptom severity</b> </p> <p>All four included studies (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>) reported clinician‐rated PTSD symptom severity and loss of PTSD diagnosis (i.e. remission from PTSD with sub‐threshold PTSD symptoms) and/or recovery from PTSD (i.e. asymptomatic of PTSD) as the primary outcome of their study aims. The Clinician Administered PTSD Scale (CAPS by <a href="./references#CD011464-bbs2-0018" title="BlakeDD , WeathersFW , NagyLM , KaloupekDG , GusmanFD , CharneyDS , et al. The development of a clinician administered PTSD scale. Journal of Traumatic Stress1995;8(1):75‐90. ">Blake 1995</a>; <a href="./references#CD011464-bbs2-0101" title="WeathersFW , KeaneTM , DavidsonJR . Clinician‐Administered PTSD Scale: a review of the first ten years of research. Depression and Anxiety2001;13(3):132‐56. ">Weathers 2001</a>) was used as the study's primary outcome measure in all four studies, with <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a> specifying using the CAPS‐schizophrenia version (<a href="./references#CD011464-bbs2-0046" title="GearonJS , BellackAS , TenhulaWN . Preliminary reliability and validity of the Clinician‐Administered PTSD Scale for schizophrenia. Journal of Consulting and Clinical Psychology2004;72:121‐5. ">Gearon 2004</a>). CAPS is a widely used, reliable and valid semi‐structured interview for the assessment of PTSD symptoms (<a href="./references#CD011464-bbs2-0046" title="GearonJS , BellackAS , TenhulaWN . Preliminary reliability and validity of the Clinician‐Administered PTSD Scale for schizophrenia. Journal of Consulting and Clinical Psychology2004;72:121‐5. ">Gearon 2004</a>; <a href="./references#CD011464-bbs2-0101" title="WeathersFW , KeaneTM , DavidsonJR . Clinician‐Administered PTSD Scale: a review of the first ten years of research. Depression and Anxiety2001;13(3):132‐56. ">Weathers 2001</a>). For each PTSD symptom, a frequency and intensity rating is provided, with overall severity scores computed by summing the frequency and intensity scores for all of the PTSD symptoms, i.e. CAPS‐total (<a href="./references#CD011464-bbs2-0018" title="BlakeDD , WeathersFW , NagyLM , KaloupekDG , GusmanFD , CharneyDS , et al. The development of a clinician administered PTSD scale. Journal of Traumatic Stress1995;8(1):75‐90. ">Blake 1995</a>; <a href="./references#CD011464-bbs2-0101" title="WeathersFW , KeaneTM , DavidsonJR . Clinician‐Administered PTSD Scale: a review of the first ten years of research. Depression and Anxiety2001;13(3):132‐56. ">Weathers 2001</a>). The higher the CAPs‐total scores, the more severe the PTSD symptoms. </p> <p>In addition, the cut‐off of CAPS‐total score (i.e. less than 40) (<a href="./references#CD011464-bbs2-0101" title="WeathersFW , KeaneTM , DavidsonJR . Clinician‐Administered PTSD Scale: a review of the first ten years of research. Depression and Anxiety2001;13(3):132‐56. ">Weathers 2001</a>) was used by three studies (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>) to determine the number of participants achieving remission from PTSD or sub‐threshold PTSD symptom severity (i.e. loss of diagnosis of PTSD) following treatment and at follow‐up. Furthermore, <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> used the CAPS‐total cut‐off of less than 20 (<a href="./references#CD011464-bbs2-0101" title="WeathersFW , KeaneTM , DavidsonJR . Clinician‐Administered PTSD Scale: a review of the first ten years of research. Depression and Anxiety2001;13(3):132‐56. ">Weathers 2001</a>) as a binary measure to indicate recovery or full remission from PTSD (i.e. asymptomatic or few symptoms of PTSD). <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a> focused on individuals with SMI and severe PTSD as defined by a minimum CAPS‐total score of 65 (<a href="./references#CD011464-bbs2-0101" title="WeathersFW , KeaneTM , DavidsonJR . Clinician‐Administered PTSD Scale: a review of the first ten years of research. Depression and Anxiety2001;13(3):132‐56. ">Weathers 2001</a>) on entry to the trial, after the intervention and at follow‐up time points; this CAPS‐total cut‐off point of 65 was used again as binary outcome for remission from (or loss of diagnosis of) severe PTSD. </p> <p>A number of validated outcome measures were used by the included studies to report self‐rated PTSD symptoms. These included: the Posttraumatic Cognitions Inventory (PTCI by <a href="./references#CD011464-bbs2-0042" title="FoaEB , EhlersA , ClarkDM , TolinDF , OrsilloSM . The Posttraumatic Cognitions Inventory (PTCI): development and validation. Psychological Assessment1999;11:303‐14. ">Foa 1999</a>) ‐ a subjective measure for PTSD patients to report trauma‐related cognitions especially negative beliefs about self, others and the world, with higher scores corresponding to greater endorsement of negative beliefs ‐ was used in all studies (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>); the Posttraumatic Stress Symptom Scale Self‐Report (PSS‐SR by <a href="./references#CD011464-bbs2-0040" title="FoaEB , RiggsDS , DancuCV , RothbaumBO . Reliability and validity of a brief instrument for assessing post‐traumatic stress disorder. Journal of Traumatic Stress1993;6:459‐73. ">Foa 1993</a>) was also used by <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> to assess patients' self‐reported frequency of PTSD symptoms (higher scores indicate poorer symptom severity). </p> <p><b>6.1.2 Quality of life or well‐being</b> </p> <p>General quality of life (across different life domains) was assessed and considered as one of the secondary outcomes in two studies (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>) using the Brief Quality of Life Interview (QOLI by <a href="./references#CD011464-bbs2-0062" title="LehmanA , KernanE , PostradoL . Toolkit for Evaluating Quality of Life for Persons with Severe Mental Illness. New York, USA: The Evaluation Center at HSRI, 1995. ">Lehman 1995</a>) and the Quality of Life Scale (QoLS by <a href="./references#CD011464-bbs2-0049" title="HeinrichsDW , HanlonTE , CarpenterWT . The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin1984;10(3):388‐98. ">Heinrichs 1984</a>), respectively. Furthermore, overall functioning was evaluated with the Global Assessment of Function scale (GAF by <a href="./references#CD011464-bbs2-0056" title="JonesSH , ThornicroftG , CoffeyM , DunnG . A brief mental health outcome scale‐reliability and validity of the Global Assessment of Functioning (GAF). British Journal of Psychiatry1995;266:654‐9. ">Jones 1995</a>) in both <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a> and <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>. <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a> reported further on participants' social functioning using the CAPS‐impact on social functioning subscale (<a href="./references#CD011464-bbs2-0018" title="BlakeDD , WeathersFW , NagyLM , KaloupekDG , GusmanFD , CharneyDS , et al. The development of a clinician administered PTSD scale. Journal of Traumatic Stress1995;8(1):75‐90. ">Blake 1995</a>). Participants' self‐reported mental health and physical functioning were assessed with the Short Form‐12 Mental Component and Physical Component respectively (SF12 by <a href="./references#CD011464-bbs2-0100" title="WareJE , KosinskiM , KellerSD . SF‐36 Physical and Mental Health Summary Scales: A User's Manual. Boston, USA: Health Assessment Lab, 1994. ">Ware 1994</a>) in <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>. </p> <p><b>6.1.3 Symptoms of co‐morbid psychosis</b> </p> <p>Overall and specific psychotic symptoms were assessed as secondary outcomes in three included studies (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>). Two studies used the Positive and Negative Syndrome Scale (PANSS by <a href="./references#CD011464-bbs2-0058" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi‐Health Systems, 1986. ">Kay 1986</a>) to assess psychiatric symptoms: <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a> reported the PANSS total for overall psychotic symptoms severity, the PANSS‐positive subscale total for positive symptoms and PANSS‐negative subscale total for negative symptoms whilst <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a> reported only the PANSS‐positive and ‐negative subscale totals. The Brief Psychiatric Rating Scale (BPRS by <a href="./references#CD011464-bbs2-0067" title="LukoffD , NuechterleinKH , VenturaJ . Manual for the expanded Brief Psychiatric Rating Scale (BPRS). Schizophrenia Bulletin1986;12:594‐602. ">Lukoff 1986</a>) was used by <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a> to assess overall psychiatric symptoms. </p> <p>Furthermore, <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a> also assessed specific psychotic symptoms, namely auditory hallucinations and delusions, using the Psychotic Symptom Rating Scale (PSYRATS by <a href="./references#CD011464-bbs2-0048" title="HaddockG , McCarronJ , TarrierN , FaraghanEB . Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychological Medicine1999;29(4):879‐89. ">Haddock 1999</a>) hallucinations and delusions subscale totals, respectively. </p> <p><b>6.1.4 Depressive symptoms</b> </p> <p>Self‐reported depressive symptoms were rated with the Beck Depression Inventory‐II (BDI‐II by <a href="./references#CD011464-bbs2-0015" title="BeckAT , SteerRA . Manual for the Beck Anxiety Inventory. San Antonio, TX: Psychological Corporation, 1990. ">Beck 1990</a>) in three included studies as one of the secondary outcomes (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>). </p> <p><b>6.1.5 Anxiety symptoms</b> </p> <p>Three studies (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>) reported anxiety symptoms as secondary outcomes and they all used the Beck Anxiety Inventory (BAI by <a href="./references#CD011464-bbs2-0016" title="BeckAT , SteerRA , BrownGK . Manual for the Beck Depression Inventory ‐ II. San Antonio, TX: Psychological Corporation, 1996. ">Beck 1996</a>). </p> <p><b>6.1.6 Adverse events</b> </p> <p><a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> reported incidents of severe adverse events, however the nature of the adverse events was not made explicit apart from that they were reported as not related to the interventions trialled. Adverse events, if any, were not reported by the other studies. </p> <p><b>6.1.7 Leaving the study early</b> </p> <p>All included studies reported a priori definition of treatment exposure (i.e. minimal sessions of treatment attended) and reported participants' dropout/attrition rate and loss to follow‐up (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>). </p> </section> <section id="CD011464-sec-0130"> <h6 class="title">6.2 Redundant data</h6> <p><b>6.2.1 Satisfaction or perceived acceptability of treatment</b> </p> <p>In <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>, participants' perceived acceptability of the TF‐CBT was assessed by service user‐led interview which implies qualitative data. However, as this study has not published to date, no data are yet available. </p> <p><b>6.2.2 Understanding of PTSD</b> </p> <p>Participants' understanding of PTSD was measured by the PTSD Knowledge Test (<a href="./references#CD011464-bbs2-0080" title="PrattSI , RosenbergSD , MueserKT , BrancatoJ , SalyersMP , JankowskiMK , et al. Evaluation of a PTSD psychoeducational program for psychiatric inpatients. Journal of Mental Health2005;14:121‐7. ">Pratt 2005</a>) in both studies led by Mueser (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>). However, we had not planned to consider PTSD knowledge on its own without subsequent data on any impact of such on PTSD symptoms and/or related distress. </p> <p><b>6.3 Missing data</b> </p> <p>None of the included studies reported health economic outcomes.</p> </section> </section> <section id="CD011464-sec-0131"> <h5 class="title">7. Follow‐up</h5> <p>All studies reported follow‐up at post treatment time point while the intervention duration varied across studies, from 10 weeks (<a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>) to six months (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>). <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a> and <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> collected follow‐up outcomes measures up to 12 months post‐intervention, although data reporting by <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> was limited to six‐month follow‐up at the time of data extraction for this review. <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a> and <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a> followed up their participants for up to six months post‐intervention. </p> </section> </section> <section id="CD011464-sec-0132"> <h4 class="title">Excluded studies</h4> <p>Studies excluded from the review are described in <a href="./references#CD011464-sec-0220" title="">Characteristics of excluded studies</a> section. These included nine full‐text papers of four studies, which were examined but excluded at the end of the full‐text screening stage, due to the study not using a randomised‐controlled design (<a href="./references#CD011464-bbs2-0005" title="deBontPA , vanMinnenA , deJonghA . Treating PTSD in patients with psychosis: a within‐group controlled feasibility study examining the efficacy and safety of evidence‐based PE and EMDR protocols. Behavior Therapy2013;44(4):717‐30. ">de Bont 2013</a>), or the study participants not meeting the diagnostic threshold of PTSD (<a href="./references#CD011464-bbs2-0007" title="ISRCTN43585723 . Promoting personal recovery from psychosis: a randomised controlled trial in first episode schizophrenia. isrctn.com/ISRCTN43585723 (first received 23 January 2004). JacksonC . Promoting personal recovery from psychosis: a randomised control trial in first episode schizophrenia. National Research Register 2003. JacksonC . Promoting personal recovery from psychosis: a randomised controlled trial in first episode schizophrenia. National Research Register 2001. JacksonC , SmithJ , BirchwoodM , TrowerP , ReidI , TownendM , et al. Preventing the traumatic sequelae of first episode psychosis: a randomised controlled trial. Schizophrenia Research2004;70(1):45‐6. JacksonC , TrowerP , ReidI , SmithJ , BirchwoodM , HallM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post‐psychotic trauma symptoms. Schizophrenia Research2006;86(Suppl 1):S39. JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47(6):454‐62. ">Jackson 2006</a>; <a href="./references#CD011464-bbs2-0006" title="ISRCTN43816889 . Trauma therapy for psychosis: Eye Movement Desensitisation and Reprocessing (EMDR) for people with a psychotic illness. isrctn.com/ISRCTN43816889 (first received 10 July 2014). ">ISRCTN43816889</a>; <a href="./references#CD011464-bbs2-0008" title="NCT00307216 . Graduated recovery intervention program for enhancing treatment for first‐episode psychosis. clinicaltrials.gov/ct2/show/NCT00307216 (first received 23 March 2006). ">NCT00307216</a>). <a href="./references#CD011464-bbs2-0005" title="deBontPA , vanMinnenA , deJonghA . Treating PTSD in patients with psychosis: a within‐group controlled feasibility study examining the efficacy and safety of evidence‐based PE and EMDR protocols. Behavior Therapy2013;44(4):717‐30. ">de Bont 2013</a> was a feasibility study using a within‐group controlled design to test the feasibility and safety of EMDR and prolonged exposure in people with co‐morbid psychosis and PTSD. <a href="./references#CD011464-bbs2-0007" title="ISRCTN43585723 . Promoting personal recovery from psychosis: a randomised controlled trial in first episode schizophrenia. isrctn.com/ISRCTN43585723 (first received 23 January 2004). JacksonC . Promoting personal recovery from psychosis: a randomised control trial in first episode schizophrenia. National Research Register 2003. JacksonC . Promoting personal recovery from psychosis: a randomised controlled trial in first episode schizophrenia. National Research Register 2001. JacksonC , SmithJ , BirchwoodM , TrowerP , ReidI , TownendM , et al. Preventing the traumatic sequelae of first episode psychosis: a randomised controlled trial. Schizophrenia Research2004;70(1):45‐6. JacksonC , TrowerP , ReidI , SmithJ , BirchwoodM , HallM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post‐psychotic trauma symptoms. Schizophrenia Research2006;86(Suppl 1):S39. JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47(6):454‐62. ">Jackson 2006</a> investigated the effectiveness of a form of cognitive therapy, which was called the 'recovery intervention', in promoting personal adjustment to psychosis and in reducing depression, trauma and other characteristic negative consequences of psychosis; participants were not assessed for having PTSD or not. <a href="./references#CD011464-bbs2-0006" title="ISRCTN43816889 . Trauma therapy for psychosis: Eye Movement Desensitisation and Reprocessing (EMDR) for people with a psychotic illness. isrctn.com/ISRCTN43816889 (first received 10 July 2014). ">ISRCTN43816889</a> tested the efficacy and safety of EMDR in patients with a psychotic illness but without a co‐morbid PTSD. A manual‐based individual therapy programme called 'The Gradual Recovery Intervention Programe' (GRIP) investigated by <a href="./references#CD011464-bbs2-0008" title="NCT00307216 . Graduated recovery intervention program for enhancing treatment for first‐episode psychosis. clinicaltrials.gov/ct2/show/NCT00307216 (first received 23 March 2006). ">NCT00307216</a> also focused on individuals recovering from their first episodes of psychosis; no PSTD diagnosis was made. </p> <p>Please note that <a href="#CD011464-fig-0001">Figure 1</a> ‐ Study flow diagram relates to exclusion of full‐text papers. </p> <section id="CD011464-sec-0133"> <h5 class="title">Studies awaiting assessment</h5> <p>No studies await assessment.</p> </section> <section id="CD011464-sec-0134"> <h5 class="title">Ongoing Studies</h5> <p>We are not aware of any ongoing studies.</p> </section> </section> </section> <section id="CD011464-sec-0135"> <h3 class="title">Risk of bias in included studies</h3> <p>Our overall impression of risk of bias in the included studies is represented in <a href="#CD011464-fig-0002">Figure 2</a> and <a href="#CD011464-fig-0003">Figure 3</a>, whilst assessment of risk of bias of each included study is reported in <a href="./references#CD011464-sec-0219" title="">Characteristics of included studies</a>. Overall, the methodological quality of all the included studies is good, with clear reporting of the trial design and conduct (except <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a> which was not yet published albeit unpublished outcome data were provided for this review). This suggests that the results can be considered to be at low to medium risk of bias, subject to the available data. </p> <div class="figure" id="CD011464-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt=",Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011464-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>,Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD011464-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011464-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD011464-sec-0136"> <h4 class="title">Allocation</h4> <p>All included studies were randomised controlled trials (RCTs). Apart from <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>, all studies reported the randomisation method used, including the method used to generate the randomisation sequence and strategies to conceal allocation to outcome assessors and participants. It was not possible to obtain further information regarding randomisation methods for <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a> as it was not published at the time of writing this review (i.e. July 2016). Hence, three studies (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>) were rated as being at low risk of bias and <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a> was rated unclear. </p> </section> <section id="CD011464-sec-0137"> <h4 class="title">Blinding</h4> <p>Three studies used waiting list or usual care as the comparison (i.e. <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>), making it impossible to blind the participants. Due to the design of the trials involving therapists delivering the trauma‐focused psychological interventions and/or active control (i.e. brief PTSD‐psychoeducation in <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>), it was not possible to blind the therapists either. Nonetheless, three studies reported clearly their use of blinded assessors for data collection to minimise detection bias (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>). <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> further described strategies to handle the few unblinding incidents enlisting another independent assessor to re‐conduct the assessment, hence this study was rated as at low risk of bias. Both USA studies also reported training and monitoring of blinded assessors, hence we also rated them as at low risk (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>). Due to inadequate detail, we rated <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a> as at unclear risk. </p> </section> <section id="CD011464-sec-0138"> <h4 class="title">Incomplete outcome data</h4> <p>All studies reported using intention‐to‐treat (ITT) method of analysis, except <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a> which is due to limited data available at the time of writing this review. There was also clear reporting of the number of participants completing the treatment exposure (as required as defined a priori) across all studies. However, in two of the studies, these data were difficult to disentangle or were inconsistent. We therefore rated two studies as at low risk of bias (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>) and two at unclear risk of bias (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>). </p> </section> <section id="CD011464-sec-0139"> <h4 class="title">Selective reporting</h4> <p>For all four included studies, we identified either a published trial protocol (i.e. <a href="./references#CD011464-bbs2-0005" title="deBontPA , vanMinnenA , deJonghA . Treating PTSD in patients with psychosis: a within‐group controlled feasibility study examining the efficacy and safety of evidence‐based PE and EMDR protocols. Behavior Therapy2013;44(4):717‐30. ">de Bont 2013</a> for <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>) and/or a detailed trial registration (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>). Three studies seemed to have reported all outcomes as specified in their study protocol and/or trial registration records (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>), although <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>, which had recently published their six‐month follow‐up primary outcome results in the previous few months (i.e. e‐publication in January 2015), has yet to report its 12‐month follow‐up results and the secondary to quaternary outcomes in due course. We therefore rated <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a> and <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a> as at low risk of bias whilst we rated <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> as at unclear risk of bias at this time. We were provided with unpublished results from <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>, however, since this study was not published at the time of writing this review, we rated it as at unclear risk of bias. </p> </section> <section id="CD011464-sec-0140"> <h4 class="title">Other potential sources of bias</h4> <p>All included studies provided information on funding sources and any potential conflict of interests. We identified no other potential sources of bias. </p> </section> </section> <section id="CD011464-sec-0141"> <h3 class="title" id="CD011464-sec-0141">Effects of interventions</h3> <p>See: <a href="./full#CD011464-tbl-0001"><b>Summary of findings for the main comparison</b> Individual TF‐CBT compared to waiting list/usual care for PTSD and severe mental illness</a>; <a href="./full#CD011464-tbl-0002"><b>Summary of findings 2</b> EMDR compared to waiting list/usual care for PTSD and severe mental illness</a>; <a href="./full#CD011464-tbl-0003"><b>Summary of findings 3</b> Individual TF‐CBT compared to EMDR for PTSD and severe mental illness</a>; <a href="./full#CD011464-tbl-0004"><b>Summary of findings 4</b> Individual TF‐CBT compared to Brief PTSD psychoeducation for PTSD and severe mental illness</a> </p> <p>There are four comparisons, and results of data analyses are summarised below. See also <a href="./full#CD011464-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD011464-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD011464-tbl-0003">summary of findings Table 3</a>; <a href="./full#CD011464-tbl-0004">summary of findings Table 4</a>. Of note, as most of the continuous outcome data were found to be skewed (i.e. un‐symmetrically distributed), we conducted analyses grouping unskewed data and skewed data separately (as outlined in <a href="#CD011464-sec-0071">Data extraction and management</a>). In the 'Summary of findings' tables, we reported the pre‐specified outcomes of interest (<a href="#CD011464-sec-0057">Types of outcome measures</a>) whenever data were available, and priority was given to the analyses drawn using unskewed continuous data. In the event of no available analyses using unskewed data, we reported the analyses pooling skewed data and downgraded the quality of evidence. </p> <section id="CD011464-sec-0142"> <h4 class="title">Comparison 1: Individual trauma‐focused cognitive behavioural therapy (TF‐CBT) versus waiting list/usual care </h4> <p>Three studies including 178 participants in total contributed to this comparison (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>). See also <a href="./full#CD011464-tbl-0001">summary of findings Table for the main comparison</a>. </p> <section id="CD011464-sec-0143"> <h5 class="title">1.1 PTSD symptoms severity: 1a. Clinician‐rated PTSD symptom severity ‐ average endpoint CAPS total score (high = poor) </h5> <p>Three studies considered this outcome with a total of 178 individuals.</p> <p>Short‐term unskewed data from one study found no differences in symptom severity between groups (1 RCT, n = 13, mean difference (MD) 13.15, 95% confidence interval (CI) ‐4.09 to 30.39; <i>low‐quailty evidence</i>, <a href="./references#CD011464-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD011464-sec-0144"> <h5 class="title">1.2 PTSD symptoms severity: 1b. Clinician‐rated PTSD symptom severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data </h5> <p>Short‐term skewed data from two studies reported data that showed no significant differences between TF‐CBT and waiting‐list control groups although there was high heterogeneity (2 RCTs, n = 147, MD ‐7.44, 95% CI ‐29.15 to 14.27, I<sup>2</sup> = 87%, <a href="./references#CD011464-fig-0005" title="">Analysis 1.2</a> ). </p> <p>Three studies reported medium‐term skewed data. No effect between groups was found (3 RCTs, n = 155, MD ‐3.92, 95% CI ‐19.25 to 11.40, <a href="./references#CD011464-fig-0005" title="">Analysis 1.2</a>). There was high heterogeneity (I<sup>2</sup> = 63%), </p> </section> <section id="CD011464-sec-0145"> <h5 class="title">1.3 PTSD symptoms severity: 2. Self‐reported trauma‐related cognitions ‐ average endpoint Posttraumatic Cognitions Inventory (PTCI) total score (high = poor) </h5> <p>Three studies reported short‐term outcome data, results were equivocal across groups (3 RCTs, n = 136, MD ‐5.45, 95% CI ‐33.61 to 22.70; I<sup>2</sup> = 76%) with high heterogeneity detected, however, medium‐term data from three studies showed an effect for TF‐CBT (3 RCTs, n = 133, MD ‐15.25, 95% CI ‐29.48 to ‐1.02). <a href="./references#CD011464-fig-0006" title="">Analysis 1.3</a>. </p> </section> <section id="CD011464-sec-0146"> <h5 class="title">1.4 PTSD symptoms severity: 3. Self‐reported frequency of PTSD symptoms ‐ average endpoint PSS‐SR total score (high = poor) ‐ skewed data </h5> <p>Only one study provided data which were skewed on this outcome. Both short‐term (1 RCT, n = 86, MD ‐9.51, 95% CI ‐13.84 to ‐5.18) and medium‐term at nine months (1 RCT, n = 85, MD ‐7.52, 95% CI ‐12.06 to ‐2.98) data show an effect for TF‐CBT. <a href="./references#CD011464-fig-0007" title="">Analysis 1.4</a>. </p> </section> <section id="CD011464-sec-0147"> <h5 class="title">1.5 PTSD symptoms severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40 </h5> <p>Two studies reported remission from PTSD as measured by below CAPS cut‐off score (i.e. &lt;40). Both short‐term and medium‐term data favoured the TF‐CBT group (short term: 2 RCTs, n = 113, risk ratio (RR) 1.99, 95% CI 1.20 to 3.30; medium term: 2 RCTs, n = 109, RR 1.44 95% CI 0.57 to 3.63; <a href="./references#CD011464-fig-0008" title="">Analysis 1.5</a>). </p> </section> <section id="CD011464-sec-0148"> <h5 class="title">1.6 PTSD symptoms severity: 5. Recovery from PTSD: Asymptomatic or few symptoms ‐ CAPS total score &lt; 20 </h5> <p>Only one study provided data on this outcome; recovery was defined as a CAPS total score below 20. The short‐term results showed that more participants in the TF‐CBT group had achieved full recovery from PTSD when compared with those in the waiting list group and the results were statistically significant (1 RCT, n = 100, RR 4.43, 95% CI 1.37 to 14.37). The medium‐term data also favour the TF‐CBT group with statistical significant results (1 RCT, n = 100, RR 4.14, 95% CI 1.27 to 13.51; <a href="./references#CD011464-fig-0009" title="">Analysis 1.6</a>). </p> </section> <section id="CD011464-sec-0149"> <h5 class="title">1.7 Quality of life: 1. General quality of life ‐ average endpoint QLS total score (high = good) </h5> <p>Only one study provided data (unskewed) on this outcome. Both the short‐term (1 RCT, n = 38, MD ‐3.00, 95% CI ‐8.26 to 2.26) and medium‐term results (1 RCT, n =39, MD ‐0.60, 95% CI ‐4.47 to 3.27) were equivocal across groups; low‐quality evidence, <a href="./references#CD011464-fig-0010" title="">Analysis 1.7</a>. </p> </section> <section id="CD011464-sec-0150"> <h5 class="title">1.8 Quality of life: 2. Overall functioning ‐ average endpoint GAF total score (high = good) </h5> <p>Again, only one study reported data (unskewed) on this outcome. Neither the short‐term (1 RCT, n = 44, MD 0.80, 95% CI ‐4.61 to 6.21); nor the medium‐term (1 RCT, n = 46, MD 2.70, 95% CI ‐3.32 to 8.72) results showed any significant differences between groups; <a href="./references#CD011464-fig-0011" title="">Analysis 1.8</a>. </p> </section> <section id="CD011464-sec-0151"> <h5 class="title">1.9 Quality of life: 3. Mental health functioning ‐ average endpoint SF‐12 mental component total score (high = good) </h5> <p>Short‐term unskewed data from one study (1 RCT, n = 11, MD ‐9.89, 95% CI ‐23.35 to 3.57) showed no effect. Medium‐term data were also equivocal across the TF‐CBT and usual care groups (1 RCT, n = 9, MD 1.96 95% CI ‐28.15 to 32.07); <a href="./references#CD011464-fig-0012" title="">Analysis 1.9</a>. </p> </section> <section id="CD011464-sec-0152"> <h5 class="title">1.10 Quality of life: 4. Physical functioning ‐ average endpoint SF‐12 physical component total score (high = good) </h5> <p>Again, only one study provided data (unskewed) for this outcome. We found no effect from data across short‐term (1 RCT, n = 11, MD 1.32, 95% CI ‐16.35 to 18.99), and at medium‐term follow‐up (1 RCT, n = 9, MD ‐2.52, 95% CI ‐25.64 to 20.60). <a href="./references#CD011464-fig-0013" title="">Analysis 1.10</a>. </p> </section> <section id="CD011464-sec-0153"> <h5 class="title">1.11 Symptoms of co‐morbid psychosis: 1. Overall mental state ‐ average endpoint BPRS total score (high = poor) </h5> <p>One study reported this outcome using the total BPRS scores; all data were unskewed. Results in the short term (1 RCT, n = 13, MD 1.00, 95% CI ‐9.96 to 11.96), and medium term (1 RCT, n = 9, MD ‐6.93 95% CI ‐34.17 to 20.31, <i>low‐quality evidence)</i> were equivocal across groups. <a href="./references#CD011464-fig-0014" title="">Analysis 1.11</a>. </p> </section> <section id="CD011464-sec-0154"> <h5 class="title">1.12 Symptoms of co‐morbid psychosis: 2. Positive symptoms ‐ average endpoint PANSS positive subscale total score (high = poor) </h5> <p>Unskewed data showed no significant differences between groups at short term (1 RCT, n = 61, MD ‐2.00, 95% CI ‐5.07 to 1.07), and at medium term (1 RCT, n = 61, MD ‐1.40, 95% CI ‐4.42 to 1.62). <a href="./references#CD011464-fig-0015" title="">Analysis 1.12</a>. </p> </section> <section id="CD011464-sec-0155"> <h5 class="title">1.13 Symptoms of co‐morbid psychosis: 3. Negative symptoms ‐ average endpoint PANSS negative subscale total score (high = poor) </h5> <p>Again, only one study reported data on this outcome, all data were unskewed. Short‐term data across the two groups were equivocal (1 RCT, n = 61, MD ‐1.40, 95% CI ‐4.19 to 1.39), as were the medium‐term data (1 RCT, n = 61, MD ‐1.10, 95% CI ‐3.38 to 1.18). <a href="./references#CD011464-fig-0016" title="">Analysis 1.13</a>. </p> </section> <section id="CD011464-sec-0156"> <h5 class="title">1.14 Symptoms of co‐morbid psychosis: 4. Hallucinations ‐ average endpoint PSYRATS‐hallucinations subscale total score (high = poor) ‐ skewed data </h5> <p>Short‐term skewed data showed no significant differences between groups (1 RCT, n = 61, MD 2.80, 95% CI ‐3.88 to 9.48), nor the medium‐term skewed data (1 RCT, n = 61, MD ‐0.30, 95% CI ‐7.48 to 6.88). <a href="./references#CD011464-fig-0017" title="">Analysis 1.14</a>. </p> </section> <section id="CD011464-sec-0157"> <h5 class="title">1.15 Symptoms of co‐morbid psychosis: 5. Delusions ‐ average endpoint PSYRATS‐delusions subscale total score (high = poor) ‐ skewed data </h5> <p>Results between groups across short term (1 RCT, n = 61, MD ‐0.70, 95% CI ‐4.73 to 3.33) and medium term (1 RCT, n = 61, MD ‐2.30, 95% CI ‐6.22 to 1.62) were equivocal. Of note, all data were skewed. <a href="./references#CD011464-fig-0018" title="">Analysis 1.15</a>. </p> </section> <section id="CD011464-sec-0158"> <h5 class="title">1.16 Anxiety symptoms ‐ average endpoint BAI total score (high = poor)</h5> <p>One study reported unskewed data for this outcome. Both short‐term (1 RCT, n = 13, MD 4.20, 95% CI ‐7.52 to 15.92) and medium‐term (1 RCT, n = 9, MD 12.57, 95% CI ‐5.54 to 30.68, <i>very low‐quality evidence</i>) unskewed data showed no significant differences between groups. <a href="./references#CD011464-fig-0019" title="">Analysis 1.16</a> </p> </section> <section id="CD011464-sec-0159"> <h5 class="title">1.17 Anxiety symptoms ‐ average endpoint BAI total score (high = poor) ‐ skewed data</h5> <p>Another study presented skewed data for this outcome, again no effect between treatments was found at either short term (1 RCT, n = 35, MD 2.00, 95% CI ‐7.02 to 11.02) or medium term (1 RCT, n = 40, (MD ‐3.00, 95% CI ‐12.36 to 6.36). <a href="./references#CD011464-fig-0020" title="">Analysis 1.17</a>. </p> </section> <section id="CD011464-sec-0160"> <h5 class="title">1.18 Depressive symptoms ‐ average endpoint BDI‐II total score (high = poor) ‐ skewed data </h5> <p>Only skewed data from two studies were available for this outcome. No effect was found at short term (2 RCTs, n = 49, MD 1.31, 95% CI ‐5.81 to 8.44), or medium term (2 RCTs, n = 48, MD 3.26, 95% CI ‐3.66 to 10.18, <i>very low‐quality evidence</i>). <a href="./references#CD011464-fig-0021" title="">Analysis 1.18</a>. </p> </section> <section id="CD011464-sec-0161"> <h5 class="title">1.19 Adverse events ‐ incidents of unspecified severe adverse events</h5> <p>Only one study reported incidents of unspecified severe adverse events, medium‐term data were equivocal across TF‐CBT and waiting‐list control groups (1 RCT, n = 100, RR 0.44, 95% CI 0.09 to 2.31, <i>low‐quality evidence</i>). These adverse events were specified as not related to the PTSD or psychotic symptoms. See <a href="./references#CD011464-fig-0022" title="">Analysis 1.19</a>. </p> </section> <section id="CD011464-sec-0162"> <h5 class="title">1.20 Leaving the study early</h5> <p>Three studies with 178 participants in total provided attrition data. No differences in numbers of participants leaving the study early across groups were at short term (3 RCTs, n = 178, RR 0.74, 95% CI 0.38 to 1.44) or medium term (3 RCTs, n = 178, RR 0.80, 95% CI 0.46 to 1.40). <a href="./references#CD011464-fig-0023" title="">Analysis 1.20</a>. </p> </section> </section> <section id="CD011464-sec-0163"> <h4 class="title">2. Comparison 2: Eye movement desensitisation and reprocessing (EMDR) versus waiting list </h4> <p>Only one study with 102 participants compared EMDR with waiting‐list control (<a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>), meta‐analyses on outcomes were therefore not possible using the data. We report the analyses on all available outcome data below. See also <a href="./full#CD011464-tbl-0002">summary of findings Table 2</a> for main outcomes of interest. </p> <section id="CD011464-sec-0164"> <h5 class="title">2.1 PTSD symptoms severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data </h5> <p>All available data were skewed. Both short‐term data (1 RCT, n = 83, MD ‐15.32, 95% CI ‐25.99 to ‐4.65) and medium‐term data (1 RCT, n = 83, MD ‐12.31, 95% CI ‐22.72 to ‐1.90, <i>very low‐quality evidence</i>) showed favourable effect for EMDR. <a href="./references#CD011464-fig-0024" title="">Analysis 2.1</a>. </p> </section> <section id="CD011464-sec-0165"> <h5 class="title">2.2 PTSD symptoms severity: 2. Self‐reported trauma‐related cognitions ‐ average endpoint PTCI total score (high = poor) </h5> <p>Data reporting this outcome were unskewed. Short‐term data favoured EMDR (1 RCT, n = 83, MD ‐23.27, 95% CI ‐38.50 to ‐8.04) and these benefits seemed to be sustained at medium‐term follow‐up (1 RCT, n = 83, MD ‐20.66, 95% CI ‐36.72 to ‐4.60). <a href="./references#CD011464-fig-0025" title="">Analysis 2.2</a> . </p> </section> <section id="CD011464-sec-0166"> <h5 class="title">2.3 PTSD symptoms severity: 3. Self‐reported frequency of PTSD symptoms ‐ average endpoint PSS‐SR total score (high = poor) ‐ skewed data </h5> <p>The EMDR group fared better in self‐reported frequency of PTSD symptoms as measured by PSS‐SR, across both short term (1 RCT, n = 83, MD ‐8.60, 95% CI ‐13.03 to ‐4.17) and medium term (1 RCT, n = 83, MD ‐7.37, 95% CI ‐12.17 to ‐2.57), although data reported were skewed. <a href="./references#CD011464-fig-0026" title="">Analysis 2.3</a>. </p> </section> <section id="CD011464-sec-0167"> <h5 class="title">2.4 PTSD symptoms severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40 </h5> <p>A favourable effect for EMDR compared to waiting list was found in both the short‐term data (1 RCT, n = 102, RR 2.17, 95% CI 1.30 to 3.61), and the medium‐term data (1 RCT, n = 102, RR 1.77, 95% CI 1.10 to 2.85). <a href="./references#CD011464-fig-0027" title="">Analysis 2.4</a>. </p> </section> <section id="CD011464-sec-0168"> <h5 class="title">2.5 PTSD symptoms severity: 4. Recovery from PTSD: Asymptomatic or few symptoms ‐ CAPS total score &lt; 20 </h5> <p>There were no significant differences in numbers of participants achieved full recovery from PTSD across EMDR and waiting‐list groups, both at short term (1 RCT, n = 102, RR 2.56, 95% CI 0.74 to 8.92) and medium term (1 RCT, n = 102, RR 2.28, 95% CI 0.64 to 8.10). <a href="./references#CD011464-fig-0028" title="">Analysis 2.5</a>. </p> <p><b>2.6 Adverse events ‐ incidents of unspecified severe adverse events</b> </p> <p>No adverse events were recorded at short term. Events were recorded at medium term, with equivocal numbers of adverse events reported across groups in medium term (1 RCT, n = 102, RR 0.21, 95% CI 0.02 to 1.85, <i>low‐quality evidence</i>). <a href="./references#CD011464-fig-0029" title="">Analysis 2.6</a>. </p> <p><b>2.7 Leaving the study early</b> </p> <p>Short‐term data showed no significant differences in number of participants lost to follow‐up between groups (1 RCT, n = 102, RR 1.18, 95% CI 0.52 to 2.68). Equivocal attrition data were also reported at medium term (1 RCT, n = 102, RR 1.46, 95% CI 0.63 to 3.42). <a href="./references#CD011464-fig-0030" title="">Analysis 2.7</a>. </p> </section> </section> <section id="CD011464-sec-0169"> <h4 class="title">Head to head comparisons of specific category of trauma‐focused psychological therapies</h4> <p>We made the following two specific comparisons and reported on primary outcomes only, as pre‐specified in our protocol. </p> <section id="CD011464-sec-0170"> <h5 class="title">Comparison 3: TF‐CBT (specifically prolonged exposure) versus EMDR</h5> <p>One study with 108 participants (<a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>) compared prolonged exposure (PE) therapy which was categorised as a type of TF‐CBT (as defined a priori in <a href="#CD011464-sec-0054">Types of interventions</a>) with EMDR. We report herewith the analyses on all the available review primary outcomes although meta‐analyses were not possible. See also <a href="./full#CD011464-tbl-0003">summary of findings Table 3</a>. </p> <section id="CD011464-sec-0171"> <h6 class="title">3.1 PTSD symptoms severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data </h6> <p>No significant differences was found between TF‐CBT and EMDR groups based on the short‐term data (1 RCT, n = 91, MD ‐2.94, 95% CI ‐13.13 to 7.25), as well as the medium‐term data (1 RCT, n = 88, MD ‐1.69, 95% CI ‐12.61 to 9.23, <i>very low‐quality evidence</i>). Of note, all available data were skewed. <a href="./references#CD011464-fig-0031" title="">Analysis 3.1</a>. </p> </section> <section id="CD011464-sec-0172"> <h6 class="title">3.2 PTSD symptoms severity: 2. Self‐reported trauma‐related cognitions ‐ average endpoint PTCI total score (high = poor) </h6> <p>Results were equivocal between the PE and EMDR groups, both in the short term (1 RCT, n = 91, MD ‐3.38, 95% CI ‐21.17 to 14.41) and in the medium term (1 RCT, n = 88, MD 2.05, 95% CI ‐16.69 to 20.79), based on unskewed data. <a href="./references#CD011464-fig-0032" title="">Analysis 3.2</a>. </p> </section> <section id="CD011464-sec-0173"> <h6 class="title">3.3 PTSD symptoms severity: 3. Self‐reported frequency of PTSD symptoms ‐ average endpoint PSS‐SR total score (high = poor) ‐ skewed data </h6> <p>There were no significant differences found between groups, both at short term (1 RCT, n = 91, MD ‐0.91, 95% CI ‐5.18 to 3.36) and at medium term (1 RCT, n = 88, MD ‐0.15, 95% CI ‐5.49 to 5.19). Of note, data reported were skewed. <a href="./references#CD011464-fig-0033" title="">Analysis 3.3</a>. </p> </section> <section id="CD011464-sec-0174"> <h6 class="title">3.4 PTSD symptoms severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40 </h6> <p>Data showed equivocal results across the PE and EMDR groups, at short term (1 RCT, n = 108, RR 0.94, 95% CI 0.69 to 1.30) and at medium term (1 RCT, n = 108, RR 1.04, 95% CI 0.75 to 1.44). <a href="./references#CD011464-fig-0034" title="">Analysis 3.4</a>. </p> </section> <section id="CD011464-sec-0175"> <h6 class="title">3.5 PTSD symptoms severity: 5. Recovery from PTSD: Asymptomatic or few symptoms ‐ CAPS total score &lt; 20 </h6> <p>Data showed equivocal results across groups, both at short term (1 RCT, n = 108, RR 1.73, 95% CI 0.83 to 3.61) and at medium term (1 RCT, n = 108, RR 1.82, 95% CI 0.83 to 3.97). <a href="./references#CD011464-fig-0035" title="">Analysis 3.5</a>. </p> </section> </section> <section id="CD011464-sec-0176"> <h5 class="title">Comparison 4: TF‐CBT versus brief PTSD psychoeducation</h5> <p>One study compared TF‐CBT with brief PTSD psychoeducation (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>). We report the analyses on available primary outcomes below although meta‐analyses were not possible. See also <a href="./full#CD011464-tbl-0004">summary of findings Table 4</a>. </p> <section id="CD011464-sec-0177"> <h6 class="title">4.1 PTSD symptoms severity: 1a. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) </h6> <p>Short‐term unskewed data (1 RCT, n = 54, MD ‐1.45, 95% CI ‐14.63 to 11.73) were equivocal across groups as were the medium‐term unskewed data (1 RCT, n = 52, MD 0.23, 95% CI ‐14.66 to 15.12, <i>low‐quality evidence</i>) <a href="./references#CD011464-fig-0036" title="">Analysis 4.1</a>. </p> </section> <section id="CD011464-sec-0178"> <h6 class="title">4.2 PTSD symptoms severity: 1b. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data </h6> <p>Long‐term skewed data (1 RCT, n = 48, MD ‐2.13, 95% CI ‐19.45 to 15.19) also showed no significant differences across groups. <a href="./references#CD011464-fig-0037" title="">Analysis 4.2</a>. </p> </section> <section id="CD011464-sec-0179"> <h6 class="title">4.3 PTSD symptoms severity: 2. Self‐reported trauma‐related cognitions ‐ average endpoint PTCI total score (high = poor) </h6> <p>Unskewed data across short term (1 RCT, n = 53, MD 1.64, 95% CI ‐24.40 to 27.68), medium term (1 RCT, n = 51, MD 7.68, 95% CI ‐18.64 to 34.00) and long term (1 RCT, n = 49, MD 16.19, 95% CI ‐10.45 to 42.83) were equivocal across the two treatment groups. <a href="./references#CD011464-fig-0038" title="">Analysis 4.3</a>. </p> </section> <section id="CD011464-sec-0180"> <h6 class="title">4. 4 PTSD symptoms severity: 3. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40 </h6> <p>The data showed no significant differences across groups at short‐term (1 RCT, n = 54, RR 1.04, 95% CI 0.47 to 2.30), at medium‐term (1 RCT, n = 52, RR 2.00, 95% CI 0.79 to 5.05), and at long‐term follow‐up (1 RCT, n = 48, RR 1.14, 95% CI 0.49 to 2.65). <a href="./references#CD011464-fig-0039" title="">Analysis 4.4</a>. </p> </section> <section id="CD011464-sec-0181"> <h6 class="title">4.5 PTSD symptoms severity: 4. Remission from severe PTSD: Loss of severe PTSD diagnosis ‐ CAPS total scores &lt; 65 </h6> <p>The results were equivocal across the two treatment groups, at short‐term (1 RCT, n = 54, RR 1.21, 95% CI 0.64 to 2.26), at medium‐term (1 RCT, n = 52, RR 1.56, 95% CI 0.82 to 2.94), and at long‐term follow‐up (1 RCT, n = 48, RR 1.30, 95% CI 0.71 to 2.37). <a href="./references#CD011464-fig-0040" title="">Analysis 4.5</a>. </p> </section> <section id="CD011464-sec-0182"> <h6 class="title">4.6 Quality of life: 1. General quality of life ‐ average endpoint QoLI total score (high = good) </h6> <p>We found no significant differences between the two treatment groups, at short term (1 RCT, n = 54, MD ‐0.58, 95% CI ‐1.35 to 0.19), at medium term (1 RCT, n = 52, MD ‐0.29, 95% CI ‐1.03 to 0.45), and at long term (1 RCT, n = 49, MD 0.11, 95% CI ‐0.74 to 0.96, <i>low‐quality evidence</i>). <a href="./references#CD011464-fig-0041" title="">Analysis 4.6</a>. </p> </section> <section id="CD011464-sec-0183"> <h6 class="title">4.7 Quality of life: 2. Overall functioning ‐ average endpoint GAF total score (high = good) </h6> <p>No significant differences were found between groups based on short‐term data (1 RCT, n = 49, MD ‐0.86, 95% CI ‐6.48 to 4.76), medium‐term data (1 RCT, n = 50, MD 0.60, 95% CI ‐4.92 to 6.12); and long‐term data (1 RCT, n = 48, MD 1.88, 95% CI ‐4.93 to 8.69). All data reported were unskewed. See <a href="./references#CD011464-fig-0042" title="">Analysis 4.7</a>. </p> </section> <section id="CD011464-sec-0184"> <h6 class="title">4.8 Quality of life: 3. Social functioning ‐ average endpoint CAPS social functioning subscale total score (high = poor) ‐ skewed data </h6> <p>We found no significant differences in this outcome across groups (short term: 1 RCT, n = 54, MD ‐0.29, 95% CI ‐0.86 to 0.28; medium term: 1 RCT, n = 52, MD ‐0.61, 95% CI ‐1.28 to 0.06; long term: 1 RCT, n = 48, MD 0.19, 95% CI ‐0.46 to 0.84). Data reported were skewed. <a href="./references#CD011464-fig-0043" title="">Analysis 4.8</a>. </p> </section> </section> </section> <section id="CD011464-sec-0185"> <h4 class="title">Subgroup analyses</h4> <p>No subgroup analyses were conducted on the two pre‐specified factors (see <a href="#CD011464-sec-0106">Subgroup analysis and investigation of heterogeneity</a>), due to the following reasons. </p> <section id="CD011464-sec-0186"> <h5 class="title">1. Participants' characteristic, i.e. by age ‐ adults versus adolescents</h5> <p>All included studies recruited adults aged 18 or above. No data were available on adolescents. </p> </section> <section id="CD011464-sec-0187"> <h5 class="title">2. Clinical characteristics, i.e. by types of trauma</h5> <p>Data on types of trauma experienced by study participants were reported on sample and group levels, but not available on an individual level, to allow for such a subgroup analysis. Furthermore, in all four included studies, it was reported that participants with co‐morbid SMI and PTSD commonly experienced multiple traumas, which were often a combination of childhood and adult traumatic events, with the nature of the trauma spanned across conventional events (such as interpersonal violence) and SMI symptom‐related experience (e.g. persecutory delusion). These findings raised queries over the feasibility and appropriateness of categorically delineating types of trauma experienced by individuals with such co‐morbid conditions and complex presentations. It also raised challenges in our attempt to estimate participants' overall and specific responsiveness to trauma‐focused psychological treatment based on types of trauma experienced, even if the individual‐level data were available. </p> </section> </section> <section id="CD011464-sec-0188"> <h4 class="title">Sensitivity analysis</h4> <p>Apart from Comparison 1 (TF‐CBT versus usual care/waiting list), which included three studies, the other three comparisons included only one study each which rendered sensitivity analysis impossible. </p> <p>Overall, all four studies included in the various analyses were of good methodological quality (see <a href="#CD011464-sec-0081">Assessment of risk of bias in included studies</a>) and therefore even for Comparison 1, there was no need to undertake a sensitivity analysis based on the following. </p> <section id="CD011464-sec-0189"> <h5 class="title">1. Implication of randomisation ‐ all included studies were clearly randomised controlled trials. </h5> </section> <section id="CD011464-sec-0190"> <h5 class="title">2. Assumptions for lost binary data ‐ the quantity of included study data lost to follow‐up was small (i.e. no studies reported over 50% of missing data). </h5> </section> <section id="CD011464-sec-0191"> <h5 class="title">3. Risk of bias ‐ no included studies were judged to be of high risk of bias.</h5> </section> <section id="CD011464-sec-0192"> <h5 class="title">4. Imputed values ‐ we were provided with the raw data by the trial authors of all four included studies, hence we had not used imputed values for various analyses. </h5> <p>Lastly, regarding meta‐analyses using fixed‐effect and random‐effects models ‐ we had used primarily the random‐effects model for analyses when data from more than one study were included; whereas the fixed‐effect model was used in analyses when only data from one study were included. </p> <p>When preparing the 'Summary of findings' tables summarising the pre‐specified outcomes together with their respective overall rating of quality of evidence, we prioritised reporting the analyses based on unskewed data (of continuous outcome measures). In the absence of analyses based on unskewed data, we reported analyses based on skewed data with the quality of evidence downgraded. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011464-sec-0193" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011464-sec-0193"></div> <p>Four randomised controlled trials (RCTs) involving 300 participants were included in this review to investigate the effectiveness of trauma‐focused psychological therapies for individuals with both severe mental illness (SMI) and post‐traumatic stress disorder (PTSD). We conducted four comparisons to assess the effectiveness of three specific modalities of PTSD psychological interventions, namely: trauma‐focused cognitive behavioural therapy (TF‐CBT) (including prolonged exposure); eye movement desensitisation and reprocessing (EMDR); and brief PTSD psychoeducation. We have created a "Summary of Findings" table for each of the comparisons (<a href="./full#CD011464-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD011464-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD011464-tbl-0003">summary of findings Table 3</a>; <a href="./full#CD011464-tbl-0004">summary of findings Table 4</a>) and the main results are discussed below. </p> <section id="CD011464-sec-0194"> <h3 class="title" id="CD011464-sec-0194">Summary of main results</h3> <section id="CD011464-sec-0195"> <h4 class="title">Trauma‐focused cognitive behavioural therapy (TF‐CBT)</h4> <p>We included four studies (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>) reporting on three specific TF‐CBT programmes in this review. The three TF‐CBT programmes ranged from a 'prolonged exposure' intervention delivered over eight sessions within a 10‐week duration (<a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>), a 12‐to 16‐week CBT programme emphasising on cognitive restructuring (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>), and a similar 12‐ to 16‐week CBT for PTSD programme with the initial few sessions focusing on psychoeducation and breathing retraining (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a> and <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a> whose study adopted the <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a> CBT treatment manual). </p> <p>Three studies provided data for comparing individual TF‐CBT against non‐active control condition, i.e. usual care or waiting‐list control (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>). Some continuous outcome data were found to be skewed, and hence meta‐analyses grouping unskewed and skewed data separately were conducted on continuous outcome measures whenever both types of data were present. In terms of clinician‐rated PTSD symptom severity as measured by Clinician Administered PTSD Symptom Scale (CAPS) total score, only one study including 13 individuals with co‐morbid PTSD and SMI ( <a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>) reported short‐term unskewed data, and these limited results were equivocal across the two groups. Further available data from the other two studies were skewed, but also showed no effect between treatment groups at either short or medium term. Data on self‐reported PTSD symptom severity as measured by Post Traumatic Cognitions Inventory (PTCI) total scores were unskewed: short‐term outcomes were equivocal across groups although follow‐up data at medium term from three studies showed a favourable effect for TF‐CBT. Meta‐analyses pooling binary data from two included studies (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>) that reported the number of participants scoring below 40 on CAPS, provided some preliminary and low‐quality evidence (2 RCTs, n = 113) that TF‐CBT is more effective than usual care/waiting list in reducing participants' PTSD symptoms to the sub‐threshold level leading to remission from PTSD (or loss of PTSD diagnosis) in both short and medium terms. Only one study (<a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>), reported full recovery from PTSD using a CAPS cut‐off score of &lt; 20, and there was some limited and very low‐quality evidence favouring TF‐CBT in promoting full recovery from PTSD at medium term (1 RCT, n = 100). Only one study provided data for the remaining primary outcomes focusing on quality of life, and secondary outcomes, hence meta‐analysis was not possible. In terms of secondary outcomes, it was not clear from the available data if TF‐CBT had any advantages than waiting list or usual care, over a range of general psychiatric symptoms, specific psychotic symptoms, affect or anxiety manifestation. Only one study (<a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>) reported incidents of unspecified severe adverse events; no significant differences were found between TF‐CBT and waiting‐list groups. In terms of tolerability of interventions, overall loss to follow‐up was equivocal across TF‐CBT and usual care/waiting‐list groups, as shown by low‐quality evidence (3 RCTs, n = 178) throughout the short‐ to medium‐term follow‐up. </p> <p>Only one study compared prolonged exposure therapy against EMDR with 108 individuals with a chronic psychotic disorder and PTSD (<a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>). Whilst it was not possible to undertake meta‐analyses, the study data indicated that outcomes of patients receiving TF‐CBT or EMDR did not differ significantly across a range of outcomes focusing on PTSD symptoms. </p> <p>Another study compared TF‐CBT against brief PTSD psychoeducation (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>). The results showed no significant differences between the two PTSD psychological therapies in terms of their impacts on patients' PTSD symptoms severity, quality of life and related functioning. </p> </section> <section id="CD011464-sec-0196"> <h4 class="title">Eye movement desensitisation and reprocessing (EMDR)</h4> <p>We identified one study that compared EMDR against a waiting list as well as against TF‐CBT (<a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>). Meta‐analyses were not feasible. Comparing EMDR with waiting list (1 RCT, n = 83), there was some very low‐quality evidence indicating that EMDR was much more effective in reducing PTSD symptoms whether they were measured with clinician‐rated tools or self‐reported cognitions and frequency assessment (of note, continuous outcome data available were skewed). A statistically significant higher number of participants receiving EMDR achieved remission from PTSD (i.e. loss of PTSD diagnosis as defined by a CAPS total score &lt; 40) at short and medium term, respectively, although there was no significant differences in terms of numbers of participants achieving full recovery from PTSD (i.e. CAPS &lt; 20) across EMDR and waiting list. The remaining data indicated equivocal results across EMDR and waiting‐list groups in terms of loss to follow‐up and unspecified severe adverse events. </p> <p>The same study also compared EMDR with TF‐CBT (<a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>) and its results suggested both interventions were equivocal in their effectiveness in reducing PTSD symptom severity, as aforementioned. No data were available on other outcomes. </p> </section> <section id="CD011464-sec-0197"> <h4 class="title">Brief PTSD Psychoeducation</h4> <p>A three‐session PTSD psychoeducation programme (<a href="./references#CD011464-bbs2-0080" title="PrattSI , RosenbergSD , MueserKT , BrancatoJ , SalyersMP , JankowskiMK , et al. Evaluation of a PTSD psychoeducational program for psychiatric inpatients. Journal of Mental Health2005;14:121‐7. ">Pratt 2005</a>) was identified as an alternative modality of trauma‐focused psychological intervention by this review. Only one trial (1 RCT, n = 67) compared TF‐CBT head to head with brief PTSD psychoeducation as an active control (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>). There was no clear evidence that brief PTSD psychoeducation was either better or worse than TF‐CBT across a range of PTSD symptom severity and quality of life outcomes. </p> </section> </section> <section id="CD011464-sec-0198"> <h3 class="title" id="CD011464-sec-0198">Overall completeness and applicability of evidence</h3> <section id="CD011464-sec-0199"> <h4 class="title">Completeness</h4> <p>Our search identified 35 unique titles and abstracts initially. We inspected all of them and contacted a number of authors known to have conducted trials in this field for further unpublished and/or ongoing study data. We also consulted a number of trial authors to establish if their studies targeted people with PTSD or not as sometimes the PTSD diagnostic thresholds used were not clearly described. Many studies implied specially developed psychological therapies focusing on trauma and/or trauma‐related experience and sequelae in association with psychotic illness experience and/or other life events (e.g. <a href="./references#CD011464-bbs2-0007" title="ISRCTN43585723 . Promoting personal recovery from psychosis: a randomised controlled trial in first episode schizophrenia. isrctn.com/ISRCTN43585723 (first received 23 January 2004). JacksonC . Promoting personal recovery from psychosis: a randomised control trial in first episode schizophrenia. National Research Register 2003. JacksonC . Promoting personal recovery from psychosis: a randomised controlled trial in first episode schizophrenia. National Research Register 2001. JacksonC , SmithJ , BirchwoodM , TrowerP , ReidI , TownendM , et al. Preventing the traumatic sequelae of first episode psychosis: a randomised controlled trial. Schizophrenia Research2004;70(1):45‐6. JacksonC , TrowerP , ReidI , SmithJ , BirchwoodM , HallM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post‐psychotic trauma symptoms. Schizophrenia Research2006;86(Suppl 1):S39. JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47(6):454‐62. ">Jackson 2006</a>; <a href="./references#CD011464-bbs2-0008" title="NCT00307216 . Graduated recovery intervention program for enhancing treatment for first‐episode psychosis. clinicaltrials.gov/ct2/show/NCT00307216 (first received 23 March 2006). ">NCT00307216</a>) without establishing if the participants met the diagnostic threshold for PTSD or not. With assistance from the trial authors who provided us with unpublished and/or psychosis data, we were able to include four studies investigating the effects of trauma‐focused psychological therapies for people with co‐morbid psychosis and PTSD ‐ one newly published online in the beginning of 2015 (<a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>); one unpublished (<a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>); and two studies which originally reported data of participants with psychosis together with others diagnosed with non‐psychotic disorder as their primary diagnosis (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>). Nonetheless, these translate into three studies which were included in the comparison of TF‐CBT with usual care/waiting list; and only one study for each of the other comparisons: EMDR with waiting list; TF‐CBT with EMDR; and TF‐CBT with psychoeducation. </p> <p>Our pre‐specified review primary outcome focusing on PTSD symptoms (severity) was reported by the four included studies using well‐established PTSD symptom severity measures, such as CAPS (<a href="./references#CD011464-bbs2-0018" title="BlakeDD , WeathersFW , NagyLM , KaloupekDG , GusmanFD , CharneyDS , et al. The development of a clinician administered PTSD scale. Journal of Traumatic Stress1995;8(1):75‐90. ">Blake 1995</a>) and PTCI (<a href="./references#CD011464-bbs2-0042" title="FoaEB , EhlersA , ClarkDM , TolinDF , OrsilloSM . The Posttraumatic Cognitions Inventory (PTCI): development and validation. Psychological Assessment1999;11:303‐14. ">Foa 1999</a>). However, we detected skewness in many outcome data reported by continuous measures, which limited the scope of analyses. To avoid the pitfall of applying parametric tests to non‐parametric data, we performed analyses grouping the unskewed and skewed data separately and reported these analyses accordingly. We reported the analyses based on unskewed data primarily in the 'Summary of findings' tables, but in the event of no such analyses were available, we reported the analyses drawing on skewed data and downgraded the evidence. When the data were reported as binary outcomes (such as remission or recovery from PTSD as defined by various cut‐off of CAPS scores), we reported the risk ratios. The other primary outcome focusing on quality of life/well‐being had relatively much less data available; and often limited data from solely one study rendered meta‐analysis impossible. This problem also applied to the secondary outcomes including psychotic symptoms and other common concurrent symptoms such as depression and anxiety, whereas continuous outcome data (and often skewed) from one study only were available, limiting the scope and extent of analyses. Unfortunately, there was a distinct lack of data on health economic outcomes. </p> <p>Lastly, as this review includes a couple of newly emerging trials (<a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>), we expect further follow‐up data will become available in due course. </p> <p>Inclusion of trials for this systematic review entailed that study participants reach diagnostic thresholds for both SMI and for PTSD, however it is likely that many of those with SMI have troublesome symptoms relating to trauma without reaching the threshold for a PTSD diagnosis. The automatic exclusion of studies evaluating the effectiveness of psychological interventions for this population is a limitation of this current review. Another possible limitation is that only trauma‐focused therapies were evaluated. It is theoretically possible that other psychological therapies have some efficacy for post‐traumatic symptoms even if not specified as such. </p> </section> <section id="CD011464-sec-0200"> <h4 class="title">Applicability</h4> <p>This review identified four RCTs investigating the effectiveness, acceptability and safety of PTSD psychological treatment, in particular TF‐CBT and EMDR, for individuals with co‐morbid SMI and PTSD, a population commonly excluded from studies focusing on the general population with PTSD (<a href="./references#CD011464-bbs2-0017" title="BissonJI , RobertsNP , AndrewM , CooperR , LewisC . Psychological therapies for chronic post‐traumatic stress disorder (PTSD) in adults. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD003388.pub4] ">Bisson 2013</a>; <a href="./references#CD011464-bbs2-0072" title="MorrisonAP , FrameL , LarkinW . Relationships between trauma and psychosis: a review and integration. British Journal of Clinical Psychology2003;42:331‐53. ">Morrison 2003</a>; <a href="./references#CD011464-bbs2-0078" title="National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Adults ‐ Treatment and Management (Clinical Guideline 136). www.nice.org.uk/guidance/cg178/evidence/full‐guideline‐490503565. London: National Collaborating Centre for Mental Health, (accessed 2014). ">NICE 2014</a>). The average profile of the study participants reflects the complexity (such as multiple trauma ranging from childhood to adulthood traumatic experiences) and history of long‐standing illness‐presentation (such as a life‐long diagnosis of psychotic disorder in <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a> and severe PTSD in <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>) of the co‐morbid population. All the included studies recruited participants from the community care settings targeting those receiving routine mental health service, with the PTSD psychological therapies delivered in an outpatient clinic setting. These review findings suggest that individual TF‐CBT including prolonged exposure and EMDR, can potentially be a feasible and safe evidence‐based treatment for the co‐morbid group, as for the general population as recommended by several systematic reviews and treatment guidelines (<a href="./references#CD011464-bbs2-0009" title="Australian Centre for Posttraumatic Mental Health. The Australian Guidelines for the Treatment for Adults with Acute Stress Disorder and Posttraumatic Stress Disorder. Melbourne: ACPMH, 2013. ">ACPMH 2013</a>; <a href="./references#CD011464-bbs2-0017" title="BissonJI , RobertsNP , AndrewM , CooperR , LewisC . Psychological therapies for chronic post‐traumatic stress disorder (PTSD) in adults. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD003388.pub4] ">Bisson 2013</a>; <a href="./references#CD011464-bbs2-0075" title="National Institute for Clinical Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ The Management of PTSD in Adults and Children in Primary and Secondary Care. London: National Collaborating Centre for Mental Health, 2005. ">NICE 2005</a>; <a href="./references#CD011464-bbs2-0077" title="National Institute for Health and Care Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ Evidence Update December 2013 (Evidence Update 49). file:///C:/Users/mszter/Downloads/PTSD+Evidence+Update+December+2013.pdf. London: NICE, (accessed 2013). ">NICE 2013</a>). </p> <p>There are only data from one study for comparing EMDR with waiting list and the head‐to‐head comparisons of trauma‐focused therapies. This has precluded meta‐analyses. While results showed that EMDR was superior than waiting list in reducing PTSD symptom severity, the analyses of the primary outcomes were largely equivocal across TF‐CBT versus EMDR, and, TF‐CBT versus brief psychoeducation. These analyses with limited data should be interpreted with caution, preliminary evidence of comparative effectiveness of TF‐CBT, EMDR and brief psychoeducation is still outstanding. </p> <p>Meanwhile, we identified further factors which may affect the generalisability of the preliminary findings to routine clinical settings. All included studies reported provision of training and ongoing supervision for therapists who were highly skilled in delivering the treatment manuals with specific considerations to the participants' complex presentations. Examples included an initial phase of breathing retraining and psychoeducation in the studies conducted in the USA and the UK (<a href="./references#CD011464-bbs2-0001" title="MueserKT , RosenbergSD , XieH , JankowskiMK , BoltonEE , LuW , et al. A randomized controlled trial of cognitive‐behavioral treatment for posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology2008;76(2):259‐71. [MEDLINE: 18377122] NCT00053690 . Cognitive‐behavioral treatment of PTSD in SMI clients. clinicaltrials.gov/ct2/show/NCT00053690 (first received 4 February 2003). ">Mueser 2008</a>; <a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>), and assessment for treatment adherence to the protocol (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>; <a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>). In addition, all participants who received an intervention also received usual care, which frequently included receipt of multiple services (such as community outreach services, case/care management, psychiatric out‐patient follow‐up and medication treatment), and so it is not possible to determine from this review the effectiveness of trauma‐focused psychological interventions for this co‐morbid patient group, in the absence of support from a multi‐disciplinary mental health service. All the included studies were conducted in the USA and Europe, therefore the results may have limited generalisability to the countries where the systems for delivering mental health care are substantially different. </p> </section> </section> <section id="CD011464-sec-0201"> <h3 class="title" id="CD011464-sec-0201">Quality of the evidence</h3> <p>Apart from Comparison 1 (comparing TF‐CBT with usual care/waiting list) which included three studies, the other three comparisons included only one study respectively, rendering limited data available and precluding meta‐analysis of a number of outcomes. Analyses, with data from a small number of studies and/or participants, should be interpreted with caution, as quite likely, such results are under‐powered. Also, it is worth noting that continuous outcome measures were used to report a good proportion of outcomes which may make interpretation of the differences in score points into clinically meaningful or significant changes difficult (e.g. mean difference between groups, or differences of scores across time points versus recovery). Furthermore, much of the continuous data available for the analyses were found to be skewed, with the study sample size relatively small (n &lt; 200) (<a href="./references#CD011464-bbs2-0071" title='MooreRA , EcclestonC , DerryS , WiffenP , BellBF , StraubeS , et al. "Evidence" in chronic pain ‐ establishing best practice in the reporting of systematic reviews. Pain2010;150:386‐9. '>Moore 2010</a>), further limiting the scope and extent of analyses on outcomes even when data from more than one study were available. We had taken the approach to pooling skewed and unskewed continuous data separately into meta‐analyses, reporting the analysis results separately and prioritising those based on unskewed data. However, in doing so to avoid the pitfall in combining parametric and non‐parametric data together and applying parametric tests on such data, we might have further diffused the already relatively limited data. Hence, the quality of evidence was often rated as low; and on occasions where only analyses based on skewed data were reported in the 'Summary of findings' tables, we had further downgraded the quality of evidence. In view of these problems with the data available, we suggest further updated reviews may consider prioritising the reporting of binary outcomes, such as remission from PTSD. </p> </section> <section id="CD011464-sec-0202"> <h3 class="title" id="CD011464-sec-0202">Potential biases in the review process</h3> <p>We believe the process of searching for studies was thorough. We followed the review protocol strictly in the process of selecting studies for inclusion, data extraction and analysis. In addition, we also contacted a number of trial authors to seek unpublished and subgroup data specific to patients with co‐morbid psychosis and PTSD. We were pleased to have received assistance from many authors who provided further data and clarification on their study design, outcome data and treatment content. Despite the small number of trials included in this review, we were pleased to have been able to include some newly emerging studies. We fully acknowledge the potential conflict of interests which might arise as one of our review authors (JS) was a trial therapist in one of the included trials (<a href="./references#CD011464-bbs2-0003" title="ISRCTN67096137 . The acceptability and effectiveness of cognitive behavioural therapy for the treatment of post‐traumatic stress disorder within schizophrenia. isrctn.com/ISRCTN67096137 (first received 23 April 2010). ">Steel 2010</a>); we took steps throughout the review process to remove JS from the screening of search results, data extraction, 'Risk of bias' assessment and data input procedures involving this study. </p> </section> <section id="CD011464-sec-0203"> <h3 class="title" id="CD011464-sec-0203">Agreements and disagreements with other studies or reviews</h3> <p>NICE published a systematic review on the effectiveness of psychological interventions for trauma in people with psychosis, integral to its guideline recommendations on treatment provision for psychosis and schizophrenia (<a href="./references#CD011464-bbs2-0078" title="National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Adults ‐ Treatment and Management (Clinical Guideline 136). www.nice.org.uk/guidance/cg178/evidence/full‐guideline‐490503565. London: National Collaborating Centre for Mental Health, (accessed 2014). ">NICE 2014</a>). Only one study was included in the NICE review whose search was undertaken in June 2013: <a href="./references#CD011464-bbs2-0007" title="ISRCTN43585723 . Promoting personal recovery from psychosis: a randomised controlled trial in first episode schizophrenia. isrctn.com/ISRCTN43585723 (first received 23 January 2004). JacksonC . Promoting personal recovery from psychosis: a randomised control trial in first episode schizophrenia. National Research Register 2003. JacksonC . Promoting personal recovery from psychosis: a randomised controlled trial in first episode schizophrenia. National Research Register 2001. JacksonC , SmithJ , BirchwoodM , TrowerP , ReidI , TownendM , et al. Preventing the traumatic sequelae of first episode psychosis: a randomised controlled trial. Schizophrenia Research2004;70(1):45‐6. JacksonC , TrowerP , ReidI , SmithJ , BirchwoodM , HallM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post‐psychotic trauma symptoms. Schizophrenia Research2006;86(Suppl 1):S39. JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47(6):454‐62. ">Jackson 2006</a> devised a specific form of cognitive therapy called "cognitive recovery therapy" and investigated its effectiveness in reducing post‐psychotic trauma symptoms, with the primary outcomes of treatment identified as trauma symptoms, depression, and self‐esteem. We had to exclude this study from our review as no PTSD diagnostic threshold was applied to the participants although some might have reached such a threshold if assessed. No other systematic reviews focusing on trauma‐focused psychological interventions for the co‐morbid population were identified. </p> <p>Overall, this review identified some limited preliminary, albeit low‐quality, evidence that supports the safety and feasibility of TF‐CBT for treating PTSD in individuals with psychosis. Existing systematic reviews on psychological therapies for PTSD (e.g. <a href="./references#CD011464-bbs2-0017" title="BissonJI , RobertsNP , AndrewM , CooperR , LewisC . Psychological therapies for chronic post‐traumatic stress disorder (PTSD) in adults. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD003388.pub4] ">Bisson 2013</a>; <a href="./references#CD011464-bbs2-0022" title="BradleyR , GreeneJ , RussE , DutraL , WestenD . A multidimensional meta‐analysis of psychotherapy for PTSD. American Journal of Psychiatry2005;162(2):214‐27. ">Bradley 2005</a>) and current clinical practice guidelines recommend TF‐CBT (including exposure therapy) and/or EMDR as an evidence‐based treatment for PTSD resulting from single‐event trauma in adulthood (<a href="./references#CD011464-bbs2-0009" title="Australian Centre for Posttraumatic Mental Health. The Australian Guidelines for the Treatment for Adults with Acute Stress Disorder and Posttraumatic Stress Disorder. Melbourne: ACPMH, 2013. ">ACPMH 2013</a>; <a href="./references#CD011464-bbs2-0075" title="National Institute for Clinical Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ The Management of PTSD in Adults and Children in Primary and Secondary Care. London: National Collaborating Centre for Mental Health, 2005. ">NICE 2005</a>; <a href="./references#CD011464-bbs2-0077" title="National Institute for Health and Care Excellence. Post‐Traumatic Stress Disorder (PTSD) ‐ Evidence Update December 2013 (Evidence Update 49). file:///C:/Users/mszter/Downloads/PTSD+Evidence+Update+December+2013.pdf. London: NICE, (accessed 2013). ">NICE 2013</a>). However, there is insufficient high‐quality evidence to determine the effectiveness of TF‐CBT for people with co‐morbid SMI and PTSD. This review also identified the first study which investigated the effectiveness and safety of EMDR for the co‐morbid population (<a href="./references#CD011464-bbs2-0004" title="ISRCTN79584912 . Treating Trauma in Psychosis. isrctn.com/ISRCTN79584912 (first received 22 December 2011). deBontPA , van denBergDP , van derVleugelBM , deRoosC , MulderCL , BeckerES , et al. A multi‐site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: Study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials2013;14:151. van denBergDP , deBontPA , van derVleugelBM , deRoosC , deJonghA , VanMinnenA . Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder ‐ a randomised clinical trial. JAMA Psychiatry2015;72(3):259‐67. [DOI: 10.1001/jamapsychiatry.2014.2637] ">van den Berg 2015</a>). EMDR was found to be more beneficial than usual care/waiting list and equivocal to TF‐CBT for individuals with PTSD and psychosis, whilst there were no significant differences reported in adverse events, dropout or loss to follow‐up. The findings of this study suggest that EMDR could potentially be applicable and feasible for people with SMI. Finally, this review also compared brief PTSD psychoeducation with TF‐CBT using psychosis data from one study (<a href="./references#CD011464-bbs2-0002" title="MueserKT , GottliebJD , XieH , LuW , YanosPT , RosenbergSD , et al. Evaluation of cognitive restructuring for post‐traumatic stress disorder in people with severe mental illness. British Journal of Psychiatry2015;206:501‐8. NCT00494650 . Cognitive behavioral treatment for post‐traumatic stress disorder in people with additional serious mental illnesses. clinicaltrials.gov/ct2/show/NCT00494650?term=NCT00494650&amp;rank=1 (first accessed 28 June 2007). ">Mueser 2015</a>), although PTSD psychoeducation is not commonly recommended for PTSD in the general population. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011464-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011464-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt=",Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011464-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>,Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011464-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 1 PTSD symptom severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor)." data-id="CD011464-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 1 PTSD symptom severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 2 PTSD symptom severity: 1a. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data." data-id="CD011464-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 2 PTSD symptom severity: 1a. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 3 PTSD symptom severity: 2. Self‐reported trauma‐related cognition ‐ average endpoint PTCI total score (high = poor)." data-id="CD011464-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 3 PTSD symptom severity: 2. Self‐reported trauma‐related cognition ‐ average endpoint PTCI total score (high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 4 PTSD symptom severity: 3. Self‐reported frequency of PTSD symptoms ‐ average endpoint PSS‐SR total score (high = poor) ‐ skewed data." data-id="CD011464-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 4 PTSD symptom severity: 3. Self‐reported frequency of PTSD symptoms ‐ average endpoint PSS‐SR total score (high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 5 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40." data-id="CD011464-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 5 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 6 PTSD symptom severity: 5. Recovery from PTSD: Asymptomatic or few symptoms ‐ CAPS total score &lt; 20." data-id="CD011464-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 6 PTSD symptom severity: 5. Recovery from PTSD: Asymptomatic or few symptoms ‐ CAPS total score &lt; 20. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 7 Quality of life: 1. General quality of life ‐ average endpoint QLS total score (high = good)." data-id="CD011464-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 7 Quality of life: 1. General quality of life ‐ average endpoint QLS total score (high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 8 Quality of life: 2. Overall functioning ‐ average endpoint GAF total score (high = good)." data-id="CD011464-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 8 Quality of life: 2. Overall functioning ‐ average endpoint GAF total score (high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 9 Quality of life: 3. Mental health functioning ‐ average endpoint SF‐12 mental component total score (high = good)." data-id="CD011464-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 9 Quality of life: 3. Mental health functioning ‐ average endpoint SF‐12 mental component total score (high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 10 Quality of life: 4. Physical functioning ‐ average endpoint SF‐12 physical component total score (high = good)." data-id="CD011464-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 10 Quality of life: 4. Physical functioning ‐ average endpoint SF‐12 physical component total score (high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 11 Symptoms of co‐morbid psychosis: 1. Overall mental state ‐ average endpoint BPRS total score (high = poor)." data-id="CD011464-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 11 Symptoms of co‐morbid psychosis: 1. Overall mental state ‐ average endpoint BPRS total score (high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 12 Symptoms of co‐morbid psychosis: 2. Positive symptoms ‐ average endpoint PANSS positive subscale total score (high = poor)." data-id="CD011464-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 12 Symptoms of co‐morbid psychosis: 2. Positive symptoms ‐ average endpoint PANSS positive subscale total score (high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 13 Symptoms of co‐morbid psychosis: 4. Negative symptoms ‐ average endpoint PANSS negative subscale total score (high = poor)." data-id="CD011464-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 13 Symptoms of co‐morbid psychosis: 4. Negative symptoms ‐ average endpoint PANSS negative subscale total score (high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 14 Symptoms of co‐morbid psychosis: 3. Hallucinations ‐ average endpoint PSYRATS‐hallucinations subscale total score (high = poor) ‐ skewed data." data-id="CD011464-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 14 Symptoms of co‐morbid psychosis: 3. Hallucinations ‐ average endpoint PSYRATS‐hallucinations subscale total score (high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 15 Symptoms of co‐morbid psychosis: 5. Delusions ‐ average endpoint PSYRATS‐delusions subscale total score (high = poor) ‐ skewed data." data-id="CD011464-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 15 Symptoms of co‐morbid psychosis: 5. Delusions ‐ average endpoint PSYRATS‐delusions subscale total score (high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 16 Anxiety symptoms: 1a. average endpoint BAI total score (high = poor)." data-id="CD011464-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 16 Anxiety symptoms: 1a. average endpoint BAI total score (high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 17 Anxiety symptoms: 1b. average endpoint BAI total score (high = poor) ‐ skewed data." data-id="CD011464-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 17 Anxiety symptoms: 1b. average endpoint BAI total score (high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 18 Depressive symptoms: 1. average endpoint BDI‐II total (high = poor) ‐ skewed data." data-id="CD011464-fig-0021" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 18 Depressive symptoms: 1. average endpoint BDI‐II total (high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 19 Adverse events ‐ incidents of unspecified severe adverse events." data-id="CD011464-fig-0022" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 19 Adverse events ‐ incidents of unspecified severe adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 20 Leaving the study early." data-id="CD011464-fig-0023" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 TF‐CBT versus WAITING LIST/TAU, Outcome 20 Leaving the study early.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 EMDR versus WAITING LIST, Outcome 1 PTSD symptom severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data." data-id="CD011464-fig-0024" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 EMDR versus WAITING LIST, Outcome 1 PTSD symptom severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 EMDR versus WAITING LIST, Outcome 2 PTSD symptom severity: 2. Self‐reported trauma‐related cognition ‐ average endpoint PTCI total score (high = poor)." data-id="CD011464-fig-0025" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 EMDR versus WAITING LIST, Outcome 2 PTSD symptom severity: 2. Self‐reported trauma‐related cognition ‐ average endpoint PTCI total score (high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 EMDR versus WAITING LIST, Outcome 3 PTSD symptom severity: 3. Self‐reported frequency of PTSD symptoms ‐ average endpoint PSS‐SR total score (high = poor) ‐ skewed data." data-id="CD011464-fig-0026" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 EMDR versus WAITING LIST, Outcome 3 PTSD symptom severity: 3. Self‐reported frequency of PTSD symptoms ‐ average endpoint PSS‐SR total score (high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 EMDR versus WAITING LIST, Outcome 4 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40." data-id="CD011464-fig-0027" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 EMDR versus WAITING LIST, Outcome 4 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 EMDR versus WAITING LIST, Outcome 5 PTSD symptom severity: 5. Recovery from PTSD: Asymptomatic or few symptoms ‐ CAPS total score &lt; 20." data-id="CD011464-fig-0028" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 EMDR versus WAITING LIST, Outcome 5 PTSD symptom severity: 5. Recovery from PTSD: Asymptomatic or few symptoms ‐ CAPS total score &lt; 20. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 EMDR versus WAITING LIST, Outcome 6 Adverse events ‐ incidents of unspecified severe adverse events." data-id="CD011464-fig-0029" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 EMDR versus WAITING LIST, Outcome 6 Adverse events ‐ incidents of unspecified severe adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 EMDR versus WAITING LIST, Outcome 7 Leaving the study early." data-id="CD011464-fig-0030" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 EMDR versus WAITING LIST, Outcome 7 Leaving the study early.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 TF‐CBT versus EMDR, Outcome 1 PTSD symptom severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data." data-id="CD011464-fig-0031" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 TF‐CBT versus EMDR, Outcome 1 PTSD symptom severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 TF‐CBT versus EMDR, Outcome 2 PTSD symptom severity: 2. Self‐reported trauma‐related cognition ‐ average endpoint PTCI total score (high = poor)." data-id="CD011464-fig-0032" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 TF‐CBT versus EMDR, Outcome 2 PTSD symptom severity: 2. Self‐reported trauma‐related cognition ‐ average endpoint PTCI total score (high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 TF‐CBT versus EMDR, Outcome 3 PTSD symptom severity: 3. Self‐reported frequency of PTSD symptoms ‐ average endpoint PSS‐SR total score (high = poor) ‐ skewed data." data-id="CD011464-fig-0033" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 TF‐CBT versus EMDR, Outcome 3 PTSD symptom severity: 3. Self‐reported frequency of PTSD symptoms ‐ average endpoint PSS‐SR total score (high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 TF‐CBT versus EMDR, Outcome 4 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40." data-id="CD011464-fig-0034" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 TF‐CBT versus EMDR, Outcome 4 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 TF‐CBT versus EMDR, Outcome 5 PTSD symptom severity: 5. Recovery from PTSD: Asymptomatic or few symptoms ‐ CAPS total score &lt; 20." data-id="CD011464-fig-0035" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 TF‐CBT versus EMDR, Outcome 5 PTSD symptom severity: 5. Recovery from PTSD: Asymptomatic or few symptoms ‐ CAPS total score &lt; 20. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 1 PTSD symptom severity: 1a. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor)." data-id="CD011464-fig-0036" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 1 PTSD symptom severity: 1a. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 2 PTSD symptom severity: 1b. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data." data-id="CD011464-fig-0037" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 2 PTSD symptom severity: 1b. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 3 PTSD symptom severity: 2. Self‐reported trauma‐related cognition ‐ average endpoint PTCI total score (high = poor)." data-id="CD011464-fig-0038" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 3 PTSD symptom severity: 2. Self‐reported trauma‐related cognition ‐ average endpoint PTCI total score (high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 4 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40." data-id="CD011464-fig-0039" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 4 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 5 PTSD symptom severity: 5. Remission from severe PTSD: Loss of severe PTSD diagnosis ‐ CAPS total score &lt; 65." data-id="CD011464-fig-0040" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 5 PTSD symptom severity: 5. Remission from severe PTSD: Loss of severe PTSD diagnosis ‐ CAPS total score &lt; 65. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 6 Quality of life: 1. General quality of life ‐ average endpoint QoLI total score (high = good)." data-id="CD011464-fig-0041" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 6 Quality of life: 1. General quality of life ‐ average endpoint QoLI total score (high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 7 Quality of life: 2. Overall functioning ‐ average endpoint GAF total score (high = good)." data-id="CD011464-fig-0042" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 7 Quality of life: 2. Overall functioning ‐ average endpoint GAF total score (high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011464-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/urn:x-wiley:14651858:media:CD011464:CD011464-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_t/tCD011464-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 8 Quality of life: 3. Social functioning ‐ average endpoint CAPS social functioning subscale total score (high = poor) ‐ skewed data." data-id="CD011464-fig-0043" src="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Individual TF‐CBT versus brief PTSD psychoeducation, Outcome 8 Quality of life: 3. Social functioning ‐ average endpoint CAPS social functioning subscale total score (high = poor) ‐ skewed data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/media/CDSR/CD011464/image_n/nCD011464-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD011464-tbl-0005"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Suggested design for future studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation: randomised, full explicit description of methods of randomisation and allocation concealment </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diagnosis: Individuals with schizophrenia or psychosis (ICD or DSM) and co‐morbid PTSD (DSM) </p> <p>N = 450*</p> <p>Age: adolescents and adults</p> <p>Sex: both</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inteventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1. Trauma‐focused cognitive behavioural therapy (modality and format to be specified), n = 150 </p> <p>2. Eye movement desensitisation and reprocessing (or another well‐defined trauma‐focused therapy as a comparative treatment), n = 150 </p> <p>3. Standard care/waiting list, n = 150</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1. PTSD symptoms<br/> 2. Quality of life or well‐being<br/> 3. Psychotic symptoms<br/> 4. Depressive symptoms<br/> 5. Anxiety symptoms<br/> 6. Adverse events<br/> 7. Health economic outcomes </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Notes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>*Powered to be able to identify a difference of 20% between groups for primary outcome with adequate degree of certainty </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>ICD: International Classification of Diseases<br/> DSM: Diagnostic and Statistical Manual of Mental Disorders<br/> PTSD: post‐traumatic stress disorder </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Suggested design for future studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011464-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Individual TF‐CBT compared to waiting list/usual care for PTSD and severe mental illness</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Individual TF‐CBT compared to</b> waiting list<b>/usual care for PTSD and severe mental illness</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Adults with co‐morbid PTSD and SMI<br/> <b>Settings:</b> Community<br/> <b>Intervention:</b> Individual TF‐CBT<br/> <b>Comparison:</b> Waiting list/usual care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Waiting list/usual care</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Individual TF‐CBT </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PTSD symptoms: Clinician‐rated PTSD symptom severity ‐ average endpoint CAPS total score (high = poor) ‐ short term (6 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean clinician‐rated PTSD symptom severity ‐ average endpoint caps total score (high = poor) ‐ short term ‐ unskewed data in the intervention groups was<br/> <b>13.15 higher</b> <br/> (4.09 lower to 30.39 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other data available for this outcome were skewed.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life: 1. General quality of life ‐ average endpoint QLS total score (high = good) ‐ medium term</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The average endpoint QLS total score ‐ medium term (10‐12 months) in the intervention groups was <b>0.60 lower</b> <br/> (4.47 lower to 3.27 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptoms of co‐morbid psychosis: 1. Overall mental state ‐ average endpoint BPRS total score (high = poor) ‐ medium term</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall mental state ‐ average endpoint BPRS total score (high = poor) ‐ medium term, in the intervention groups was<br/> <b>6.93 lower</b> <br/> (34.17 lower to 20.31 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anxiety symptoms ‐ average endpoint BAI total score (high = poor) ‐ medium term (12 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean anxiety symptoms in the intervention groups was<br/> <b>12.57 higher</b> <br/> (5.54 lower to 30.68 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depressive symptoms ‐ average endpoint BDI‐II total (high = poor) ‐ medium term (12 months) ‐ skewed data</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean depressive symptoms ‐ average endpoint BDI‐II total (high = poor) in the intervention groups was<br/> <b>3.26 higher</b> <br/> (3.66 lower to 10.18 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48<br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No unskewed data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Adverse events ‐ incidents of unspecified severe adverse events ‐ medium term</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>100<br/> (1 study) </p> <p><b>RR (0.44) CI 0.09 to 2.31</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b> <br/> (8 to 197) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b> <br/> (8 to 196) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Health economics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Indirectness: downgraded by one level to 'serious' ‐ continuous measure with a wide score range used which may not reflect clinical significant change accurately.<br/> <sup>2</sup> Imprecision: downgraded by one level to 'serious' ‐ only one study with a small sample size (or subgroup sample size) provides data for this outcome.<br/> <sup>3</sup> Imprecision: downgraded by one level to 'serious' ‐ all available data from 2 studies were skewed. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Individual TF‐CBT compared to waiting list/usual care for PTSD and severe mental illness</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011464-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">EMDR compared to waiting list/usual care for PTSD and severe mental illness</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>EMDR compared to</b> waiting list<b>/usual care for PTSD and severe mental illness</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Adults with co‐morbid PTSD and SMI<br/> <b>Settings:</b> Community<br/> <b>Intervention:</b> EMDR<br/> <b>Comparison:</b> Waiting list </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Waiting list</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> EMDR </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PTSD symptom severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ Medium term ‐ skewed data</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean clinician‐rated PTSD symptom severity ‐ average endpoint caps total score (high = poor) ‐ medium term (7‐9 months) ‐ skewed data in the intervention groups was<br/> <b>12.31 lower</b> <br/> (22.72 to 1.90 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only available data were skewed.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life: 1. General quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptoms of co‐morbid psychosis: 1. Overall mental state</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anxiety symptoms</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depressive symptoms</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Adverse events ‐ incidents of unspecified severe adverse events ‐ medium term</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>102<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> <br/> (2 to 157) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> <br/> (2 to 157) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Health economics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Only data available were skewed.<br/> <sup>2</sup> Continuous measure with a wide score range used which may not reflect clinical significant change accurately.<br/> <sup>3</sup> Only one study provided data on this outcome. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">EMDR compared to waiting list/usual care for PTSD and severe mental illness</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011464-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Individual TF‐CBT compared to EMDR for PTSD and severe mental illness</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Individual TF‐CBT compared to EMDR for PTSD and severe mental illness</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Adults with co‐morbid PTSD and SMI<br/> <b>Settings:</b> Community<br/> <b>Intervention:</b> TF‐CBT<br/> <b>Comparison:</b> EMDR </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> EMDR</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> TF‐CBT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PTSD symptom severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ Medium term ‐ skewed data</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean clinician‐rated PTSD symptom severity ‐ average endpoint caps total score (high = poor) ‐ medium term (7‐9 months) ‐ skewed data in the intervention groups was<br/> <b>1.69 lower</b> <br/> (12.61 lower to 9.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only data available were skewed.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life: 1. General quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptoms of co‐morbid psychosis: 1. Overall mental state</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anxiety symptoms</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depressive symptoms</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events ‐ incidents of unspecified severe events ‐ medium term</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary review outcomes not analysed in this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Health economics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Only one study provided data which were skewed.<br/> <sup>2</sup> Continuous outcome measure with a wide score range was used, score changes may not reflect meaningful clinical changes. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Individual TF‐CBT compared to EMDR for PTSD and severe mental illness</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011464-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Individual TF‐CBT compared to Brief PTSD psychoeducation for PTSD and severe mental illness</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Individual TF‐CBT compared to Brief PTSD psychoeducation for PTSD and severe mental illness</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Adults with co‐morbid PTSD and SMI<br/> <b>Settings:</b> Community<br/> <b>Intervention:</b> Individual TF‐CBT versus brief PTSD psychoeducation<br/> <b>Comparison:</b> Brief PTSD psychoeducation </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Brief PTSD psychoeducation</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Individual TF‐CBT versus brief PTSD psychoeducation</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PTSD symptom severity: 1. Clinician‐rated PTSD severity ‐ average endpoint CAPS total score (high = poor) ‐ Medium term</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean clinician‐rated PTSD symptom severity ‐ average endpoint caps total score (high = poor) ‐ medium term (10‐12 months) ‐ unskewed data in the intervention groups was<br/> <b>0.23 higher</b> <br/> (14.66 lower to 15.12 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life: 1. General quality of life ‐ average endpoint QoLI total score (high = good) ‐ Long term</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life: (a) general quality of life ‐ average endpoint QoLI total score (high = good) ‐ long term (16‐18 months) ‐ unskewed data in the intervention groups was<br/> <b>0.11 higher</b> <br/> (0.74 lower to 0.96 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptoms of co‐morbid psychosis: 1. Overall mental state</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary review outcomes not analysed in this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anxiety symptoms</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary review outcomes not analysed in this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depressive symptoms</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Secondary review outcomes not analysed in this comparison.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events ‐ incidents of unspecified severe adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Health economics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Only data from one study with small subgroup sample available.<br/> <sup>2</sup> Continuous measure used which may not reflect clinical significant change accurately. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Individual TF‐CBT compared to Brief PTSD psychoeducation for PTSD and severe mental illness</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/full#CD011464-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011464-tbl-0010"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Differences between protocol and review</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Protocol stated comparisons as:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>The current review states comparisons as:</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We will conduct separate analyses focusing on each category of active psychological interventions based on a shared modality and format of delivery (i.e. TF‐CBT ‐ individual or group based, EMDR, or any psychological intervention for PTSD), comparing them to all the control conditions pooled together. If there are sufficient data extracted from included studies, we will then proceed to analyse each category of active psychological intervention targeting PTSD comparing each modality and format of active intervention against: 1) active control conditions (i.e. non‐PTSD focused intervention/s); and 2) usual care/treatment as usual/waiting list, for primary outcomes. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We conducted separate analyses focusing on each category of active psychological interventions based on a shared modality and format of delivery (i.e. TF‐CBT ‐ individual or group based, EMDR, or any psychological intervention for PTSD), comparing them to all the control conditions pooled together. Whenever there were sufficient data extracted from included studies, we then proceeded to analyse each category of active psychological intervention targeting PTSD comparing each modality and format of active intervention against: 1) active control conditions (i.e. non‐PTSD focused intervention/s); 2) usual care/treatment as usual/waiting list; and 3) other modality and format of active intervention, for primary outcomes. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>EMDR: eye movement desensitisation and reprocessing<br/> PTSD: post‐traumatic stress disorder<br/> TF‐CBT: trauma‐focused cognitive behavioural therapy </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Differences between protocol and review</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/information#CD011464-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011464-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">TF‐CBT versus WAITING LIST/TAU</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 PTSD symptom severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.15 [‐4.09, 30.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.15 [‐4.09, 30.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 PTSD symptom severity: 1a. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 short term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.44 [‐29.15, 14.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 medium term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.92 [‐19.25, 11.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 PTSD symptom severity: 2. Self‐reported trauma‐related cognition ‐ average endpoint PTCI total score (high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.45 [‐33.61, 22.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.25 [‐29.48, ‐1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 PTSD symptom severity: 3. Self‐reported frequency of PTSD symptoms ‐ average endpoint PSS‐SR total score (high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 short term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.51 [‐13.84, ‐5.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 medium term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.52 [‐12.06, ‐2.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.99 [1.20, 3.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.57, 3.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 PTSD symptom severity: 5. Recovery from PTSD: Asymptomatic or few symptoms ‐ CAPS total score &lt; 20 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.43 [1.37, 14.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.14 [1.27, 13.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Quality of life: 1. General quality of life ‐ average endpoint QLS total score (high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.0 [‐8.26, 2.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐4.47, 3.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Quality of life: 2. Overall functioning ‐ average endpoint GAF total score (high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [‐4.61, 6.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.70 [‐3.32, 8.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Quality of life: 3. Mental health functioning ‐ average endpoint SF‐12 mental component total score (high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.89 [‐23.35, 3.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.96 [‐28.15, 32.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Quality of life: 4. Physical functioning ‐ average endpoint SF‐12 physical component total score (high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [‐16.35, 18.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.52 [‐25.64, 20.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Symptoms of co‐morbid psychosis: 1. Overall mental state ‐ average endpoint BPRS total score (high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [‐9.96, 11.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.93 [‐34.17, 20.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Symptoms of co‐morbid psychosis: 2. Positive symptoms ‐ average endpoint PANSS positive subscale total score (high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.0 [‐5.07, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.40 [‐4.42, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Symptoms of co‐morbid psychosis: 4. Negative symptoms ‐ average endpoint PANSS negative subscale total score (high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.40 [‐4.19, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐3.38, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Symptoms of co‐morbid psychosis: 3. Hallucinations ‐ average endpoint PSYRATS‐hallucinations subscale total score (high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 short term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.80 [‐3.88, 9.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 medium term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐7.48, 6.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Symptoms of co‐morbid psychosis: 5. Delusions ‐ average endpoint PSYRATS‐delusions subscale total score (high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 short term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐4.73, 3.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 medium term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.30 [‐6.22, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Anxiety symptoms: 1a. average endpoint BAI total score (high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.20 [‐7.52, 15.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.57 [‐5.54, 30.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Anxiety symptoms: 1b. average endpoint BAI total score (high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.41 [‐6.90, 6.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 Short term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [‐7.02, 11.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 medium term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐12.36, 6.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Depressive symptoms: 1. average endpoint BDI‐II total (high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 short term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [‐5.81, 8.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 medium term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.26 [‐3.66, 10.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Adverse events ‐ incidents of unspecified severe adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.09, 2.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.38, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.46, 1.40]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">TF‐CBT versus WAITING LIST/TAU</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011464-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">EMDR versus WAITING LIST</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 PTSD symptom severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Short term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.32 [‐25.99, ‐4.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Medium term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.31 [‐22.72, ‐1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 PTSD symptom severity: 2. Self‐reported trauma‐related cognition ‐ average endpoint PTCI total score (high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐23.27 [‐38.50, ‐8.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐20.66 [‐36.72, ‐4.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 PTSD symptom severity: 3. Self‐reported frequency of PTSD symptoms ‐ average endpoint PSS‐SR total score (high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Short term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.60 [‐13.03, ‐4.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Medium term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.37 [‐12.17, ‐2.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.17 [1.30, 3.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.77 [1.10, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 PTSD symptom severity: 5. Recovery from PTSD: Asymptomatic or few symptoms ‐ CAPS total score &lt; 20 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.56 [0.74, 8.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.28 [0.64, 8.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse events ‐ incidents of unspecified severe adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.02, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.52, 2.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.63, 3.42]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">EMDR versus WAITING LIST</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011464-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">TF‐CBT versus EMDR</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 PTSD symptom severity: 1. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Short term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.94 [‐13.13, 7.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Medium term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.69 [‐12.61, 9.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 PTSD symptom severity: 2. Self‐reported trauma‐related cognition ‐ average endpoint PTCI total score (high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.38 [‐21.17, 14.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Medium term (7‐9 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.05 [‐16.69, 20.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 PTSD symptom severity: 3. Self‐reported frequency of PTSD symptoms ‐ average endpoint PSS‐SR total score (high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Short term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.91 [‐5.18, 3.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Medium term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐5.49, 5.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.69, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.75, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 PTSD symptom severity: 5. Recovery from PTSD: Asymptomatic or few symptoms ‐ CAPS total score &lt; 20 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.73 [0.83, 3.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.82 [0.83, 3.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">TF‐CBT versus EMDR</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011464-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Individual TF‐CBT versus brief PTSD psychoeducation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 PTSD symptom severity: 1a. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.71 [‐10.58, 9.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.45 [‐14.63, 11.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [‐14.66, 15.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 PTSD symptom severity: 1b. Clinician‐rated severity ‐ average endpoint CAPS total score (high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.13 [‐19.45, 15.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Long term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.13 [‐19.45, 15.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 PTSD symptom severity: 2. Self‐reported trauma‐related cognition ‐ average endpoint PTCI total score (high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.64 [‐24.40, 27.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.68 [‐18.64, 34.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.19 [‐10.45, 42.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 PTSD symptom severity: 4. Remission from PTSD: Symptoms below diagnostic threshold ‐ CAPS total score &lt; 40 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.47, 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.79, 5.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.49, 2.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 PTSD symptom severity: 5. Remission from severe PTSD: Loss of severe PTSD diagnosis ‐ CAPS total score &lt; 65 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.64, 2.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.82, 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.3 [0.71, 2.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Quality of life: 1. General quality of life ‐ average endpoint QoLI total score (high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.58 [‐1.35, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐1.03, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.74, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Quality of life: 2. Overall functioning ‐ average endpoint GAF total score (high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.86 [‐6.48, 4.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [‐4.92, 6.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.88 [‐4.93, 8.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Quality of life: 3. Social functioning ‐ average endpoint CAPS social functioning subscale total score (high = poor) ‐ skewed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Short term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐0.86, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Medium term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.61 [‐1.28, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Long term ‐ skewed data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [‐0.46, 0.84]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Individual TF‐CBT versus brief PTSD psychoeducation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011464.pub2/references#CD011464-tbl-0009">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011464.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011464-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011464-note-0007">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011464-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011464-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD011464-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD011464-note-0009">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD011464-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD011464-note-0006">Polski</a> </li> <li class="section-language"> <a class="" href="th#CD011464-note-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011464-note-0002">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD011464-note-0019">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011464\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011464\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011464\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011464\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011464\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011464.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011464.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011464.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011464.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011464.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727303265"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011464.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727303269"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011464.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea8c689999377',t:'MTc0MDcyNzMwMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 